{"idx": 0, "label_json": "{ \"label\": \"False\" }", "question": "What is the gene mutated in the Gaucher disease?", "gold_answer": "glucocerebrosidase", "predicted_answer": "The gene mutated in Gaucher disease is **GBA1**.  \n\n**Answer:** GBA1"}
{"idx": 1, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 2, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "phospholamban", "predicted_answer": "Based on the context, the main regulatory molecule of SERCA2a function in cardiac muscle is **phospholamban**.\n\n**Key evidence from the context:**\n1.  The text explicitly states \"phospholamban-SERCA2a interaction\" as the critical calcium cycling defect in dilated cardiomyopathy.\n2.  It identifies that inhibiting this interaction (via a phospholamban mutant) activates contractility.\n3.  Interfering with the \"phospholamban-SERCA2a interaction\" is proposed as a therapeutic approach.\n\n**Answer:** Phospholamban"}
{"idx": 3, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "S-adenosylmethionine", "predicted_answer": "Answer: S-adenosylmethionine (SAMe)\n\nBased on the context:\n- SAMe feeding increased H3K27me3 (a histone methylation mark)\n- SAMe is a universal methyl donor in biological methylation reactions\n- Histone methyltransferases specifically use SAMe as their methyl donor substrate"}
{"idx": 4, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: stroke"}
{"idx": 5, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "The gene responsible for Mowat-Wilson syndrome is **ZFHX1B**.\n\n**Answer: ZFHX1B**"}
{"idx": 6, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "The disease associated with ectopic expression of the protein encoded by the DUX4 gene is **FSHD** (Facioscapulohumeral Muscular Dystrophy).  \n\nAnswer: FSHD"}
{"idx": 7, "label_json": "{ \"label\": \"True\" }", "question": "Which receptor is targeted by telcagepant?", "gold_answer": "calcitonin gene-related peptide", "predicted_answer": "Based on the provided context, telcagepant targets the **calcitonin gene-related peptide (CGRP) receptor**. This is inferred from established pharmacological knowledge, as telcagepant is a known CGRP receptor antagonist used for migraine treatment. The context itself does not explicitly name the receptor but references telcagepant's distinct mechanism of action compared to ibuprofen (NSAID) and acetaminophen (analgesic), aligning with its role as a CGRP antagonist.  \n\n**Answer: CGRP receptor**"}
{"idx": 8, "label_json": "{ \"label\": \"True\" }", "question": "The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?", "gold_answer": "PD-1", "predicted_answer": "Based on the context, CT-011 is explicitly described as **\"a humanized antibody interacting with PD-1\"**.  \nWhile MK-3475 (pembrolizumab) is not mentioned in this specific context, it is a well-known PD-1 inhibitor.  \n\n**Answer: PD-1**"}
{"idx": 9, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine\n\n**Explanation:**  \nThe context explicitly refers to K201 (the alternative name for JTV519) and its modification (\"dioxole congener\"). While the passage focuses on enhancing its electron donor properties, it confirms K201/JTV519 as the base compound being modified. As established in the prior example (and consistent with known pharmacology), JTV519 (K201) is a derivative of the **1,4-benzothiazepine** class of chemical compounds"}
{"idx": 10, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Answer: Xist RNA"}
{"idx": 11, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "adenosylmethionine", "predicted_answer": "The methyl donor for histone methyltransferases is **S-adenosylmethionine (AdoMet)**.  \n\n*This is derived from the context where AdoMet is explicitly mentioned as a methyl donor for enzymatic reactions (e.g., in the SMM cycle and as a substrate for homocysteine S-methyltransferases), aligning with its established role as the universal methyl donor in histone methylation.*"}
{"idx": 12, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene associated with McLeod syndrome is **XK**.  \n\n**Explanation from the context:**  \n- The molecular analysis identified a mutation in the **XK** gene (a single-base deletion at nucleotide position 1095).  \n- This mutation causes defective Kx protein production, directly linked to the McLeod phenotype"}
{"idx": 13, "label_json": "{ \"label\": \"True\" }", "question": "What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations?", "gold_answer": "Fanconi anemia", "predicted_answer": "Fanconi anemia\n\n**Answer Explanation:**  \nThe context explicitly states that Fanconi anemia (FA) is an autosomal disorder causing genome instability, and patients are sensitive to DNA interstrand crosslinking agents. This sensitivity leads to chromosomal aberrations, bone marrow failure, and cancer predisposition. The FA pathway specifically addresses interstrand crosslink repair, confirming the disease's association with crosslinking agent sensitivity"}
{"idx": 14, "label_json": "{ \"label\": \"True\" }", "question": "What is the name of Bruton's tyrosine kinase inhibitor that can be used for treatment of chronic lymphocytic leukemia?", "gold_answer": "Ibrutinib", "predicted_answer": "Answer: ibrutinib"}
{"idx": 15, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 16, "label_json": "{ \"label\": \"True\" }", "question": "Treatment of which disease was investigated in the MR CLEAN study?", "gold_answer": "acute ischemic stroke", "predicted_answer": "The disease investigated in the MR CLEAN study is **acute ischemic stroke**.  \n\nAnswer: acute ischemic stroke"}
{"idx": 17, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium binding protein of the sarcoplasmic reticulum?", "gold_answer": "Calsequestrin", "predicted_answer": "Answer: calsequestrin"}
{"idx": 18, "label_json": "{ \"label\": \"True\" }", "question": "DX-88 is investigational name of which drug?", "gold_answer": "ecallantide", "predicted_answer": "Answer: ecallantide"}
{"idx": 19, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)"}
{"idx": 20, "label_json": "{ \"label\": \"False\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "Dermatitis herpetiformis", "predicted_answer": "The typical rash associated with gluten is a **papulovesicular rash**.  \n\nAnswer: papulovesicular rash"}
{"idx": 21, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone deficiency is implicated in the Costello syndrome ?", "gold_answer": "growth hormone", "predicted_answer": "Based on the context, the hormone implicated is **insulin**, but the issue is **excess secretion (hyperinsulinism)**, not deficiency.\n\nThe context explicitly states:\n1.  Both patients had **persistent hyperinsulinemic hypoglycemia**.\n2.  This involves **unregulated insulin secretion**.\n3.  Treatment required diazoxide to **stop the unregulated insulin secretion**.\n\nTherefore, the problem is an **excess of insulin**, leading to low blood sugar (hypoglycemia). The context does not describe a hormone deficiency in Costello syndrome related to this endocrine manifestation.\n\n**Answer: Insulin excess (hyperinsulinism)**"}
{"idx": 22, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of Acromicric dysplasia?", "gold_answer": "autosomal dominant", "predicted_answer": "Based on the context, Acromicric dysplasia (AD) follows an **autosomal dominant** mode of inheritance.  \n\nThis is explicitly stated in the context:  \n> *\"We then identified mutations in ADAMTSL2 in the recessive form of GD and a hotspot of mutations in FBN1 in the dominant form of GD and in AD\"*  \n\nAnswer: **Autosomal dominant**"}
{"idx": 23, "label_json": "{ \"label\": \"False\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "phospholamban", "predicted_answer": "Based solely on the provided context, the main regulatory molecule of SERCA2a function in cardiac muscle is **not explicitly named**. The context states:\n\n1.  \"SERCA2 activity is also regulated by **post-translational modifications** including **SUMOylation** and **acetylation**.\"\n2.  It mentions that the review will \"highlight the molecular mechanisms underlying the regulation of SERCA2a activity\".\n\nHowever, the context does **not** specify a single primary regulatory molecule (like phospholamban, which is a common regulator but not mentioned here). It only lists types of modifications (SUMOylation, acetylation) as regulatory mechanisms.\n\nTherefore, the answer from the given text is that the specific main regulatory molecule is **not identified**. The regulation discussed involves **post-translational modifications (SUMOylation and acetylation)**"}
{"idx": 24, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the common hormone abnormality in Williams syndrome (WS) is **subclinical hypothyroidism**, characterized by elevated thyroid-stimulating hormone (TSH) with normal free thyroxine (fT4) levels.  \n\nKey evidence from the context:  \n- 31.5% (29/92 patients) had subclinical hypothyroidism.  \n- No patients had overt hypothyroidism.  \n- Thyroid antibodies were absent, ruling out autoimmune thyroiditis.  \n- Thyroid ultrasound abnormalities (e.g., hypoplasia) were common but did not always correlate with dysfunction.  \n\nThis indicates thyroid hormone regulation (specifically TSH elevation) is a frequent endocrine issue in WS.  \n\n**Answer: Subclinical hypothyroidism (elevated TSH with normal fT4)**"}
{"idx": 25, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Answer: IL-1β"}
{"idx": 26, "label_json": "{ \"label\": \"True\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based on established biomedical knowledge (as the provided context does not specify the exact number):\n\n**Answer: 7**\n\nHumans express multiple TAp73 isoforms generated by alternative splicing at the C-terminus. The primary isoforms are TAp73α, β, γ, δ, ε, ζ, and η"}
{"idx": 27, "label_json": "{ \"label\": \"True\" }", "question": "What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?", "gold_answer": "SECIS", "predicted_answer": "Answer: SECIS (SelenoCysteine Insertion Sequence)"}
{"idx": 28, "label_json": "{ \"label\": \"True\" }", "question": "Which medication should be administered when managing patients with suspected acute opioid overdose?", "gold_answer": "naloxone", "predicted_answer": "Answer: naloxone"}
{"idx": 29, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 30, "label_json": "{ \"label\": \"True\" }", "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?", "gold_answer": "LepChorionDB", "predicted_answer": "Answer: LepChorionDB"}
{"idx": 31, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: facioscapulohumeral muscular dystrophy (FSHD)"}
{"idx": 32, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "Medicarpin", "predicted_answer": "Answer: medicarpin"}
{"idx": 33, "label_json": "{ \"label\": \"False\" }", "question": "What is the name of Bruton's tyrosine kinase inhibitor that can be used for treatment of chronic lymphocytic leukemia?", "gold_answer": "ibrutinib", "predicted_answer": "Based solely on the provided context, **no Bruton's tyrosine kinase inhibitor is mentioned or identified**. The text focuses on lymphocyte cytosolic protein 1 (LCP1) as a membrane-associated antigen and target in CLL, describing research strategies and findings related to LCP1's role in migration. It does not discuss any specific drugs, including Bruton's tyrosine kinase inhibitors.\n\n**Answer:** The context does not specify the name of any Bruton's tyrosine kinase inhibitor"}
{"idx": 34, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: stroke"}
{"idx": 35, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the characteristic hormone abnormality in Pendred syndrome is:\n**Defective thyroid hormone synthesis due to an iodine organification defect.**\n\nThis is evidenced by:\n1.  The explicit measurement of \"iodine organification in the thyroid identified in a test with potassium perchlorate\" (the perchlorate discharge test).\n2.  The association of Pendred syndrome with thyroid dysfunction, specifically an impairment in the process where iodine is incorporated into thyroglobulin to form thyroid hormones (organification).\n3.  While not explicitly stating abnormal T3/T4 levels in the results, the diagnostic protocol includes measuring thyroid hormone levels and focuses on identifying this specific defect in iodine metabolism.\n\nThe characteristic endocrine finding is this **organification defect**, which can lead to goiter and sometimes hypothyroidism"}
{"idx": 36, "label_json": "{ \"label\": \"True\" }", "question": "Which is the process that Conserved noncoding elements mostly regulate?", "gold_answer": "development", "predicted_answer": "Based on the context, Conserved Noncoding Elements (CNEs) are most prominently implicated in regulating **development**.\n\n**Key evidence from the context:**\n> \"some of which have been implicated in the regulation of crucially important processes, **including development**.\"\n\nThe context explicitly identifies development as a crucially important process regulated by CNEs, while no other specific processes are mentioned as primary regulatory targets.\n\nAnswer: **development**"}
{"idx": 37, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)\n\nBased on the context:\n-   The text explicitly states \"Ca²⁺ influx via the reverse of NCX is involved\".\n-   SEA0400 prevents the SNP-induced increase in Ca²⁺ influx, ROS production, ERK/p38 phosphorylation, and cytotoxicity.\n-   The conclusion directly states \"NO activates the NCX through guanylate cyclase/PKG pathway\" and SEA0400 blocks its effects"}
{"idx": 38, "label_json": "{ \"label\": \"False\" }", "question": "Is Rheumatoid Arthritis more common in men or women?", "gold_answer": "women", "predicted_answer": "Based solely on the provided context, **the study does not address or provide information about whether Rheumatoid Arthritis (RA) is more common in men or women.** The research focuses exclusively on comparing disease *expression* (symptoms, lab results, treatment, etc.) between genders in patients *already diagnosed* with early RA. It does not investigate or report the prevalence (how common it is) in either gender.\n\n**Answer:** The context does not provide information on whether RA is more common in men or women"}
{"idx": 39, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 40, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits Factor Xa. \n\nAnswer: Factor Xa"}
{"idx": 41, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: stroke\n\nBased on the context:\n- The study evaluates diagnostic scales (ROSIER and FAST) for identifying stroke and transient ischemic attack (TIA) in emergency departments.\n- ROSIER is explicitly compared as a tool for the \"initial assessment of patients with suspected acute stroke.\"\n- Results and conclusions discuss its performance in diagnosing stroke/TIA versus mimics. \n\nThus, ROSIER is used for **stroke** (including TIA as a stroke-related event)"}
{"idx": 42, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "Na(+)/Ca(2+) exchanger", "predicted_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)  \n\n**Concise Explanation:**  \nSEA0400 is a well-characterized selective inhibitor of the plasma membrane Na⁺/Ca²⁺ exchanger (NCX), which aligns with the context's focus on NCX as a target in glial toxicity"}
{"idx": 43, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: Facioscapulohumeral Muscular Dystrophy (FSHD)  \n\nThe context explicitly states:  \n- FSHD1 (the most common form of Facioscapulohumeral Muscular Dystrophy) is caused by D4Z4 repeat contraction, leading to epigenetic derepression and **variegated expression of DUX4 in skeletal muscle**.  \n- The transgenic mouse model recapitulates **FSHD-specific variegated DUX4 expression** in muscle nuclei.  \n\nThus, ectopic expression of the DUX4-encoded protein is directly associated with FSHD pathogenesis.  \n\n---  \n**Key Evidence from Context:**  \n1. *\"FSHD1 is caused by... variegated expression of DUX4 in skeletal muscle\"*  \n2. *\"FSHD-specific variegated DUX4 expression in sporadic muscle nuclei\"*  \n3. The mouse model is designated *\"for FSHD\"*"}
{"idx": 44, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most widely used model for the study of multiple sclerosis (MS)?", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "predicted_answer": "Answer: EAE"}
{"idx": 45, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits **Factor Xa**.\n\n**Key points from the context supporting this:**\n1.  Betrixaban is classified as a \"new oral anticoagulant\" alongside dabigatran (a direct thrombin inhibitor), rivaroxaban, and apixaban (both direct Factor Xa inhibitors).\n2.  Drugs ending in \"-xaban\" (like rivaroxaban, apixaban, **betrixaban**) are specifically known pharmacologically as direct Factor Xa inhibitors.\n3.  The context discusses its pharmacology, development, and clinical trials for thromboprophylaxis and atrial fibrillation, which are standard indications for Factor Xa inhibitors"}
{"idx": 46, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 47, "label_json": "{ \"label\": \"True\" }", "question": "Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?", "gold_answer": "BRG1", "predicted_answer": "Based on the context, the SWI/SNF protein complex subunit demonstrated to interact with the FANCA gene product is **BRG1**.\n\nThis is directly stated in the context:  \n*\"FANCA was demonstrated to associate with the endogenous SWI/SNF complex\"* and *\"we demonstrated co-localization in the nucleus between transfected FANCA and BRG1\"*"}
{"idx": 48, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context, the receptor evaluated with [18F]altanserin is:\n\n**5-HT2A receptors (5-hydroxytryptamine receptor 2A/Serotonin receptor 2A).**\n\nKey evidence from the context:\n1.  The purpose states: \"Suitability of [18F]altanserin and PET to determine **5-HT2A receptor availability** in the rat brain\".\n2.  The conclusion states: \"[18F]Altanserin PET is a reliable tool for in vivo quantification of **5-HT2AR availability**\".\n3.  The validation (in vivo PET and in vitro autoradiography) specifically targets this receptor type.\n\nAnswer: **5-HT2A receptors**"}
{"idx": 49, "label_json": "{ \"label\": \"True\" }", "question": "LY450139 is investigational name of which drug?", "gold_answer": "Semagacestat", "predicted_answer": "Answer: Semagacestat  \n\n**Explanation:**  \nThe context states that \"Semagacestat\" is in phase III trials. LY450139 is the investigational code name for Semagacestat, an experimental gamma-secretase inhibitor studied for Alzheimer's disease"}
{"idx": 50, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits factor Xa.  \n\nThis is directly indicated in the context:  \n- Betrixaban is classified as a **novel oral anticoagulant** targeting factor Xa.  \n- The text explicitly references \"anticoagulants with anti-Xa activity\" in relation to betrixaban and its reversal agent PRT4445.  \n\n**Answer: Factor Xa**"}
{"idx": 51, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits Factor Xa.  \n\n**Answer:** Factor Xa"}
{"idx": 52, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-synuclein", "predicted_answer": "The antibody used for immunostaining of Lewy bodies is raised against **alpha-synuclein**.  \n\nThis is explicitly stated in the context:  \n- The central amygdaloid nucleus contained **\"anti-alpha-synuclein\"**-positive dystrophic axonal terminals.  \n- The study links Lewy body (LB) formation to alpha-synuclein accumulation, with findings showing proportional relationships between alpha-synuclein-positive neurons and terminal degeneration.  \n\nAdditionally, phosphorylated alpha-synuclein antibodies were used, but the core target for Lewy body identification remains alpha-synuclein"}
{"idx": 53, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", "gold_answer": "aryl hydrocarbon receptor interacting protein", "predicted_answer": "Answer: AIP (aryl hydrocarbon receptor-interacting protein)\n\n**Key point:**  \nThe context states that classical mutations (proto-oncogene/tumor suppressor) account for <5% of *sporadic* pituitary macroadenomas. However, familial isolated pituitary adenoma (FIPA) is specifically associated with **AIP mutations**, which are germline mutations in a tumor suppressor gene. This is established biomedical knowledge consistent with the context's focus on trophic mechanisms and genetic underpinnings of pituitary tumors"}
{"idx": 54, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Mepolizumab?", "gold_answer": "interleukin-5", "predicted_answer": "Answer: interleukin-5 (IL-5)"}
{"idx": 55, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "The context identifies **1** TAp73 isoform among the five N-terminal p73 isoforms measured (TAp73, ΔNp73, ΔN'p73, Ex2p73, Ex2/3p73).\n\nAnswer: 1"}
{"idx": 56, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets **active genes**. Specifically, it repairs the **transcribed strand** of these genes. This is evident from the description of Cockayne syndrome (CS) fibroblasts, which are \"deficient in the transcription-coupled repair (TCR) of active genes,\" contrasting with their proficiency in repairing inactive (bulk) DNA. The study further confirms TCR's role in repairing UV-damaged reporter gene expression in active transcriptional contexts.  \n\n**Answer: Active genes (specifically the transcribed strand)**"}
{"idx": 57, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 58, "label_json": "{ \"label\": \"True\" }", "question": "PBT2 has been tested for which disorder?", "gold_answer": "Alzheimer's disease", "predicted_answer": "Answer: Alzheimer's disease"}
{"idx": 59, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context, the [18F]altanserin PET tracer is used to evaluate **5-HT2A receptors**.\n\nThis is explicitly stated in the context:\n*   \"in cortical brain regions with a high density of **5-HT2A receptors**\"\n*   \"This study demonstrates that [18F]altanserin PET... has very low variability, particularly in larger brain regions with high **5-HT2A receptor** density.\"\n\nAnswer: **5-HT2A receptors**"}
{"idx": 60, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is targeted by Evolocumab?", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "predicted_answer": "Answer: PCSK9 (Proprotein Convertase Subtilisin/Kexin type 9)  \n\n**Explanation:**  \n- Evolocumab is explicitly identified as a **PCSK9 inhibitor** in the context.  \n- PCSK9 is an enzyme that regulates LDL receptor degradation; inhibiting it lowers LDL cholesterol.  \n- The context contrasts PCSK9 inhibitors (evolocumab/alirocumab) with mipomersen (which targets apolipoprotein B mRNA)"}
{"idx": 61, "label_json": "{ \"label\": \"False\" }", "question": "Which deficiency is the cause of restless leg syndrome?", "gold_answer": "iron", "predicted_answer": "Based solely on the provided context, **no specific deficiency is identified as the cause of restless leg syndrome**. The text explicitly states:  \n**\"The etiology is unknown, sometimes it is familial.\"**  \n\nWhile treatments include dopaminergic, opiate, benzodiazepine, anticonvulsant drugs, or clonidine, these address symptoms and not an underlying deficiency. The context does not attribute RLS to any nutritional, hormonal, or biochemical deficiency.  \n\n**Answer:** The context does not specify a deficiency as the cause"}
{"idx": 62, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "The ROSIER scale is used for **acute stroke**.\n\nAnswer: acute stroke"}
{"idx": 63, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "Bcr-Abl", "predicted_answer": "Answer: BCR-ABL"}
{"idx": 64, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Based on the context of Philadelphia chromosome-positive chronic myeloid leukemia (CML), the tyrosine kinase targeted by Imatinib (Gleevec) is:\n\n**BCR-ABL**\n\nThis is the fusion tyrosine kinase resulting from the Philadelphia chromosome translocation, which drives the pathogenesis of CML. Imatinib specifically inhibits its activity"}
{"idx": 65, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 66, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is explicitly identified as a **repressor**.\n\nKey evidence from the context:\n1. Directly stated: \"the transcriptional repressor Bach1\".\n2. Function described: Suppresses ARE transcriptional activity (\"reversed the ARE transcriptional activity suppressed by ectopically expressed Bach1\").\n3. Mechanism: Its repressive function is regulated by redox state (diamide reverses suppression).\n\nAnswer: **Repressor**"}
{"idx": 67, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies is **alpha-synuclein**.  \n\n**Key evidence from the context:**  \n1. The term \"alpha-synucleinopathy\" explicitly defines disorders characterized by abnormal alpha-synuclein deposition.  \n2. Lewy bodies are a hallmark of alpha-synucleinopathies (e.g., Parkinson's disease, dementia with Lewy bodies).  \n3. The context states that accumulations of alpha-synuclein in these disorders share a fibrillar configuration, directly implicating it as the core component.  \n\nNo other protein is described as the primary constituent in Lewy bodies within this text"}
{"idx": 68, "label_json": "{ \"label\": \"False\" }", "question": "Which is the vector of Louping ill virus?", "gold_answer": "Ixodes ricinus", "predicted_answer": "Answer: tick"}
{"idx": 69, "label_json": "{ \"label\": \"True\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based on the context:\n**APOBEC3B is predominantly nuclear.**\n\nExplanation:\n- During interphase, APOBEC3 proteins have distinct localizations: \"cell-wide, cytoplasmic or nuclear.\"\n- The context explicitly states APOBEC3B is among the proteins **excluded from chromatin throughout mitosis**, implying it lacks nuclear access even when the nuclear envelope breaks down.\n- This contrasts with APOBEC3A/C/H, which become cell-wide during telophase and have nuclear access.\n- The conclusion further confirms nuclear access is restricted to specific APOBEC3s (AID, APOBEC3A, and APOBEC3B are highlighted for causing DNA damage and cell cycle alterations, but APOBEC3B's nuclear activity occurs despite its mitotic exclusion)"}
{"idx": 70, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Mepolizumab?", "gold_answer": "interleukin-5", "predicted_answer": "Answer: Interleukin-5 (IL-5)  \n\nMepolizumab is a monoclonal antibody that specifically binds to and inhibits interleukin-5 (IL-5), a cytokine critical for eosinophil growth, differentiation, and survival. This mechanism aligns with the context describing mepolizumab as \"an agent designed to target eosinophils,\" resulting in reduced blood eosinophil counts and corticosteroid-sparing effects in hypereosinophilic syndrome.  \n\n**Key evidence from the context**:  \n- The study achieved sustained eosinophil reduction (<600/μL) in 95% of mepolizumab-treated patients.  \n- The conclusion explicitly states mepolizumab targets eosinophils, which is mediated through IL-5 inhibition.  \n\n*(Note: While the context does not explicitly name IL-5, this targeting mechanism is well-established in biomedical literature and is directly inferred from the described eosinophil-specific effects.)*"}
{"idx": 71, "label_json": "{ \"label\": \"True\" }", "question": "Which methyl-CpG-binding protein when mutant becomes the hallmark for Rett syndrome?", "gold_answer": "methyl-CpG-binding protein 2 (Mecp2)", "predicted_answer": "Answer: Mecp2"}
{"idx": 72, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "dermatitis herpetiformis", "predicted_answer": "Answer: Dermatitis herpetiformis  \n\nKey points from the context:  \n- Dermatitis herpetiformis is directly linked to gluten sensitivity.  \n- It is characterized by a rash with granular IgA deposits in the skin.  \n- The condition is gluten-dependent and associated with celiac disease"}
{"idx": 73, "label_json": "{ \"label\": \"True\" }", "question": "Which drug should be used as an antidote in benzodiazepine overdose?", "gold_answer": "Flumazenil", "predicted_answer": "Answer: flumazenil  \n\n**Explanation:**  \nThe context explicitly states that flumazenil was used as a continuous infusion to reverse chlordiazepoxide (a benzodiazepine) toxicity, preventing resedation and respiratory insufficiency. It further emphasizes that continuous-infusion flumazenil should be considered for managing benzodiazepine toxicity to ensure recovery of respiratory function and mental awareness"}
{"idx": 74, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 75, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is targeted by Evolocumab?", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "predicted_answer": "Based on the context and established biomedical knowledge, Evolocumab targets the enzyme:\n\n**PCSK9 (Proprotein Convertase Subtilisin/Kexin type 9)**\n\n**Explanation:**  \nWhile the context describes the clinical effects of Evolocumab (significant LDL cholesterol reduction), it doesn't explicitly name the target. However, Evolocumab is a well-known monoclonal antibody that specifically binds to and inhibits PCSK9. PCSK9 normally degrades LDL receptors on the liver surface. By inhibiting PCSK9, Evolocumab increases the number of LDL receptors, enhancing clearance of LDL cholesterol from the bloodstream. This mechanism aligns with the significant LDL-C reductions reported in the trial"}
{"idx": 76, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "dermatitis herpetiformis", "predicted_answer": "Based on the context provided, the typical rash associated with gluten is **dermatitis herpetiformis**.\n\n**Explanation:**  \nThe context explicitly contrasts linear IgA disease (LAD) with dermatitis herpetiformis, stating they are \"separate entities.\" It notes that LAD's rash did not respond to a gluten-free diet, whereas dermatitis herpetiformis is a well-established gluten-sensitive disorder characterized by an intensely itchy, blistering skin rash. This rash is the cutaneous manifestation of celiac disease"}
{"idx": 77, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 78, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "DNMT1", "predicted_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNMT1**.  \n\n**Key evidence from the context:**  \n1. The study explicitly examines \"**DNMT1-mediated maintenance DNA methylation**\" in the title and abstract.  \n2. The structural analysis focuses on a \"**mouse DNMT1(731-1602)-DNA complex**\" acting on a **hemimethylated CpG site**, which is the hallmark substrate for maintenance methylation.  \n3. The mechanisms described (e.g., recognition of hemimethylated DNA, autoinhibitory controls) are specific to DNMT1's role in preserving methylation patterns after DNA replication.  \n\nThis distinguishes DNMT1 from *de novo* methyltransferases (e.g., DNMT3A/3B), which establish new methylation patterns"}
{"idx": 79, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "Dnmt1", "predicted_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **Dnmt1**.  \n\n**Key evidence from the context:**  \n- The text explicitly states that \"the de novo methyltransferases, Dnmt3a and Dnmt3b, can also contribute to the maintenance of the methylation pattern\" but emphasizes that \"manipulation of these enzymes, **especially Dnmt1**, provides a means to alter DNA methylation levels.\"  \n- Dnmt1 is classically defined as the *maintenance* methyltransferase, responsible for copying methylation patterns during DNA replication, while Dnmt3a/3b are primarily *de novo* methyltransferases. The context prioritizes Dnmt1 for targeted manipulation of methylation maintenance.  \n\n**Answer:** Dnmt1"}
{"idx": 80, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "Medicarpin", "predicted_answer": "The major phytoalexin in alfalfa (*Medicago sativa* L.) is **medicarpin**.  \nThis is evident from the context, which discusses:  \n- The induction of IOMT (isoflavone-O-methyltransferase) as part of medicarpin biosynthesis.  \n- Medicarpin accumulation following elicitation.  \n- The enzyme's role in methylating precursors (e.g., daidzein, 6a-hydroxymaackiain) en route to medicarpin formation.  \n\n**Answer: Medicarpin**"}
{"idx": 81, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "bcr-abl", "predicted_answer": "Answer: BCR-ABL"}
{"idx": 82, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: factor Xa  \n\n**Explanation:**  \n- The context explicitly states that \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development\" and that they inhibit \"factor Xa\" in the coagulation cascade.  \n- Betrixaban is a known member of this class of drugs (direct factor Xa inhibitors), consistent with the mechanism described in the text"}
{"idx": 83, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na+/Ca2+ exchanger isoform NCX1  \n\nBased on the context:  \n- SEA0400 is explicitly tested as an inhibitor targeting NCX1-mediated retinal cell death.  \n- It reduces damage induced by NMDA, ischemia-reperfusion, and oxygen-glucose deprivation, all linked to NCX1 activity.  \n- The conclusion states NCX1 plays a key role in these pathways, and SEA0400 directly counteracts NCX1-dependent damage"}
{"idx": 84, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context, [18F]altanserin is used to evaluate **5-HT2A receptors**. \n\nKey evidence:  \n1. The study directly compares [18F]altanserin and [18F]MH.MZ for **5-HT2A receptor imaging** with PET.  \n2. Autoradiography experiments confirm binding to 5-HT2A receptors in cortical regions.  \n3. Blocking experiments with ketanserin (a 5-HT2A antagonist) further validate specificity.  \n\nAnswer: 5-HT2A receptors"}
{"idx": 85, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Answer: factor Xa"}
{"idx": 86, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Answer: Interleukin-1 beta (IL-1β)\n\nExplanation:  \nThe context explicitly states gevokizumab is a \"novel IL-1β-neutralizing antibody\" in the CONCLUSIONS section. This directly identifies IL-1β as the targeted molecule. Supporting evidence includes:  \n1. The study objective references IL-1β's role in β-cell failure in type 2 diabetes.  \n2. Biological activity results show reduced inflammation markers (e.g., cytokines) consistent with IL-1β neutralization"}
{"idx": 87, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "The gene mutated in type 1 neurofibromatosis is **NF1** (neurofibromatosis 1 gene).  \n\nAnswer: NF1"}
{"idx": 88, "label_json": "{ \"label\": \"False\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: stroke and transient ischaemic attack (TIA)"}
{"idx": 89, "label_json": "{ \"label\": \"True\" }", "question": "Which medication should be administered when managing patients with suspected acute opioid overdose?", "gold_answer": "naloxone", "predicted_answer": "Based on the context, the medication administered for managing suspected acute opioid overdose is **naloxone**.  \n\nThe study specifically compares intravenous (i.v.) versus subcutaneous (s.q.) administration routes of naloxone (0.4 mg i.v. vs. 0.8 mg s.q.) for treating opioid overdose, concluding no clinical difference in efficacy between the two routes.  \n\n**Answer: naloxone**"}
{"idx": 90, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "XIST", "predicted_answer": "The transcript responsible for X-chromosome inactivation is **Xist**, located within the X-inactivation center (XIC). \n\n*(Note: While the context focuses on the XIC locus and choice mechanisms, Xist is the established non-coding RNA transcript that directly initiates and spreads silencing across the X chromosome, as confirmed by extensive genetic studies beyond this passage.)*"}
{"idx": 91, "label_json": "{ \"label\": \"True\" }", "question": "What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?", "gold_answer": "SECIS", "predicted_answer": "The stem-loop structure present in the 3' end of genes encoding for selenoproteins is the **SECIS element** (SelenoCysteine Insertion Sequence).  \n\nThis is confirmed in the context where the variant 2 transcript of the *SelS* gene contains a SECIS element in its 3'UTR, which is essential for selenocysteine (Sec) incorporation at the UGA codon. The proximal stem-loop and downstream regulatory structures mentioned modulate SECIS activity but do not replace its core function"}
{"idx": 92, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Answer: CYP17A1"}
{"idx": 93, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the antibody used for immunostaining of Lewy bodies is raised against **alpha-synuclein**.\n\nThis is directly stated in the context:  \n*\"Rare neuronal soma in PD brain were immunoreactive for alpha-synuclein\"* and the study characterizes alpha-synuclein expression in PD/DLB brain tissues"}
{"idx": 94, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia chromosome-positive chronic myelogenous leukemia is **BCR-ABL**. \n\nAnswer: BCR-ABL"}
{"idx": 95, "label_json": "{ \"label\": \"True\" }", "question": "What disease is small bowel lymphoma commonly associated with", "gold_answer": "celiac disease", "predicted_answer": "Based on the context, small bowel lymphoma is commonly associated with **celiac disease**. The study specifically identifies MR enterography features that help suggest whether underlying celiac disease is likely in cases of small-bowel lymphoma.  \n\nAnswer: celiac disease"}
{"idx": 96, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene associated with McLeod syndrome is **XK**.  \n\n**Key points from context and background knowledge:**  \n- McLeod syndrome is explicitly described as **X-linked**.  \n- The syndrome is caused by mutations in the **XK gene**, which encodes the Kx blood group antigen.  \n- While the context identifies a specific deletion (938-942delCTCTA), it does not name the gene. Established biomedical knowledge confirms **XK** as the gene mutated in McLeod syndrome.  \n\n**Answer: XK**"}
{"idx": 97, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based on the context, the study measured \"all 5 N-terminal isoforms\" of p73, which are explicitly listed as:  \n1. **TAp73**  \n2. DeltaNp73  \n3. DeltaN'p73  \n4. Ex2p73  \n5. Ex2/3p73  \n\n**Answer: 1**  \n(Only one TAp73 isoform is identified among the five N-terminal isoforms studied)"}
{"idx": 98, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "Answer: ZFHX1B"}
{"idx": 99, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na+/Ca2+ exchanger (NCX1)  \n\nBased on the context:  \n- SEA0400 is explicitly tested as an inhibitor of NCX1, a Na+/Ca2+ exchanger isoform.  \n- It reduces retinal damage in models (NMDA injection, ischemia-reperfusion) where NCX1 dysregulation contributes to cell death.  \n- In RGC-5 cells, SEA0400 counters damage induced by oxygen-glucose deprivation and ouabain (which exacerbates Na+ overload), confirming its role in blocking NCX1-mediated Ca2+ influx.  \n\nThe context consistently identifies NCX1 as the target of SEA0400"}
{"idx": 100, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets the **transcribed strand**.\n\nDirect evidence from the context:  \n*   \"TCR, responsible for maintenance of **transcribed strands**\"  \n*   The context explicitly contrasts TCR (for transcribed strands) with the newly proposed NTSR (non-transcribed strand repair) for the non-transcribed strand in quiescent cells.  \n\nAnswer: **transcribed strand**"}
{"idx": 101, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Answer: serotonin 5-HT2A receptors"}
{"idx": 102, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 103, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene mutated in the Gaucher disease?", "gold_answer": "glucocerebrosidase", "predicted_answer": "Based on the context:\n\n**The gene mutated in Gaucher disease is GBA (glucocerebrosidase gene).**\n\n**Explanation:** The context explicitly states: \"almost 300 mutations in the glucocerebrosidase gene (GBA) have been identified\" and later refers to \"the phenotypic diversity seen in GD\" (Gaucher Disease). GBA encodes the enzyme glucocerebrosidase, and mutations in this gene cause Gaucher disease"}
{"idx": 104, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of Wilson's disease?", "gold_answer": "autosomal recessive", "predicted_answer": "Answer: autosomal recessive"}
{"idx": 105, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the common hormone abnormality in Williams syndrome is **elevated TSH (thyroid-stimulating hormone)**, as explicitly stated:  \n*\"TSH elevation declines with age.\"*  \n\nThe study measured FT3, FT4, and TSH but only identified TSH elevation as a recurring abnormality. No other hormone irregularities (e.g., FT3/FT4) are reported as common findings.  \n\n**Answer: Elevated TSH**"}
{"idx": 106, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "The disease associated with ectopic expression of DUX4 is **Facioscapulohumeral Muscular Dystrophy (FSHD)**.  \n\n**Answer:** Facioscapulohumeral Muscular Dystrophy (FSHD)"}
{"idx": 107, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Based on the context, the transcript responsible for X-chromosome inactivation is **Xist**.\n\n**Reasoning:**  \nThe context explicitly states that the region showing modified methylation lies \"15 kb distal to Xist\" and that this region is proposed to be involved in the initial stages of inactivation. Xist is consistently referenced as the central locus within the X-chromosome inactivation center (Xic), confirming its established role as the non-coding RNA transcript that triggers X-chromosome silencing"}
{"idx": 108, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: factor Xa"}
{"idx": 109, "label_json": "{ \"label\": \"True\" }", "question": "Which type of lung cancer is the most strongly associated with Lambert-Eaton syndrome?", "gold_answer": "small-cell lung cancer", "predicted_answer": "Based on medical knowledge and the context of Lambert-Eaton myasthenic syndrome (LEMS) as a paraneoplastic syndrome:\n\n**Answer: Small cell lung cancer**\n\n**Explanation:**  \n- LEMS is most strongly associated with **small cell lung cancer (SCLC)**, accounting for 50-60% of LEMS cases.  \n- This link exists because SCLC tumor cells express **voltage-gated calcium channels** (specifically P/Q-type), triggering autoantibody production (as mentioned in the context).  \n- The context confirms this association by identifying high-titer anti-P/Q-type VGCC antibodies and noting clinical improvement with cancer-directed therapy.  \n\nWhile other cancers (e.g., lymphoma) may rarely cause LEMS, SCLC is the primary malignancy implicated"}
{"idx": 110, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "Answer: X-linked dystonia-parkinsonism (XDP)"}
{"idx": 111, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "dermatitis herpetiformis", "predicted_answer": "The typical rash associated with gluten is **dermatitis herpetiformis**.  \n\nThis is directly indicated in the context, which studies patients with dermatitis herpetiformis—a chronic, intensely itchy blistering rash triggered by gluten sensitivity. The study confirms this rash is not activated by oats in most cases.  \n\n**Answer: dermatitis herpetiformis**"}
{"idx": 112, "label_json": "{ \"label\": \"True\" }", "question": "Treatment of which disease was investigated in the MR CLEAN study?", "gold_answer": "Acute ischemic stroke", "predicted_answer": "The disease investigated in the MR CLEAN study was **acute ischemic stroke (AIS)**.  \n\nAnswer: acute ischemic stroke"}
{"idx": 113, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits factor Xa.  \n\n**Answer:** Factor Xa"}
{"idx": 114, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Answer: antiparallel"}
{"idx": 115, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Based on the context, the **ROSIER scale** is used for **acute stroke**. \n\nKey evidence from the context:\n1. The scale was developed to differentiate **acute stroke** from stroke mimics in the emergency room (ER).  \n2. It assesses clinical features typical of stroke (e.g., limb weakness, speech disturbance).  \n3. Validation results explicitly state its effectiveness for \"initial differentiation of **acute stroke** from stroke mimics.\"  \n4. The study excluded only asymptomatic TIAs, reinforcing its focus on acute neurological deficits.  \n\nAnswer: **Acute stroke**"}
{"idx": 116, "label_json": "{ \"label\": \"True\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based on the context, APOBEC3B (A3B) is **nuclear**. \n\nKey evidence from the text:  \n1. It undergoes \"active nuclear import\" requiring a specific N-terminal motif (Val54).  \n2. This import mechanism is analogous to the nuclear localization determinant of AID (a nuclear enzyme).  \n3. A3B interacts with the same importin proteins as AID for nuclear translocation.  \n4. The study focuses on mechanisms guiding nuclear import to \"prevent gratuitous chromosomal DNA damage,\" implying nuclear activity.  \n\nThe context emphasizes its nuclear import mechanism and distinguishes it from cytoplasmic retention mechanisms"}
{"idx": 117, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Based on the context provided, pridopidine has been tested for the treatment of **Huntington disease**.\n\nKey evidence from the context:\n1. The title explicitly states: \"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in **patients with Huntington disease**.\"\n2. The objectives section confirms the study investigated metabolic changes in \"**patients with Huntington disease**\" before and after pridopidine treatment.\n3. The methods describe using [(18)F]Fluorodeoxyglucose PET imaging in \"**8 patients with Huntington disease**.\"\n4. Clinical assessments used the **Unified Huntington's Disease Rating Scale**, a specific tool for Huntington disease"}
{"idx": 118, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Answer: repressor"}
{"idx": 119, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based on the context, **one** TAp73 isoform is explicitly identified and discussed. \n\nThe context states:\n*   \"TAp73 possesses pro-apoptotic functions\"\n*   \"TAp73, but not deltaNp73, is covalently modified by NEDD8\"\n*   It consistently refers to \"TAp73\" as a singular entity distinct from \"deltaNp73\".\n\nWhile the context mentions \"various p73 isoforms\" exist due to alternative promoters and splicing (primarily categorized as TA and deltaN), it specifically discusses only **one** TAp73 isoform that undergoes neddylation. It does not mention or imply the existence of multiple distinct TAp73 isoforms.\n\nAnswer: 1"}
{"idx": 120, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa\n\nBetrixaban is a direct oral anticoagulant that specifically inhibits Factor Xa. It belongs to the class of Factor Xa inhibitors, which prevent the conversion of prothrombin to thrombin, thereby reducing clot formation"}
{"idx": 121, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Pridopidine has been tested for the treatment of **Huntington disease**.  \n\n**Answer: Huntington disease**"}
{"idx": 122, "label_json": "{ \"label\": \"True\" }", "question": "Which is the histone residue methylated by MLL1?", "gold_answer": "H3K4", "predicted_answer": "Answer: H3K4"}
{"idx": 123, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone receptor function is altered in patients with Donohue syndrome?", "gold_answer": "insulin", "predicted_answer": "Answer: Insulin receptor\n\nThe context explicitly states that the patient has Donohue syndrome-like features due to novel mutations in the **INSR gene** (insulin receptor gene), specifically within the insulin binding domain. While insulin binding assays showed no impairment in this case, the immunofluorescence studies revealed abnormal distribution of the INSR subunits, confirming dysfunction of the **insulin receptor**. Donohue syndrome (leprechaunism) is defined by severe insulin resistance caused by mutations impairing insulin receptor function"}
{"idx": 124, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most common type of pediatric cerebellar tumor?", "gold_answer": "Medulloblastoma", "predicted_answer": "Answer: medulloblastoma\n\nBased on the context:\n1.  The entire context discusses \"medulloblastoma\" metastatic to the marrow.\n2.  Medulloblastoma is a primary tumor of the cerebellum, specifically the most common malignant pediatric brain tumor.\n3.  It is the most common type of malignant pediatric cerebellar tumor"}
{"idx": 125, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene mutated in the Gaucher disease?", "gold_answer": "glucocerebrosidase", "predicted_answer": "The gene mutated in Gaucher disease is **GBA** (glucocerebrosidase gene).  \n\nAnswer: GBA"}
{"idx": 126, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets the **transcribed strand** of an active gene.\n\n**Key evidence from the context:**\n*   \"Cells deleted for elc1 show normal NER in the **transcribed strand** of an active gene but have no detectable NER in the **non-transcribed strand**.\"\n*   This directly contrasts TCR (which operates on the transcribed strand) with global genomic repair (GGR) (which operates on the non-transcribed strand).\n*   The conclusion states: \"Elc1 has no function in TCR but plays an important role in GGR.\" TCR's function is specifically associated with the transcribed strand"}
{"idx": 127, "label_json": "{ \"label\": \"True\" }", "question": "Which receptor is targeted by telcagepant?", "gold_answer": "calcitonin gene-related peptide", "predicted_answer": "Answer: calcitonin gene-related peptide (CGRP) receptor"}
{"idx": 128, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "predicted_answer": "Answer: AIP"}
{"idx": 129, "label_json": "{ \"label\": \"False\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "DNMT1", "predicted_answer": "Answer: DNMT3B"}
{"idx": 130, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "The gene responsible for Mowat-Wilson syndrome is **ZEB2** (also known as *ZFHX1B* or *SIP1*).\n\n**Key points from the context supporting this:**\n1. The context describes Mowat-Wilson syndrome as a \"multiple congenital anomaly syndrome\" caused by genetic factors.\n2. It explicitly mentions \"68 **deletion/mutation-positive** cases,\" confirming a genetic etiology.\n3. While the context does not name the gene directly, Mowat-Wilson syndrome is definitively caused by heterozygous pathogenic variants (deletions or mutations) in the *ZEB2* gene on chromosome 2q22.3. This is well-established in medical literature"}
{"idx": 131, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?", "gold_answer": "RET", "predicted_answer": "RET"}
{"idx": 132, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the common hormone abnormalities in Williams syndrome are related to thyroid function, specifically:\n\n1.  **Subclinical hypothyroidism** (15% prevalence)\n2.  **Overt hypothyroidism** (10% prevalence)\n\nThese abnormalities are associated with structural thyroid defects (primarily hypoplasia) and occur independently of autoimmune thyroid disease (as thyroid antibodies were negative in all patients).\n\n**Answer:** Subclinical hypothyroidism and overt hypothyroidism"}
{"idx": 133, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Based on the context provided, the mutation associated with McLeod syndrome is in the **XK gene**.  \n\n**Direct Answer:** XK"}
{"idx": 134, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", "gold_answer": "aryl hydrocarbon receptor interacting protein", "predicted_answer": "Answer: AIP\n\nThe context explicitly states: \"Families with AIP mutations present particular problems...\" and discusses the identification of carriers for the R304* AIP mutation, confirming that mutations in the **AIP gene** are implicated in familial isolated pituitary adenoma"}
{"idx": 135, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?", "gold_answer": "RET", "predicted_answer": "The gene frequently mutated in both Multiple Endocrine Neoplasia type 2 (MEN2) and Hirschsprung disease is **RET**.\n\n**Answer: RET**"}
{"idx": 136, "label_json": "{ \"label\": \"False\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the provided context, BACH1 is **not explicitly mentioned**; therefore, the text does not specify whether it functions as an activator or repressor.  \n\nThe context only discusses:  \n- **Hap1** (heme-activated transcription factor in yeast)  \n- **IRR** (iron regulatory protein in bacteria)  \n- **Heme-regulated inhibitor** (eIF2α kinase in reticulocytes)  \n\nFor accuracy: *BACH1 is not addressed in this excerpt*.  \n\n**Expert Note**: Outside this context, BACH1 is widely recognized as a **transcriptional repressor** regulated by heme, but this detail is absent here.  \n\nAnswer: Not specified in the context"}
{"idx": 137, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.  \n\n**Key points from the context:**  \n- The text explicitly discusses **p53**, its regulatory domain (RD), tetramer stabilization, and phosphorylation.  \n- p53 is universally recognized by this epithet due to its role in DNA repair, cell cycle arrest, and apoptosis initiation upon DNA damage.  \n\n**Answer:** p53"}
{"idx": 138, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nKey evidence from the context:\n1. Directly stated: \"transcription repressor Bach1\" (first sentence).\n2. Genetic ablation (removal) of Bach1 **increases** HO-1 expression.\n3. This inverse relationship (removal leads to higher expression) confirms its role as a repressor that normally suppresses HO-1.\n\nAnswer: **Repressor**"}
{"idx": 139, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Based on the context, alpha-spectrin and beta-spectrin subunits form **antiparallel heterodimers**.\n\nThis is explicitly stated in the first sentence of the context:  \n*\"Influence of lateral association on forced unfolding of **antiparallel spectrin heterodimers**.\"*  \n\nThe subsequent discussion of \"lateral heterodimers\" and their unfolding behavior under atomic force microscopy further confirms this structural arrangement"}
{"idx": 140, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits **factor Xa**.\n\n**Key evidence from the context:**  \n1. Betrixaban is explicitly classified as a **novel oral anticoagulant** belonging to the class of **direct factor Xa inhibitors**.  \n2. The context discusses a \"factor Xa decoy\" (PRT4445) being evaluated as a reversal agent for betrixaban, confirming its mechanism targets factor Xa.  \n3. Betrixaban's pharmacokinetic profile aligns with other direct factor Xa inhibitors (e.g., limited renal excretion, minimal CYP450 metabolism).  \n\n*(Answer derived from the classification of betrixaban as a direct factor Xa inhibitor and the context of its reversal agent targeting anti-Xa activity.)*"}
{"idx": 141, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: facioscapulohumeral muscular dystrophy (FSHD)  \n\n**Key evidence from the context:**  \n1. Explicitly states: *\"the aberrantly expressed DUX4 in FSHD\"*  \n2. The entire study focuses on PITX1 as part of FSHD disease mechanisms, with morpholino treatment proposed as a therapeutic strategy extendable to DUX4 suppression in FSHD.  \n\nFSHD is caused by toxic gain-of-function expression of the DUX4 protein in skeletal muscle, leading to progressive muscle degeneration"}
{"idx": 142, "label_json": "{ \"label\": \"True\" }", "question": "Which receptor is targeted by telcagepant?", "gold_answer": "Calcitonin gene-related peptide", "predicted_answer": "Answer: Calcitonin gene-related peptide (CGRP) receptor  \n\nNote: While the context does not explicitly state the targeted receptor, telcagepant is a well-established CGRP receptor antagonist for migraine treatment, as confirmed by its pharmacological class and mechanism of action"}
{"idx": 143, "label_json": "{ \"label\": \"False\" }", "question": "Abnormality in which vertebral region is important in the Bertolotti's syndrome?", "gold_answer": "lumbosacral", "predicted_answer": "The abnormality in Bertolotti's syndrome occurs in the **lumbosacral vertebral region**, specifically involving a transitional vertebra at the L5-S1 junction where an enlarged transverse process (mega-apophysis) forms a pseudoarticulation with the sacrum or ilium. \n\nAnswer: lumbosacral junction"}
{"idx": 144, "label_json": "{ \"label\": \"False\" }", "question": "How is bladder wall thickness measured?", "gold_answer": "ultrasound", "predicted_answer": "Based on the provided context, bladder wall thickness is measured using:\n\n**Automated measurement**\n\nThis is explicitly stated in the conclusion: *\"automated measurement of bladder is here to stay\"* and *\"Standardization of bladder wall and weight measurement\"*. The context emphasizes that new technological developments allow for standardized and automated measurement of bladder wall thickness and weight"}
{"idx": 145, "label_json": "{ \"label\": \"True\" }", "question": "Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?", "gold_answer": "BRG1", "predicted_answer": "Based on the context, the SWI/SNF protein complex subunit demonstrated to interact with the FANCA gene product is **BRG1**.\n\nThis is directly supported by:\n1. \"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"\n2. \"We demonstrated co-localization in the nucleus between transfected FANCA and BRG1.\"\n3. The analysis of BRG1-associated factors in FANCA-mutant cells.\n\nAnswer: **BRG1**"}
{"idx": 146, "label_json": "{ \"label\": \"False\" }", "question": "How many tissue kallikrein genes are present in the human genome?", "gold_answer": "15", "predicted_answer": "Answer: 14  \n\n**Key points from the context:**  \n- The kallikrein locus contains **at least 14 functional hormone response elements**.  \n- The text explicitly refers to the regulation of **\"all kallikreins\"** and the **\"extended kallikrein locus\"** as a unified system.  \n- This number aligns with established genomic knowledge that the human kallikrein family comprises **15 genes (KLK1-KLK15)**, with KLK2-KLK15 forming a steroid-responsive cluster on chromosome 19. The context's focus on steroid regulation and the 14 hormone response elements corresponds to these 14 kallikreins (excluding KLK1, which is less hormonally regulated).  \n\n*Source: Context directly states \"at least 14 functional hormone response elements\" in the kallikrein locus.*"}
{"idx": 147, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Mepolizumab?", "gold_answer": "interleukin-5", "predicted_answer": "Interleukin-5"}
{"idx": 148, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 149, "label_json": "{ \"label\": \"True\" }", "question": "What are the structures formed when keratin molecules come together?", "gold_answer": "intermediate filaments", "predicted_answer": "Answer: intermediate filaments"}
{"idx": 150, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia chromosome-positive chronic myelogenous leukemia is **BCR-ABL**. \n\nThis kinase results from the (9;22) translocation (Philadelphia chromosome), forming the constitutively active BCR-ABL fusion protein that drives CML pathogenesis. Imatinib specifically inhibits its activity"}
{"idx": 151, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Based on the context, SEA0400 is an inhibitor of the **Na⁺/Ca²⁺ exchanger (NCX)**.  \n\nThis is directly supported by:  \n1. The context states that SNP-induced effects (increased intracellular Ca²⁺, ROS production, ERK/p38 phosphorylation) were prevented by SEA0400.  \n2. It explicitly identifies \"Ca²⁺ influx via the reverse of NCX\" as part of the apoptotic cascade and confirms SEA0400 blocks this pathway.  \n\n**Answer: Na⁺/Ca²⁺ exchanger**"}
{"idx": 152, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Answer: Xist"}
{"idx": 153, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 154, "label_json": "{ \"label\": \"False\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "tofacitinib", "predicted_answer": "Based solely on the provided context, **no specific JAK inhibitor is named or identified as approved for rheumatoid arthritis**.\n\n**Explanation:**\n1.  The context discusses a systematic review of **multiple protein kinase inhibitor (PKi) families** used in clinical trials for rheumatoid arthritis (RA), including JAK, SYK, p38, and c-Kit inhibitors.\n2.  It states that 41 articles reported data on **21 PKi** belonging to these families.\n3.  While the JAK family is mentioned as one of the families studied, **the context does not provide the name of any specific JAK inhibitor molecule**.\n4.  The context also does not explicitly state which, if any, of the studied PKi are *approved* for RA treatment; it focuses on summarizing adverse events reported in clinical trials.\n\nTherefore, the specific JAK inhibitor approved for RA treatment is **not identified in the given context excerpt**.\n\n**Answer:** The context does not specify the name of the approved JAK inhibitor"}
{"idx": 155, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "The synonym for Lubag disease is **X-linked dystonia-parkinsonism**.  \n\n**Answer:** X-linked dystonia-parkinsonism"}
{"idx": 156, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "The receptors that can be evaluated with [18F]altanserin are **serotonin 5-HT2A receptors**.  \n\nAnswer: serotonin 5-HT₂A receptors"}
{"idx": 157, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2a", "predicted_answer": "Based on the context, [18F]altanserin is used to evaluate **5-HT2a receptors (5-HT2aR)**. The text explicitly states:\n- \"BP(nd) for [(18)F]altanserin\" reflects \"5-HT2aR interaction\"\n- Changes in BP(nd) are interpreted as changes in \"availability of 5-HT2aR\"\n- The observed effects are attributed to modulation \"by the serotoninergic system via the 5-HT2aR\"\n\nAnswer: **5-HT2a receptors**"}
{"idx": 158, "label_json": "{ \"label\": \"True\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "Tofacitinib", "predicted_answer": "Based on the context provided:\n\n**Answer: tofacitinib**\n\nThe context explicitly states: \"Tofacitinib, a JAK1/JAK3 inhibitor\" and describes its effects on dendritic cell function. Tofacitinib is clinically approved for the treatment of rheumatoid arthritis"}
{"idx": 159, "label_json": "{ \"label\": \"False\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Answer: transcribed strands"}
{"idx": 160, "label_json": "{ \"label\": \"True\" }", "question": "Which is the molecular target of the immunosuppressant drug Rapamycin?", "gold_answer": "mTOR", "predicted_answer": "The molecular target of rapamycin is mTOR (mechanistic Target of Rapamycin).  \n\n**Answer: mTOR**"}
{"idx": 161, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZEB2", "predicted_answer": "The gene responsible for Mowat-Wilson syndrome is **ZEB2**.\n\n**Key evidence from the context:**  \n1. The syndrome description (intellectual disability, epilepsy, facial dysmorphism, Hirschsprung disease, corpus callosum anomalies) matches classic Mowat-Wilson presentation.  \n2. The combination of corpus callosum hypoplasia and histological Hirschsprung disease is a hallmark of MWS, which is caused by heterozygous mutations or deletions in the *ZEB2* gene (also known as *SIP1*).  \n\nThis genetic cause is well-established in medical literature, though not explicitly named in the provided excerpt"}
{"idx": 162, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on medical knowledge and the context provided, the hormone abnormalities commonly associated with Williams syndrome (WBS) include:\n\n1.  **Hypercalcemia (elevated blood calcium levels):** This is a hallmark feature, occurring in approximately 15% of infants/children with WBS, often resolving in childhood.\n2.  **Hypercalciuria (elevated calcium in urine):** More common than hypercalcemia.\n3.  **Thyroid dysfunction:** As illustrated in the context (hypothyroidism due to hypoplasia), thyroid abnormalities, including hypothyroidism, are recognized features.\n4.  **Growth hormone abnormalities:** Short stature is common, and growth hormone deficiency or insensitivity can occur.\n5.  **Precocious puberty:** Early onset of puberty is more frequent than in the general population.\n\n**Direct Answer:** Hypercalcemia, hypercalciuria, thyroid dysfunction (including hypothyroidism), growth hormone abnormalities, and precocious puberty"}
{"idx": 163, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context and biomedical knowledge:\nAnswer: Hypothyroidism and goiter (thyroid enlargement)"}
{"idx": 164, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "The transcript responsible for X-chromosome inactivation is **Xist**.  \n\n**Key evidence from the context**:  \n1. The context explicitly references the *Xist locus* as the critical region in eutherian mammals (e.g., humans, mice) for X-chromosome inactivation.  \n2. *Chic1* and *Slc16a2* flank the *Xist* locus in eutherians, and the region's evolutionary conservation underscores *Xist*'s role.  \n3. *Lnx3* is noted as the evolutionary precursor to *Xist*, further tying *Xist* to the mechanism of X inactivation.  \n\n**Answer: Xist**"}
{"idx": 165, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based on the provided context:\n\n**The text does not specify the exact number of TAp73 isoforms identified in humans.**\n\nWhile it explicitly states that the P1 promoter controls the expression of \"the pro-apoptotic **TAp73 isoforms**\" (plural), indicating there is more than one isoform, it **does not provide a specific number** of how many have been identified.\n\nTherefore, the context confirms the existence of multiple TAp73 isoforms but does not state how many"}
{"idx": 166, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 167, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Based on the context, the transcript responsible for X-chromosome inactivation is **Xist**.\n\nKey evidence from the context:\n- Mutations at the 5' end of the **Xist locus** cause skewed X inactivation.\n- X chromosome choice depends on the balance of **Xist sense transcription** and antisense transcription (Tsix).\n- Ectopic **sense transcription across Xist** correlates directly with nonrandom inactivation"}
{"idx": 168, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene mutation associated with McLeod syndrome is in the **XK gene**.  \n*(McLeod syndrome is an X-linked disorder caused by mutations in the XK gene, leading to the characteristic neuroacanthocytosis phenotype described in the context.)*"}
{"idx": 169, "label_json": "{ \"label\": \"False\" }", "question": "How many clinical trials for off-label drugs in neonates are cited in the literature.", "gold_answer": "0", "predicted_answer": "Based solely on the provided context, **the number of clinical trials for off-label drugs in neonates is not mentioned or cited.** The context focuses on Paediatric Investigation Plans (PIPs) submitted for pain medications and their outcomes (e.g., waivers, withdrawals, decisions), but does not reference specific clinical trials for off-label neonatal use.\n\n**Answer:** The context does not provide this information"}
{"idx": 170, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: Stroke\n\nBased on the context:\n1.  The context explicitly states that the ROSIER scale is an **\"adult stroke recognition tool\"**.\n2.  The study's objective was to assess the applicability of **\"adult stroke scales\"** (including ROSIER) in childhood arterial ischemic stroke (AIS).\n3.  The results discuss the sensitivity of the ROSIER scale specifically for **radiologically confirmed childhood AIS**.\n4.  The conclusion refers to the ROSIER scale as an **\"adult stroke recognition tool\"** that showed fair to good sensitivity in childhood AIS.\n\nTherefore, the ROSIER scale is fundamentally designed and used for the recognition of **stroke**, specifically in adults, though this study investigated its applicability to children"}
{"idx": 171, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene mutated in the Gaucher disease?", "gold_answer": "Glucocerebrosidase", "predicted_answer": "The gene mutated in Gaucher disease is **GBA**. This gene encodes the enzyme glucocerebrosidase, and its mutations cause the lysosomal storage disorder characteristic of Gaucher disease. \n\n*While the provided context does not explicitly name the gene, this is established biomedical knowledge consistent with the description of \"mutated alleles\" and the disease mechanism referenced in the study.*"}
{"idx": 172, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "Dnmt1", "predicted_answer": "Answer: DNA methyltransferase 1 (Dnmt1)  \n\n**Key points from the context:**  \n1. The study explicitly states it examines \"maintenance methylation by mouse **DNA methyltransferase 1 (Dnmt1)**\".  \n2. Dnmt1 is described as the enzyme responsible for recognizing hemimethylated DNA during replication, a hallmark of maintenance methylation.  \n3. Structural details (e.g., CXXC motif positioning, conformational changes) directly relate to Dnmt1's role in preserving cytosine methylation patterns.  \n\nThis enzyme ensures faithful inheritance of DNA methylation patterns after cell division"}
{"idx": 173, "label_json": "{ \"label\": \"True\" }", "question": "Which is the receptor for substrates of Chaperone Mediated Autophagy?", "gold_answer": "LAMP2A", "predicted_answer": "The receptor for substrates of Chaperone-Mediated Autophagy is **LAMP2A** (Lysosome-Associated Membrane Protein 2A).  \n\n*This is established knowledge consistent with the described process: HSPA8/HSC70 recognizes the substrate motif and delivers it to LAMP2A on the lysosomal membrane for translocation.*"}
{"idx": 174, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "The ROSIER scale is used for **acute stroke**.\n\nBased on the context:\n1.  It is explicitly described as a \"stroke recognition instrument\".\n2.  Its purpose is the \"initial differentiation of acute stroke from stroke mimics in the ER\".\n3.  It was developed and validated specifically on patients with suspected acute stroke admitted from the emergency room.\n4.  The results measure its accuracy in diagnosing stroke (sensitivity, specificity, PPV, NPV for stroke).\n5.  The interpretation states it \"improved the appropriateness of referrals to the **stroke team**\""}
{"idx": 175, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 176, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "Na(+)/Ca(2+) exchanger", "predicted_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)"}
{"idx": 177, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "Medicarpin", "predicted_answer": "The major phytoalexin in alfalfa (*Medicago sativa* L.) is **medicarpin**.  \nThis is evident from the context, which explicitly states that vestitone reductase catalyzes a penultimate step in medicarpin biosynthesis, and transcript/enzyme activity increases directly correlate with medicarpin production in elicited alfalfa tissues.  \n\n**Key evidence from the context:**  \n- Vestitone reductase is the \"penultimate enzyme in **medicarpin** biosynthesis.\"  \n- Elicitor-induced increases in vestitone reductase activity precede \"rapid increases in [...] **medicarpin** biosynthesis.\"  \n- Medicarpin and its conjugate are synthesized in alfalfa roots/nodules, where vestitone reductase transcripts are most abundant.  \n\nAnswer: **medicarpin**"}
{"idx": 178, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context of pendrin's role in thyroid iodide transport and hormone synthesis, the characteristic hormone abnormalities in Pendred syndrome are:\n\n1. **Hypothyroidism** (low levels of thyroid hormones T3/T4)  \n2. **Elevated TSH** (thyroid-stimulating hormone) due to compensatory feedback  \n\nThis results from impaired pendrin-mediated iodide efflux into thyroid follicles, disrupting thyroid hormone synthesis. The context confirms pendrin's critical role in apical iodide transport for hormone production.\n\nAnswer: Hypothyroidism and elevated TSH"}
{"idx": 179, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the exact number of TAp73 isoforms identified in humans is **not specified**.\n\nThe context mentions \"transactivating p73 isoforms (TAp73)\" in plural form and discusses their role, but it does not state how many distinct isoforms have been identified. It focuses on the *functional role* of TAp73 isoforms in chemosensitivity rather than enumerating them"}
{"idx": 180, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, **two** TAp73 isoforms are explicitly identified: **TAp73α** and **TAp73β**.\n\nThe evidence from the text:\n1.  \"...all six p53 isoforms examined can form complexes with **TAp73β**, whereas only Δ133p53α/β/γ isoforms form complex with **TAp73α**.\"\n2.  \"...apoptotic activity of **TAp73β** was augmented...\"\n3.  \"...only three isoforms... stabilize **TAp73β**.\"\n\nThe context mentions only TAp73α and TAp73β. While other isoforms may exist, the text specifically identifies these two"}
{"idx": 181, "label_json": "{ \"label\": \"False\" }", "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "predicted_answer": "Based on the context, the gene implicated in familial isolated pituitary adenoma (FIPA) is:\n\n**AIP**\n\nThe context explicitly states:\n*   \"AIP-mutated FIPA patients\"\n*   References \"phenotypic diversity of AIP-mutated families\"\n*   Discusses \"AIP-negative FIPA families\", confirming AIP is the primary known susceptibility gene.\n\nOther chromosomal loci (11q13, 2p16-12, etc.) are candidate regions for *additional* genes in AIP-negative families"}
{"idx": 182, "label_json": "{ \"label\": \"False\" }", "question": "What is the gold standard treatment for Iatrogenic male incontinence?", "gold_answer": "AUS", "predicted_answer": "Based solely on the provided context, the gold standard treatment for iatrogenic male incontinence **is not explicitly stated.**\n\nThe context describes the study's evaluation of the **Bone-Anchored Sub-Urethral Sling (BAUS)** as a treatment option for this condition. It concludes that BAUS is \"a safe, effective, minimally invasive option\" but does not compare it to other treatments or declare it the gold standard.\n\n**Answer:** The gold standard treatment is not specified in the provided context. The context describes the Bone-Anchored Sub-Urethral Sling (BAUS) as an evaluated option"}
{"idx": 183, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on established biomedical knowledge (as the context does not explicitly state the component), the main component of Lewy bodies is:\n\n**Alpha-synuclein**\n\nLewy bodies are pathological aggregates primarily composed of misfolded alpha-synuclein protein. This is the defining pathological feature of Lewy body diseases, including Parkinson's disease and dementia with Lewy bodies"}
{"idx": 184, "label_json": "{ \"label\": \"True\" }", "question": "Where is the histone variant CENPA preferentially localized?", "gold_answer": "centromeres", "predicted_answer": "Based on the context provided, the histone variant CENPA is preferentially localized at **centromeres**.\n\nKey evidence from the context:\n1. The study examines \"centromeric minor satellite sequences\" and nucleosomal phasing at the centromere.\n2. It references \"centromeric protein gene variant\" and \"centromeric nucleosomal/chromatin level\".\n3. Cenpa-GFP assembles functional kinetochores (structures built on centromeres) that bind centromere-specific proteins.\n4. The research contrasts Cenpa-GFP phenotypes with \"Cenpa null mice,\" confirming its essential centromeric role.\n\nAnswer: **centromeres**"}
{"idx": 185, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Based on the established chemical classification from prior research (as referenced in the provided example context), the answer is:\n\n**1,4-benzothiazepine**\n\n*(Note: While the specific context provided in this query does not repeat the chemical classification, the question directly asks for the group of chemical compounds JTV519 is derived from, which is definitively established as 1,4-benzothiazepine in the biomedical literature and the example context given.)*"}
{"idx": 186, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL tyrosine kinase  \n\n**Explanation:**  \n- Imatinib (Gleevec) specifically inhibits the BCR-ABL tyrosine kinase, which is generated by the Philadelphia chromosome translocation (t(9;22)) in chronic myelogenous leukemia (CML).  \n- The context confirms Imatinib's role as a tyrosine kinase inhibitor for CML treatment, directly implicating BCR-ABL as its target.  \n\n*(Source: Context confirms Imatinib targets the Philadelphia chromosome-associated tyrosine kinase in CML)*"}
{"idx": 187, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits clotting factor Xa.  \n\nAnswer: factor Xa"}
{"idx": 188, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene mutated in the Gaucher disease?", "gold_answer": "glucocerebrosidase", "predicted_answer": "The gene mutated in Gaucher disease is **GBA**.  \n\n**Key evidence from the context**:  \n1. Explicitly mentions \"recombinant GBA alleles in patients with Gaucher disease\".  \n2. Refers to probes targeting \"the GBA gene or pseudogene\" for detecting mutations.  \n3. States that the method identifies \"recombinant alleles in patients with Gaucher disease\", directly linking GBA mutations to the disease.  \n\nGBA encodes the enzyme glucocerebrosidase, and its mutations cause impaired lysosomal lipid metabolism, leading to Gaucher disease"}
{"idx": 189, "label_json": "{ \"label\": \"True\" }", "question": "Mutations in which gene determine response to both erlotinib and gefitinib?", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "predicted_answer": "Answer: EGFR"}
{"idx": 190, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: alpha-synuclein"}
{"idx": 191, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "Dnmt1", "predicted_answer": "Based on the context, the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **Dnmt1** (DNA methyltransferase 1).  \n\n**Key evidence from the context:**  \n- The study specifically uses a \"Dnmt1 knockdown model\" to demonstrate epigenetic silencing.  \n- Sustained Dnmt1 knockdown induces gene reexpression (e.g., *Nnat*) via partial demethylation of CpG islands, directly linking Dnmt1 to methylation maintenance.  \n- Dnmt1 is the primary enzyme responsible for copying DNA methylation patterns during cell division, ensuring epigenetic stability.  \n\n**Answer:** Dnmt1"}
{"idx": 192, "label_json": "{ \"label\": \"False\" }", "question": "Which is the process that Conserved noncoding elements mostly regulate?", "gold_answer": "development", "predicted_answer": "Based on the context, conserved noncoding elements (specifically ultraconserved elements/UCEs) are **regulatory**, meaning they primarily regulate:\n\n**Gene expression**\n\nThis is directly stated in the context: \"many of which are regulatory\" and \"appear to be important regulatory innovations\""}
{"idx": 193, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Answer: 5-HT2A receptors"}
{"idx": 194, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)\n\nThe context explicitly states:\n1. \"inhibiting the NCX with SEA0400\"\n2. \"combining an NCX inhibitor with MEMRI\"\n3. SEA0400 reduces the rate of Mn²⁺ efflux, which is used here as a surrogate for Ca²⁺ efflux via the NCX"}
{"idx": 195, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene mutation associated with McLeod syndrome is **XK**.  \n\n**Key evidence from the context:**  \n1. Explicitly states: \"XK missense mutation\" (first sentence).  \n2. Describes the syndrome as \"X-linked\" and involves \"XK DNA sequence\" analysis.  \n3. Confirms the mutation (E327K) in the XK gene alters the XK protein's function.  \n4. Notes the McLeod phenotype results from this mutated XK protein.  \n\nThis aligns with McLeod syndrome being caused by mutations in the *XK* gene on the X chromosome"}
{"idx": 196, "label_json": "{ \"label\": \"True\" }", "question": "Which is the molecular target of the immunosuppressant drug Rapamycin?", "gold_answer": "mTOR", "predicted_answer": "The molecular target of the immunosuppressant drug Rapamycin is **mTOR (molecular target of rapamycin)**.  \n\nAnswer: mTOR"}
{"idx": 197, "label_json": "{ \"label\": \"False\" }", "question": "Which type of lung cancer is afatinib used for?", "gold_answer": "EGFR-mutant NSCLC", "predicted_answer": "Answer: non-small cell lung cancer (NSCLC)"}
{"idx": 198, "label_json": "{ \"label\": \"True\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "tofacitinib", "predicted_answer": "Answer: tofacitinib"}
{"idx": 199, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits **factor Xa**.\n\n**Key evidence from the context:**  \n1. Betrixaban is classified as a \"novel oral anticoagulant\" targeting factor Xa, similar to other drugs in its class.  \n2. It is explicitly associated with anti-Xa activity, as evidenced by the mention of PRT4445 (a factor Xa decoy) being developed as its reversal agent.  \n3. PRT4445 is described as a \"universal reversal agent for all anticoagulants with anti-Xa activity,\" confirming betrixaban's mechanism"}
{"idx": 200, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?", "gold_answer": "thyroid", "predicted_answer": "Thyroid hormone (TH) concentrations are altered in patients with Allan–Herndon–Dudley syndrome (AHDS). Specifically, MCT8 deficiency disrupts TH transport, leading to:  \n- **Elevated serum triiodothyronine (T3)**  \n- **Reduced serum thyroxine (T4)**  \n\nThis is directly inferred from the context, as MCT8 is a critical thyroid hormone transporter, and its mutations cause impaired TH homeostasis.  \n\n**Answer:** Thyroid hormones (specifically elevated T3 and reduced T4)"}
{"idx": 201, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene most commonly mutated in Tay-Sachs disease?", "gold_answer": "HEXA", "predicted_answer": "The gene most commonly mutated in Tay-Sachs disease is **HEXA**.  \n\n**Key evidence from the context:**  \n- The study explicitly identifies mutations in the **HEXA** gene (e.g., c.814G>A, c.1305C>T).  \n- The research focuses on HEXA cDNA constructs and aberrant HEXA transcripts.  \n- Tay-Sachs disease (TSD) is defined by deficient Hexosaminidase A (Hex A) enzyme activity, directly encoded by HEXA.  \n\n**Background knowledge:**  \nTay-Sachs is an autosomal recessive disorder primarily caused by loss-of-function mutations in **HEXA**, leading to toxic GM2 ganglioside accumulation. Other genes (e.g., HEXB, GM2A) cause related GM2-gangliosidoses but not classic Tay-Sachs.  \n\n**Answer: HEXA**"}
{"idx": 202, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Based on the provided context and the prior example, JTV519 is a derivative of **1,4-benzothiazepine**.\n\n**Direct Answer:** 1,4-benzothiazepine"}
{"idx": 203, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits clotting factor Xa.  \n\n**Key evidence from the context**:  \n1. Betrixaban is described as a novel oral anticoagulant with \"anti-Xa activity.\"  \n2. The reversal agent PRT4445 (a factor Xa decoy) is noted to be universal for anticoagulants targeting factor Xa, including betrixaban.  \n\n**Answer**: Factor Xa"}
{"idx": 204, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits factor Xa.  \n\nAnswer: Factor Xa"}
{"idx": 205, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "JNK", "predicted_answer": "Answer: JNK (c-Jun N-terminal kinase)  \n\n**Explanation:**  \nWhile the provided context does not explicitly name the kinase, c-Jun is a well-established substrate of JNK (a MAP kinase family member). JNK phosphorylates c-Jun at Ser63/73, enhancing its transcriptional activity as part of AP-1. This biochemical mechanism is consistent with the context's focus on c-Jun's role in cell cycle arrest"}
{"idx": 206, "label_json": "{ \"label\": \"False\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "The synonym for lubag disease is **rapid-onset dystonia-parkinsonism (DYT12)**.  \n\n**Key evidence from the context:**  \n- The text explicitly references \"rapid-onset dystonia-parkinsonism locus (DYT12; OMIM*128235)\", which is the clinical designation for lubag disease.  \n- Lubag disease is a historically used term for X-linked dystonia-parkinsonism primarily observed in Filipino populations, now classified as DYT12.  \n\n**Answer:** rapid-onset dystonia-parkinsonism"}
{"idx": 207, "label_json": "{ \"label\": \"False\" }", "question": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?", "gold_answer": "craniosynostosis", "predicted_answer": "Answer: Chiari-I malformation\n\nThe context explicitly states that a Chiari-I malformation of the brain is one of the radiologic findings specific to Shprintzen-Goldberg syndrome, distinguishing it from other syndromes. This is highlighted in the sentence:  \n\"*...an abnormality of the first and second cervical vertebrae, hydrocephalus, dilatation of the lateral ventricles, and a Chiari-I malformation of the brain were found only in the patients with Shprintzen-Goldberg syndrome.*\""}
{"idx": 208, "label_json": "{ \"label\": \"True\" }", "question": "Which protein is affected by dusp8 activation?", "gold_answer": "JNK", "predicted_answer": "The protein affected by DUSP8 (M3/6) activation is **JNK** (c-Jun N-terminal kinase).  \n\n**Key evidence from the context:**  \n- DUSP8 (M3/6) is a phosphatase that directly targets JNK isoforms.  \n- Mutations in DUSP8 delay JNK phosphorylation and activation by arsenite, demonstrating that DUSP8 activity regulates JNK signaling.  \n- The study concludes that DUSP8 phosphorylation attenuates its phosphatase activity, thereby accelerating JNK activation.  \n\n**Answer: JNK**"}
{"idx": 209, "label_json": "{ \"label\": \"True\" }", "question": "Which drug should be used as an antidote in benzodiazepine overdose?", "gold_answer": "flumazenil", "predicted_answer": "Answer: flumazenil\n\n**Key evidence from the context:**  \n- Explicitly identifies flumazenil as \"the benzodiazepine antagonist\"  \n- Demonstrates efficacy: Significantly increased Glasgow Coma Scale (GCS) scores in benzodiazepine-overdosed patients (e.g., from 4.5 to 10.7 within 5 minutes)  \n- Shows specificity: Placebo had no effect, while flumazenil reversed coma when administered after placebo  \n- Notes rapid action: Effects begin within 1-2 minutes of administration  \n- Confirms safety: No adverse reactions or withdrawal symptoms observed"}
{"idx": 210, "label_json": "{ \"label\": \"True\" }", "question": "What is generic name of drug Adempas?", "gold_answer": "Riociguat", "predicted_answer": "Answer: Riociguat"}
{"idx": 211, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "The context does not specify the exact number of TAp73 isoforms identified in humans. It only refers to \"TAp73 isoforms\" in plural form without providing a numerical count.\n\nAnswer: Not specified in the context"}
{"idx": 212, "label_json": "{ \"label\": \"False\" }", "question": "What type of enzyme is peroxiredoxin 2 (PRDX2)?", "gold_answer": "antioxidant", "predicted_answer": "Peroxiredoxin 2 (PRDX2) is a **peroxidase**.  \n\nThis classification is evident from its function in the context:  \n1. It reduces endogenous and exogenous hydrogen peroxide (H₂O₂), a key peroxidase activity.  \n2. It protects cells from oxidative stress by scavenging peroxides, aligning with the enzymatic role of peroxidases.  \n\nAnswer: peroxidase"}
{"idx": 213, "label_json": "{ \"label\": \"True\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based on the functional context provided, APOBEC3B is predominantly **nuclear** for its mutagenic role in breast cancer.\n\n**Reasoning:**\n1.  The context describes APOBEC3B as an enzymatic source of mutation acting on **genomic DNA** (\"mutations occur... throughout the genome\", \"genomic uracil\", \"DNA fragmentation\", \"γ-H2AX accumulation\").\n2.  Its mechanism involves **catalyzing deamination of cytosines in DNA**, leading directly to C-to-T mutations in the genome.\n3.  These mutations occur in the nucleus, requiring the enzyme to access nuclear DNA.\n\nTherefore, while the text doesn't explicitly state \"nuclear\", the described function (deaminating genomic DNA to cause mutations and DNA damage) necessitates that APOBEC3B acts within the nucleus"}
{"idx": 214, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 215, "label_json": "{ \"label\": \"True\" }", "question": "Neurostimulation of which nucleus is used for treatment of dystonia?", "gold_answer": "globus pallidus internus", "predicted_answer": "Answer: globus pallidus internus (GPi)"}
{"idx": 216, "label_json": "{ \"label\": \"True\" }", "question": "Which protein is causing Netherton syndrome?", "gold_answer": "LEKTI", "predicted_answer": "Based on the context, Netherton syndrome is caused by a **deficiency of the LEKTI protein**. \n\nKey evidence from the context:  \n- The study uses a \"LEKTI-deficient mouse model\" of Netherton syndrome.  \n- Ablation of matriptase in LEKTI-deficient mice alleviates disease symptoms, confirming that LEKTI deficiency is the primary defect enabling matriptase to trigger the pathogenic cascade.  \n\nThus, the protein whose absence causes Netherton syndrome is **LEKTI**.  \n\n**Answer: LEKTI**"}
{"idx": 217, "label_json": "{ \"label\": \"True\" }", "question": "Which G protein is essential in the formation and function of lamellipodia?", "gold_answer": "Rac1", "predicted_answer": "The G protein essential for the formation and function of lamellipodia is **Rac1**. \n\n**Key points:**  \n- Rac1 (a Rho-family GTPase) activates the Arp2/3 complex to nucleate branched actin networks, driving lamellipodial protrusion.  \n- It is directly implicated in cell migration, membrane ruffling, and lamellipodia dynamics.  \n\n(Note: The provided context discusses light-activated protein dimerization in *Arabidopsis* and is unrelated to lamellipodia or G proteins. The answer is derived from established cell biology knowledge.)"}
{"idx": 218, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?", "gold_answer": "Clostridium botulinum", "predicted_answer": "The most known bacterium responsible for botulism, including sausage poisoning, is **Clostridium botulinum**.  \n\nAnswer: Clostridium botulinum"}
{"idx": 219, "label_json": "{ \"label\": \"False\" }", "question": "Which deficiency is the cause of restless leg syndrome?", "gold_answer": "iron", "predicted_answer": "Based solely on the provided context, **no specific deficiency is identified as the cause of restless leg syndrome (RLS)**.\n\nThe context describes:\n1.  Primary RLS (often familial).\n2.  Secondary RLS (associated with other conditions, most common in later life onset).\n3.  Treatments (dopaminergic therapies, anti-convulsants, opioids).\n4.  The importance of correcting the underlying problem in secondary RLS.\n\nIt does not mention any specific vitamin, mineral, or other deficiency (like iron deficiency, which is a known association in secondary RLS from broader medical knowledge) as the cause within this excerpt.\n\n**Answer:** The context does not specify a deficiency as the cause of restless leg syndrome"}
{"idx": 220, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Based on the context, SEA0400 is an inhibitor of the **sodium-calcium exchanger (NCX)**.\n\nThe evidence is:\n1.  The context explicitly states it examined the effect of SEA0400 on \"**NCX currents**\".\n2.  It measures changes in inward and outward \"NCX current\" during ischemia/reperfusion.\n3.  SEA0400's effect is studied in relation to intracellular Ca²⁺ overload, a key function regulated by the NCX"}
{"idx": 221, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: stroke"}
{"idx": 222, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of Facioscapulohumeral muscular\ndystrophy (FSHD)?", "gold_answer": "autosomal dominant", "predicted_answer": "The mode of inheritance for Facioscapulohumeral Muscular Dystrophy (FSHD) is **autosomal dominant**.\n\n**Key supporting evidence from the context:**  \n- The diagnosis relies on identifying a deletion in the D4Z4 repeats on chromosome 4q35, consistent with autosomal dominant transmission.  \n- While not explicitly stated here, autosomal dominance is well-established for FSHD in medical literature, where a single mutated allele from one parent suffices to cause the disease.  \n\n*(Note: The provided context emphasizes genetic testing for diagnosis but does not directly state the inheritance pattern. The answer reflects standard medical knowledge about FSHD.)*"}
{"idx": 223, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-Synuclein", "predicted_answer": "Answer: alpha-synuclein"}
{"idx": 224, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.  \n\n**Key points from the context:**  \n1. PTEN is described as **\"a new guardian of the genome\"**, implying it shares this protective role but is not the original \"guardian\".  \n2. The context explicitly states: *\"PTEN is the second most frequently mutated gene in human cancer **after p53\"***, identifying p53 as the primary guardian.  \n\nThus, while PTEN is proposed as a *new* guardian, **p53** retains the classic title of \"the guardian of the genome\".  \n\n**Answer: p53**"}
{"idx": 225, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Answer: Huntington disease"}
{"idx": 226, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK gene"}
{"idx": 227, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based on the context, one TAp73 isoform has been identified in humans. The study explicitly lists \"all 5 N-terminal isoforms\" as TAp73, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73, confirming TAp73 as a single distinct isoform among the five measured.\n\nAnswer: 1"}
{"idx": 228, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of Wilson's disease?", "gold_answer": "autosomal recessive", "predicted_answer": "Answer: autosomal recessive"}
{"idx": 229, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Answer: Interleukin-1β (IL-1β)  \n\n**Key evidence from the context:**  \n1. The context explicitly states that both gevokizumab and canakinumab form binary complexes with IL-1β.  \n2. Gevokizumab's mechanism involves occupying an allosteric site on IL-1β.  \n3. The study compares epitopes on IL-1β targeted by both antibodies.  \n4. IL-1β is identified as the target molecule whose signaling is modulated by these drugs.  \n\nThis directly aligns with the question about Gevokizumab's target molecule"}
{"idx": 230, "label_json": "{ \"label\": \"True\" }", "question": "How is myotonic dystrophy inherited?", "gold_answer": "autosomal dominant", "predicted_answer": "Myotonic dystrophy (both DM1 and DM2) is inherited in an **autosomal dominant** pattern. This means that inheriting a single copy of the mutated gene (either the expanded CTG repeat in *DMPK* for DM1 or the expanded CCTG repeat in *ZNF9* for DM2) from one affected parent is sufficient to cause the disease"}
{"idx": 231, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa**.\n\n**Explanation:**  \nThe context explicitly states that \"direct factor Xa inhibitors\" comprise the largest class of oral anticoagulants in development and describes them as inhibiting factor Xa. Betrixaban is a member of this class of direct factor Xa inhibitors"}
{"idx": 232, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Answer: antiparallel\n\nBased on established structural biology knowledge of spectrin:\n1.  Alpha-spectrin and beta-spectrin subunits associate to form heterodimers.\n2.  Within these heterodimers, the subunits align in an **antiparallel** orientation.\n3.  This antiparallel arrangement allows their triple-helical coiled-coil segments to align correctly, enabling the formation of functional tetramers (head-to-head association of two heterodimers) crucial for the spectrin-based membrane skeleton's flexibility and stability.\n\n*(The provided context focuses on cysteine labeling dynamics under shear stress in the spectrin-actin network and does not explicitly state the subunit orientation. The answer relies on fundamental, well-documented structural knowledge of spectrin heterodimers.)*"}
{"idx": 233, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "The gene mutated in type 1 neurofibromatosis is **NF1**.  \n\n**Directly from the context**:  \n- The mouse model involves mutation of \"two tumour-suppressor genes, **Nf1** and Trp53\".  \n- **Nf1** is the mouse homolog of the human **NF1** gene, which is mutated in neurofibromatosis type 1"}
{"idx": 234, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "DNMT1", "predicted_answer": "Answer: DNMT1"}
{"idx": 235, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context, [18F]altanserin is specifically used to evaluate **serotonin 5-HT2A receptors**.\n\nKey evidence from the context:\n1.  Explicitly stated purpose: \"[18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the **serotonin 5-HT2A receptor**.\"\n2.  Validation: The regional binding values significantly correlated with postmortem autoradiographic studies of **5-HT2A receptors**.\n3.  Specificity: Radiolabeled metabolites of [18F]altanserin were confirmed to *not* bind specifically to the **5-HT2A receptor**.\n\nAnswer: **serotonin 5-HT2A receptors**"}
{"idx": 236, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 237, "label_json": "{ \"label\": \"True\" }", "question": "Which drug is benserazide usually co-administered with?", "gold_answer": "L-DOPA", "predicted_answer": "Based on the context, benserazide is co-administered with **L-DOPA** (L-3,4-dihydroxyphenylalanine).  \n\nAnswer: L-DOPA"}
{"idx": 238, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "medicarpin", "predicted_answer": "Answer: Medicarpin  \n\n**Key evidence from context:**  \n- During elicitor treatment (stress response), [(14)C]phenylalanine was incorporated **\"predominantly into medicarpin\"**.  \n- Medicarpin is identified as a **phytoalexin** released under stress conditions (e.g., via inhibitor treatment).  \n- Afrormosin conjugates are constitutive metabolites unaffected by elicitation, confirming medicarpin as the stress-induced phytoalexin"}
{"idx": 239, "label_json": "{ \"label\": \"True\" }", "question": "Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?", "gold_answer": "calcineurin", "predicted_answer": "The calcium/calmodulin-dependent protein phosphatase involved in NFAT activation is **calcineurin (CaN)**.  \n\n**Key evidence from the context:**  \n1. Directly states: \"Dephosphorylation of NFAT by **CaN** is required for NFAT nuclear localization.\"  \n2. References immunosuppressants (cyclosporin A, FK506) that inhibit **CaN** to block NFAT translocation.  \n3. Confirms BTP compounds block NFAT nuclear import without directly inhibiting **CaN**'s phosphatase activity, implying CaN's central role.  \n\n**Answer: Calcineurin (CaN)**"}
{"idx": 240, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "Answer: ZFHX1B"}
{"idx": 241, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)"}
{"idx": 242, "label_json": "{ \"label\": \"True\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based on the context, APOBEC3B (A3B) is **nuclear**.  \nThe text explicitly describes A3B's nuclear import as an active process, requiring a specific N-terminal motif (Val54) and interaction with importin proteins, analogous to the nuclear localization mechanism of AID. This confirms its predominant nuclear localization after import.  \n\n**Key evidence from the context:**  \n1. A3B nuclear import is \"an active process.\"  \n2. It requires a nuclear localization motif (Val54) similar to AID.  \n3. It interacts with importin proteins for nuclear translocation.  \n4. The text discusses mechanisms guiding nuclear A3B to its substrates and preventing cytoplasmic DNA damage, implying nuclear activity.  \n\nAnswer: **Nuclear**"}
{"idx": 243, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Based on the provided context, betrixaban inhibits **factor Xa**.\n\n**Direct Answer:** Factor Xa"}
{"idx": 244, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "Phospholamban", "predicted_answer": "Based on the context, the main regulatory molecule of SERCA2a function in cardiac muscle is **phospholamban (PLN)**.  \n\nThis is explicitly stated in the opening sentence:  \n> *\"SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling...\"*  \n\nThe entire study focuses on the functional consequences of human PLN (hPLN) superinhibiting SERCA2a, confirming its role as the primary regulator"}
{"idx": 245, "label_json": "{ \"label\": \"True\" }", "question": "What is the name of Bruton's tyrosine kinase inhibitor that can be used for treatment of chronic lymphocytic leukemia?", "gold_answer": "ibrutinib", "predicted_answer": "The Bruton's tyrosine kinase inhibitor used for treating chronic lymphocytic leukemia mentioned in the context is **ibrutinib**.  \n\nAnswer: ibrutinib"}
{"idx": 246, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context and established knowledge of Williams syndrome (WBS), the common hormone abnormalities include:\n\n1.  **Hypercalcemia** (elevated blood calcium levels), often occurring in infancy.\n2.  **Impaired glucose tolerance / Diabetes mellitus.**\n3.  **Thyroid dysfunction** (as illustrated in the case, including hypothyroidism or hyperthyroidism).\n\n**Answer: Hypercalcemia, impaired glucose tolerance/diabetes, and thyroid dysfunction.**"}
{"idx": 247, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "Dermatitis herpetiformis", "predicted_answer": "Answer: dermatitis herpetiformis"}
{"idx": 248, "label_json": "{ \"label\": \"True\" }", "question": "What is the name of Bruton's tyrosine kinase inhibitor that can be used for treatment of chronic lymphocytic leukemia?", "gold_answer": "ibrutinib", "predicted_answer": "Answer: ibrutinib"}
{"idx": 249, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "DNMT1", "predicted_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNA methyltransferase 1 (DNMT1)**.  \n\n**Key points from the context:**  \n1. The context explicitly addresses the **maintenance** of DNA methylation patterns during somatic cell division.  \n2. DNMT1 is the primary enzyme responsible for copying methylation patterns to the newly synthesized DNA strand after replication, ensuring epigenetic inheritance.  \n\n*(Note: While DNMT3A/DNMT3B handle de novo methylation, the context specifically focuses on maintenance, implicating DNMT1.)*"}
{"idx": 250, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context and established medical knowledge of Pendred syndrome:\n\n**Answer: Hypothyroidism due to impaired thyroid hormone synthesis (specifically, an organification defect).**\n\n**Explanation:**\n1.  Pendred syndrome is characterized by a defect in thyroid hormone production, specifically in the step where iodine is incorporated into thyroglobulin (organification defect).\n2.  This leads to inadequate production of thyroid hormones (T3 and T4), resulting in hypothyroidism.\n3.  The context supports this by:\n    *   Mentioning \"dyshormonogenetic goitre\" (goiter caused by a defect in hormone synthesis).\n    *   Stating the patient required \"substitution therapy with L-thyroxine\" to replace the deficient thyroid hormones.\n    *   Describing the goiter's progression despite adequate L-thyroxine treatment, which is a known feature of dyshormonogenetic goiters like those in Pendred syndrome"}
{"idx": 251, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Orteronel inhibits the enzyme **CYP17A1 (17α-hydroxylase/17,20-lyase)**, a key enzyme in androgen biosynthesis. This inhibition suppresses androgen synthesis in the testes, adrenal glands, and prostate tumor tissue, which underlies its mechanism of action in prostate cancer therapy.  \n\n*(Answer derived from context: Orteronel suppresses androgen synthesis more completely than conventional androgen deprivation therapies, which target only testicular androgens. This indicates inhibition of extragonadal androgen production pathways, specifically CYP17A1, a known target of novel hormonal therapies like orteronel.)*"}
{"idx": 252, "label_json": "{ \"label\": \"True\" }", "question": "What disease is Velcade (bortezomib) mainly used for?", "gold_answer": "multiple myeloma", "predicted_answer": "Answer: multiple myeloma"}
{"idx": 253, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL"}
{"idx": 254, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "The synonym for Lubag disease is **X-linked dystonia-parkinsonism**.  \n\n**Explanation:**  \nLubag disease is a genetic disorder primarily affecting males of Filipino descent, characterized by dystonia (including lingual dystonia, as referenced in the context) and parkinsonism. Its clinical and genetic identity is defined as **X-linked dystonia-parkinsonism (XDP)**"}
{"idx": 255, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "Dermatitis herpetiformis", "predicted_answer": "The typical rash associated with gluten is **dermatitis herpetiformis (DH)**, as explicitly referenced in the context discussing \"lesional DH skin\" and \"cutaneous DH blisters\" in patients. This rash is the cutaneous manifestation of gluten sensitivity"}
{"idx": 256, "label_json": "{ \"label\": \"False\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based solely on the provided context, the cellular localization (cytoplasmic or nuclear) of the APOBEC3B protein is **not specified**. The text describes its function in inhibiting L1 retrotransposition via a DNA deamination-independent mechanism and acting as a \"preintegration barrier,\" but does not state where within the cell this occurs"}
{"idx": 257, "label_json": "{ \"label\": \"True\" }", "question": "Treatment of which disease was investigated in the MR CLEAN study?", "gold_answer": "acute ischemic stroke", "predicted_answer": "Based on the context, the disease investigated in the MR CLEAN study is:\n\n**Acute Ischemic Stroke (AIS)**\n\nThe context explicitly states the meta-analysis evaluates \"endovascular therapies for **acute ischemic stroke**\" and includes MR CLEAN as one of the prospective randomized controlled trials (RCTs) in the analysis. The trials specifically compared endovascular therapies with medical management for AIS, focusing on patients with large vessel occlusion (LVO), a type of acute ischemic stroke"}
{"idx": 258, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits clotting factor **Xa**.  \n\nKey evidence from the context:  \n- Betrixaban is described as a \"novel oral anticoagulant\" with \"anti-Xa activity\".  \n- It is specifically referenced in relation to \"a factor Xa decoy, PRT4445\", which is under evaluation as a reversal agent for anticoagulants like betrixaban that target factor Xa.  \n- This aligns with betrixaban's classification as a **direct factor Xa inhibitor**.  \n\nAnswer: **Factor Xa**"}
{"idx": 259, "label_json": "{ \"label\": \"True\" }", "question": "The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?", "gold_answer": "PD-1", "predicted_answer": "Answer: PD-1"}
{"idx": 260, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with Achondroplasia?", "gold_answer": "fibroblast growth factor receptor 3 (FGFR3)", "predicted_answer": "The gene associated with Achondroplasia is **FGFR3**.  \n\n**Key points from the context:**  \n- The case describes hypochondroplasia due to an **FGFR3 gene mutation (N540K)**.  \n- Achondroplasia and hypochondroplasia are both caused by mutations in the **FGFR3 gene**, though at different residues (achondroplasia typically involves G380R, while hypochondroplasia involves N540K).  \n\n**Answer:** FGFR3"}
{"idx": 261, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "JNK", "predicted_answer": "Answer: JNK (c-Jun N-terminal kinase)"}
{"idx": 262, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: Stroke\n\nBased on the context:\n- The ROSIER scale is compared to the Cincinnati Prehospital Stroke Scale (CPSS) for evaluating suspected stroke patients.\n- The reference standard is neurologists' final diagnosis of stroke or transient ischemic attack (TIA).\n- Performance metrics (sensitivity, specificity, etc.) are calculated for stroke recognition.\n- The conclusion explicitly states it cannot replace comprehensive assessment for \"stroke as a diagnosis.\""}
{"idx": 263, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "Answer: NF1"}
{"idx": 264, "label_json": "{ \"label\": \"False\" }", "question": "What type of enzyme is peroxiredoxin 2 (PRDX2)?", "gold_answer": "antioxidant", "predicted_answer": "Based on the context provided, peroxiredoxin-2 (PRDX2) is a **peroxidase**.\n\n**Reasoning:**  \n1. The context states that the natural compound **gliotoxin** \"is known to exert a **Prx-like activity**\" (where \"Prx\" refers to peroxiredoxin).  \n2. Gliotoxin is a well-characterized **inhibitor of peroxidase enzymes**, specifically mimicking peroxiredoxin activity.  \n3. Peroxiredoxins (including PRDX2) are a family of thioredoxin-dependent **peroxidases** that reduce hydrogen peroxide and organic hydroperoxides.  \n\nThus, PRDX2 functions as a peroxidase enzyme.  \n\n**Answer:** Peroxidase"}
{"idx": 265, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Answer: Huntington disease\n\nThe context explicitly states:  \n- \"patients with Huntington disease\"  \n- \"investigate the metabolic changes in patients with Huntington disease\"  \n- Clinical assessments used the \"Unified Huntington's Disease Rating Scale\"  \n- Conclusions reference \"compensatory mechanisms in Huntington disease\" and \"Huntington disease-related metabolic activity\"  \n\nNo other disorders are mentioned in the provided context"}
{"idx": 266, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "S-Adenosyl methionine", "predicted_answer": "The methyl donor for histone methyltransferases is **S-adenosyl methionine (SAM)**.  \n\n**Key points from context:**  \n- Ezh2 methylates H3K27 (histone H3 at lysine 27).  \n- Histone methyltransferases universally use SAM as the methyl group donor for methylation reactions.  \n\nWhile the context doesn't explicitly name SAM, this biochemical mechanism is well-established for all histone methyltransferases, including Ezh2"}
{"idx": 267, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.", "gold_answer": "cerebral hemiatrophy", "predicted_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is **cerebral hemiatrophy** (unilateral brain atrophy) with associated compensatory changes, including:\n1. Calvarial thickening\n2. Hyperpneumatization of the frontal sinuses\n3. Elevation of the petrous ridge  \n*(all ipsilateral to the atrophied hemisphere)*\n\nThis neuroimaging triad is diagnostic and underlies the clinical manifestations (e.g., hemiplegia, seizures, developmental delay) described in the case"}
{"idx": 268, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, **the text does not specify an exact number of identified TAp73 isoforms in humans.**\n\nThe context clearly states:\n1.  \"Transcription from two different promoters... results in generation of transcriptionally active **TAp73 isoforms** (plural)\".\n2.  It contrasts these with \"dominant negative **DeltaNp73 isoforms**\".\n3.  It refers to \"TAp73 isoforms\" multiple times.\n\nWhile this confirms the *existence* of multiple TAp73 isoforms, the context **does not state how many have been identified** in humans. The focus is on the functional difference between the TAp73 group and the DeltaNp73 group, and the role of PIR2 in regulating their stability ratio.\n\n**Answer:** The context does not specify the number of identified TAp73 isoforms in humans"}
{"idx": 269, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 acts as a **repressor**.\n\n**Evidence from the context:**\n1. BACH1 regulates HO-1 expression via **feedback repression** (stated explicitly in the introduction).\n2. Bach1 deficiency **enhanced HO-1 immunopositivity** (results section), indicating removal of BACH1 lifts suppression of HO-1 expression.\n3. Inhibition of BACH1 reduced injury and inflammation, consistent with the removal of a repressive influence on protective genes like HO-1.\n\n**Answer: Repressor**"}
{"idx": 270, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nThis is directly stated (\"transcriptional repressor Bach1\") and supported by the experimental results:\n1.  Inhibiting heme production (with SA) increased BACH1 binding to the NA site and decreased alpha-globin transcription.\n2.  Adding hemin (heme) decreased BACH1 binding to the NA site and restored alpha-globin transcription.\n3.  Heme induced the nuclear export of BACH1, removing it from its repressive site.\n\nTherefore, BACH1 represses alpha-globin gene expression by binding to the NA site in the HS-40 enhancer, and heme relieves this repression.\n\n**Answer: Repressor**"}
{"idx": 271, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?", "gold_answer": "Clostridium botulinum", "predicted_answer": "The most known bacterium responsible for botulism (sausage-poisoning) is **Clostridium botulinum**.  \n\nAnswer: Clostridium botulinum"}
{"idx": 272, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZEB2", "predicted_answer": "Answer: ZEB2"}
{"idx": 273, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?", "gold_answer": "Clostridium botulinum", "predicted_answer": "Based on the context and general biomedical knowledge, the most known bacterium responsible for botulism (including sausage poisoning) is:\n\n**Clostridium botulinum**\n\n**Key points from the context:**  \n- The text explicitly names *Clostridium botulinum* group III as the producer of botulinum toxins (types C, D, and mosaic variants).  \n- Botulism is universally attributed to neurotoxins produced by *Clostridium botulinum* strains.  \n- While the context focuses on group III (animal botulism), the bacterium itself is synonymous with botulism in humans and animals, with historical links to sausage poisoning due to foodborne contamination.  \n\n**Answer: Clostridium botulinum**"}
{"idx": 274, "label_json": "{ \"label\": \"True\" }", "question": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?", "gold_answer": "nestin", "predicted_answer": "Based on the context, the intermediate filament (IF) protein used as a non-specific marker for neuronal precursor cells is **nestin**.  \n\n**Key evidence from the context**:  \n- \"Cultivation in serum-free medium... resulted in a markedly higher percentage of **nestin-positive cells**.\"  \n- Nestin is a well-established intermediate filament protein marking neural stem/progenitor cells, including those in the subventricular zone.  \n\n**Answer**: nestin"}
{"idx": 275, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies is **alpha-synuclein**.  \n\nKey evidence from the context:  \n1. Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.  \n2. Synphilin-1A inclusion bodies recruit alpha-synuclein.  \n3. Synphilin-1A inclusions in neurons recruit alpha-synuclein alongside synphilin-1.  \n4. Synphilin-1A is found in brain samples from **alpha-synucleinopathy** patients, directly linking Lewy bodies to alpha-synuclein aggregation.  \n\nAnswer: **alpha-synuclein**"}
{"idx": 276, "label_json": "{ \"label\": \"True\" }", "question": "DX-88 is investigational name of which drug?", "gold_answer": "ecallantide", "predicted_answer": "Answer: ecallantide\n\n**Explanation:**  \n- DX-88 is the investigational name for **ecallantide**, a plasma kallikrein inhibitor used to treat acute attacks of hereditary angioedema (HAE).  \n- In the context, DX-88 rapidly resolved bowel obstruction and symptoms in an HAE patient, consistent with ecallantide's mechanism of action (blocking bradykinin production, which drives HAE symptoms)"}
{"idx": 277, "label_json": "{ \"label\": \"False\" }", "question": "LY450139 is investigational name of which drug?", "gold_answer": "semagacestat", "predicted_answer": "Based on the context provided:\n\n**Answer: γ-secretase inhibitor**\n\n**Explanation:**  \nThe context explicitly states:  \n- *\"the γ-secretase inhibitor LY450139\"*  \n- *\"9 dogs were treated with a single dose of the γ-secretase modulator E2012, the γ-secretase inhibitor LY450139, or vehicle\"*  \n\nLY450139 (semagacestat) is identified by its pharmacological function as a **γ-secretase inhibitor** in this study. No alternative generic or brand name is mentioned in the provided text"}
{"idx": 278, "label_json": "{ \"label\": \"True\" }", "question": "Which amino acid residue appears mutated in most of the cases reported with  cadasil syndrome?", "gold_answer": "cysteine", "predicted_answer": "Based on the context, the amino acid residue most commonly mutated in CADASIL syndrome is **cysteine**.  \n\n**Key evidence from the context:**  \n1. The mutations occur in exons encoding **EGF-like domains** of the NOTCH3 gene.  \n2. The conclusion explicitly states that genetic variants *different from* **\"loss or gain of a cysteine residue\"** were identified, implying that cysteine alterations are the primary hallmark of pathogenic mutations in CADASIL.  \n\n**Scientific background (implicit in the context):**  \n- CADASIL-associated NOTCH3 mutations typically involve **cysteine residues** within EGF-like domains, disrupting disulfide bond formation and protein function.  \n\n**Answer:** Cysteine"}
{"idx": 279, "label_json": "{ \"label\": \"False\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "di", "predicted_answer": "Answer: p53"}
{"idx": 280, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa**.\n\n**Reasoning:**  \nThe context explicitly states that \"direct factor Xa inhibitors\" target and inhibit factor Xa in the coagulation cascade. Betrixaban is a member of this class of oral anticoagulants, as confirmed by its pharmacological classification.\n\nAnswer: **factor Xa**"}
{"idx": 281, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 282, "label_json": "{ \"label\": \"True\" }", "question": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?", "gold_answer": "chaperone-mediated autophagy (CMA)", "predicted_answer": "Based on the context, the autophagy pathway triggered by the KFERQ motif is **chaperone-mediated autophagy (CMA)**, though it is not explicitly named in the text.  \n\nThe context states:  \n*\"Ubiquitination patterns on proteins targeted for degradation determine whether adapter proteins will bring them to developing autophagosomes or to proteasomes.\"*  \nWhile this describes macroautophagy (ubiquitin-dependent) and proteasomal degradation, the KFERQ motif is specifically recognized by cytosolic chaperones (e.g., Hsc70) in **chaperone-mediated autophagy**, where proteins are directly translocated across the lysosomal membrane for degradation.  \n\n**Direct answer:** Chaperone-mediated autophagy (CMA)"}
{"idx": 283, "label_json": "{ \"label\": \"False\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Transcription-coupled repair (TCR) targets the **template strand** of actively transcribed genes.  \n\nThis is inferred from the context:  \n- TCR defects (e.g., in *RAD26* mutants or Cockayne syndrome cells) impair repair of DNA lesions specifically in transcribed regions.  \n- TCR is mechanistically linked to RNA polymerase stalling, which occurs on the template strand during transcription.  \n\nAnswer: **template strand**"}
{"idx": 284, "label_json": "{ \"label\": \"False\" }", "question": "Which is the main calcium pump of the sarcoplasmic reticulum?", "gold_answer": "SERCA2", "predicted_answer": "Based on the provided context, the main calcium pump of the sarcoplasmic reticulum is:\n\n**SERCA2a**\n\nThe context explicitly states: \"SERCA is mainly represented by the **SERCA2a** isoform in the heart.\""}
{"idx": 285, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "Answer: NF1\n\nThe context explicitly states: \"The evidence points to the NF1 gene being a tumor-suppressor gene\" and concludes that \"the double inactivation of the NF1 gene in benign neurofibromas\" is confirmed. The study focuses on analyzing the NF1 locus in neurofibromas from neurofibromatosis type 1 (NF1) patients"}
{"idx": 286, "label_json": "{ \"label\": \"True\" }", "question": "Which is the histone residue methylated by MLL1?", "gold_answer": "H3K4", "predicted_answer": "Answer: H3K4\n\nThe context explicitly states that the COMPASS family members, including Trx (which corresponds to human MLL1/2), are H3K4 methyltransferases. Specifically, it notes: \"all three complexes in Drosophila are H3K4 methyltransferases,\" and Trx is the Drosophila homolog of human MLL1/2. Thus, MLL1 methylates the H3K4 residue (histone H3 at lysine 4)"}
{"idx": 287, "label_json": "{ \"label\": \"True\" }", "question": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?", "gold_answer": "p16INK4", "predicted_answer": "Based on the context, the cyclin-dependent kinase inhibitor regulated by Bmi-1 is **p16INK4a**.  \n\nThe context explicitly states:  \n*\"there was no correlation between expression of Bmi-1 and p16INK4a\"*  \nand concludes:  \n*\"the oncogenic role of Bmi-1... is not determined by its capacity to inhibit INK4a/ARF proteins\"*.  \n\nThis confirms that **p16INK4a** (part of the INK4a/ARF locus) is the relevant cyclin-dependent kinase inhibitor studied in relation to Bmi-1 regulation.  \n\n**Answer: p16INK4a**"}
{"idx": 288, "label_json": "{ \"label\": \"True\" }", "question": "LY450139 is investigational name of which drug?", "gold_answer": "Semagacestat", "predicted_answer": "Answer: Semagacestat  \n\n**Explanation:**  \nWhile the context discusses γ-secretase modulators (GSMs) like Tarenflurbil, it does not explicitly mention LY450139. However, based on established biomedical knowledge, LY450139 is the investigational name for **Semagacestat**, a γ-secretase inhibitor (not a modulator) developed by Eli Lilly for Alzheimer's disease. Unlike GSMs (which shift Aβ cleavage sites), Semagacestat broadly inhibits γ-secretase activity, reducing total Aβ production. Clinical trials were discontinued due to adverse effects"}
{"idx": 289, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "The synonym for Lubag disease mentioned in the context is:  \n**X-linked dystonia-parkinsonism**  \n\nThis is explicitly stated in the context through repeated references to \"X-linked dystonia-parkinsonism\" as the disease affecting the patient, with \"Lubag\" being the colloquial term for this condition"}
{"idx": 290, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Answer: antiparallel"}
{"idx": 291, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Based on the provided context, betrixaban inhibits **factor Xa**.\n\nThis is explicitly stated in the context:  \n*   Betrixaban is classified as a **direct factor Xa inhibitor** (alongside direct thrombin inhibitors) under the \"new classes of orally administered anticoagulants\".  \n*   The context further discusses a \"factor Xa decoy\" (PRT4445) being evaluated as a reversal agent specifically for betrixaban and other anticoagulants with **anti-Xa activity**.  \n\n**Answer: Factor Xa**"}
{"idx": 292, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Based on the context provided and the established biomedical knowledge referenced in the example, JTV519 is a derivative of **1,4-benzothiazepine**.  \n\n**Direct Answer:**  \n1,4-benzothiazepine  \n\n**Explanation:**  \nWhile the current context compares JTV519 to diltiazem (a 1,5-benzothiazepine derivative), it does not explicitly restate JTV519's classification. However, the prior context (included in the example) explicitly identifies JTV519 as a **1,4-benzothiazepine derivative**. Since the question references both contexts, the answer remains consistent with the established compound class"}
{"idx": 293, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "Answer: Zfhx1b"}
{"idx": 294, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "Alpha-synuclein", "predicted_answer": "The main component of Lewy bodies is **alpha-synuclein**.  \n\n*(This is established knowledge in Parkinson's disease pathology, where Lewy bodies are characterized by aggregated alpha-synuclein protein, as referenced in the context of PD belonging to \"Lewy body disorders\" and the functional role of alpha-synuclein described.)*"}
{"idx": 295, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, **one** TAp73 isoform is explicitly identified and measured in humans.\n\n**Explanation:**\nThe context specifically names and measures:\n- TAp73\n- DeltaNp73\n- DeltaN'p73\n\nIt refers to these collectively as \"five p73 isoform levels\" (likely including other isoforms not named here), but **TAp73** is mentioned only as a single entity. The text does not subdivide TAp73 into distinct isoforms (like TAp73α, TAp73β, etc.) within this study description. Therefore, according to this context, **one TAp73 isoform** was identified and analyzed"}
{"idx": 296, "label_json": "{ \"label\": \"True\" }", "question": "Which drug should be used as an antidote in benzodiazepine overdose?", "gold_answer": "flumazenil", "predicted_answer": "Answer: Flumazenil"}
{"idx": 297, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "medicarpin", "predicted_answer": "Based on the context, the major phytoalexin in alfalfa is **medicarpin**.  \n\nKey evidence from the context:  \n1. IFR is described as \"the penultimate enzyme in **medicarpin** biosynthesis\".  \n2. Induction of IFR correlates with \"the accumulation of **medicarpin**\".  \n3. Healthy plant parts accumulate \"a **medicarpin** glucoside\".  \n4. The study aims to manipulate \"phytoalexin biosynthesis\" via IFR, confirming **medicarpin** as the target compound.  \n\nAnswer: **medicarpin**"}
{"idx": 298, "label_json": "{ \"label\": \"True\" }", "question": "Which receptor is targeted by telcagepant?", "gold_answer": "calcitonin gene-related peptide", "predicted_answer": "Answer: CGRP receptor"}
{"idx": 299, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "Dnmt1", "predicted_answer": "Based on the context, the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **Dnmt1**.  \n\n**Key evidence from the context**:  \n1. The text explicitly discusses \"Dnmt1\" and its role in recognizing **hemimethylated CpG sites**, which is the hallmark of maintenance methylation after DNA replication.  \n2. It references Dnmt1's catalytic domain and CXXC domain in regulating specificity for methylation of hemimethylated DNA.  \n3. The M1235S variant in the catalytic domain reduces specificity for hemimethylated sites, directly linking Dnmt1 to maintenance methylation.  \n\n**Answer: Dnmt1**"}
{"idx": 300, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: α-Synuclein (AS)"}
{"idx": 301, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the exact number of TAp73 isoforms identified in humans is **not specified**.\n\nThe context states:\n*   \"p73 ... encodes an **array** of p73 proteins\"\n*   It specifically names two examples: \"p73 alpha full-length (TAp73 alpha)\" and \"amino-truncated isoforms (Delta Np73 alpha)\".\n\nWhile it confirms the existence of multiple isoforms (an \"array\"), it only names **TAp73 alpha** as a specific TAp73 isoform. It does not provide a total count of how many TAp73 isoforms have been identified"}
{"idx": 302, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) specifically targets the **transcribed strands** of genes. \n\nThis is explicitly stated in the sentence:  \n*\"repair of **transcribed strands**.\"*  \n\nTCR recognizes lesions (like those caused by UV) that stall RNA polymerase during transcription, prioritizing repair of the actively transcribed DNA strand to restore transcription and ensure cell survival. The context contrasts this with global genome repair (GGR), which operates genome-wide"}
{"idx": 303, "label_json": "{ \"label\": \"False\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "Based on the provided context, the gene responsible for Mowat-Wilson syndrome (MWS) is not explicitly mentioned. The text focuses on clinical features, management, and diagnostic considerations but does not identify the causative gene. \n\n**Expert Knowledge Supplementation:**  \nMowat-Wilson syndrome is caused by heterozygous mutations or deletions in the *ZEB2* gene (also known as *ZFHX1B*), located on chromosome 2q22. This genetic etiology is well-established in medical literature but is not referenced in the given excerpt.  \n\n**Answer:**  \n*The context does not specify the gene.* (Externally, *ZEB2* is responsible)"}
{"idx": 304, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Answer: CYP17A1"}
{"idx": 305, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 306, "label_json": "{ \"label\": \"True\" }", "question": "Which deficiency is the cause of restless leg syndrome?", "gold_answer": "iron", "predicted_answer": "Answer: iron deficiency"}
{"idx": 307, "label_json": "{ \"label\": \"True\" }", "question": "LY450139 is investigational name of which drug?", "gold_answer": "semagacestat", "predicted_answer": "Answer: Semagacestat"}
{"idx": 308, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium pump of the sarcoplasmic reticulum?", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "predicted_answer": "Answer: SERCA"}
{"idx": 309, "label_json": "{ \"label\": \"True\" }", "question": "What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?", "gold_answer": "SECIS", "predicted_answer": "Answer: SECIS element"}
{"idx": 310, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene associated with McLeod syndrome is **XK**.  \n\nThis is directly stated in the context:  \n- \"McLeod phenotype associated with a XK missense mutation\"  \n- \"The X-linked McLeod neuroacanthocytosis syndrome\"  \n- \"Analysis of XK DNA sequence\"  \n- Confirmation of the McLeod phenotype via immunohematology and Western blotting further supports the XK gene's involvement.  \n\nAnswer: **XK**"}
{"idx": 311, "label_json": "{ \"label\": \"False\" }", "question": "What is the major adverse effect of adriamycin(doxorubicin)?", "gold_answer": "Cardiotoxicity", "predicted_answer": "Based on the provided context, the major adverse effect (dose-limiting toxicity) of adriamycin (doxorubicin) is **myelosuppression**, specifically **neutropenia and leucopenia**.\n\nThis is explicitly stated in the context: *\"Myelosuppression, predominantly neutropenia and leucopenia, is the dose-limiting toxicity.\"* While cardiotoxicity is a significant chronic concern, myelosuppression is identified as the primary dose-limiting adverse effect"}
{"idx": 312, "label_json": "{ \"label\": \"True\" }", "question": "DX-88 is investigational name of which drug?", "gold_answer": "Ecallantide", "predicted_answer": "Based on the context provided:\n\n**Answer: ecallantide**\n\n**Explanation:**\n*   The context explicitly discusses the drug **ecallantide** and its efficacy/safety for treating hereditary angioedema (HAE) attacks.\n*   While the context does not mention \"DX-88\", it is established knowledge in pharmacology that **DX-88 is the investigational name for ecallantide**.\n*   The context confirms ecallantide is a \"novel plasma kallikrein inhibitor\" used for HAE, which aligns perfectly with the known profile of DX-88/ecallantide"}
{"idx": 313, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "JNK", "predicted_answer": "Answer: JNK (c-Jun N-terminal kinase)  \n\n**Explanation:**  \nWhile the context mentions activation of mitogen-activated protein kinase (MAPK) pathways in apoptosis, it does not explicitly name the specific kinase phosphorylating c-Jun. However, based on established biomedical knowledge:  \n- **c-Jun** is a key component of the AP-1 transcription complex.  \n- Its phosphorylation at serine residues 63 and 73 is **specifically mediated by JNK** (a subfamily of MAP kinases).  \n- JNK activation occurs in response to cellular stress and apoptosis pathways, aligning with the context of cardiomyocyte apoptosis.  \n\nThus, the answer is JNK, derived from standard mechanistic understanding beyond the provided text"}
{"idx": 314, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Based on the context provided:\n\n**Answer: Na+-Ca2+ exchanger (NCX)**"}
{"idx": 315, "label_json": "{ \"label\": \"True\" }", "question": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?", "gold_answer": "nestin", "predicted_answer": "Based on the context, the intermediate filament (IF) protein used as a non-specific marker for neuronal precursor cells in the subventricular zone is **nestin**.\n\n**Answer: nestin**"}
{"idx": 316, "label_json": "{ \"label\": \"True\" }", "question": "What type of enzyme is peroxiredoxin 2 (PRDX2)?", "gold_answer": "antioxidant", "predicted_answer": "Based on the context, peroxiredoxin 2 (PRDX2) is an **antioxidant enzyme**.\n\nThis is evident from:\n1. Its identification as a target of sulfiredoxin (Srx), which specifically reduces hyperoxidized peroxiredoxins.\n2. Its role in the described ovarian antioxidant system that manages H₂O₂ levels during the periovulatory period.\n3. The context explicitly refers to reactive oxygen species (ROS) involvement in ovulation and the necessity of antioxidant systems like the PRDX2/Srx pathway.\n\nAnswer: Antioxidant enzyme"}
{"idx": 317, "label_json": "{ \"label\": \"True\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "Fungi", "predicted_answer": "Based on current classification supported by genomic evidence, microsporidia belong to the kingdom **Fungi**. \n\nKey evidence from the context:  \n1. Genome-wide analysis shows 91% of microsporidial genes have the closest relationship to other microsporidia (monophyletic origin).  \n2. Functional clustering uses the **KOG (Eukaryotic COG) database**, confirming placement within eukaryotes.  \n3. Modern phylogenomic studies (implied by DarkHorse methodology) resolve microsporidia as a highly derived fungal lineage, not protists.  \n\n*Note: While historically debated, contemporary taxonomy classifies Microsporidia within Fungi based on conserved eukaryotic machinery and molecular phylogenetics.*"}
{"idx": 318, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Answer: Huntington disease"}
{"idx": 319, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Based on the context, alpha-spectrin and beta-spectrin subunits form **antiparallel heterodimers**.\n\n**Evidence from the context:**\n1.  The pairing is specifically described as **alpha21-beta1** and **alpha20-beta2**.\n2.  This complementary pairing of motifs (alpha21 with beta1, alpha20 with beta2) implies the subunits run in opposite directions relative to each other.\n3.  The protease protection data showing burial of sites upon dimer formation is consistent with an interface formed in an antiparallel arrangement.\n4.  The electrostatic complementarity described also supports the specific docking required for an antiparallel orientation"}
{"idx": 320, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-Parkinsonism", "predicted_answer": "The synonym for Lubag disease is **X-linked dystonia-parkinsonism (XDP)**.  \n\n(Note: While the context describes dystonia treatment, it does not explicitly name Lubag disease. The synonym provided is based on established medical terminology for Lubag disease.)"}
{"idx": 321, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Based on the context, SEA0400 inhibits the **sodium-calcium exchanger (NCX)**.\n\n**Key evidence from the context:**\n1. The study explicitly examines the effect of SEA0400 on **NCX currents**.\n2. SEA0400 blocks both the inward and outward **NCX currents** induced by ischemia/reperfusion (I/R) in a dose-dependent manner.\n3. It also blocks the I/R-induced increase in intracellular Ca²⁺ ([Ca²⁺]i), which is directly linked to NCX activity.\n\n**Answer:** NCX (sodium-calcium exchanger)"}
{"idx": 322, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "The receptors that can be evaluated with [18F]altanserin are **serotonin 5-HT2A receptors**.  \n\nAnswer: serotonin 5-HT2A receptors"}
{"idx": 323, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context and established knowledge of Pendred syndrome:\n\n**Answer: None (euthyroid state).**\n\n**Explanation:**\n1.  **Normal Serum Thyrotropin (TSH):** The context explicitly states serum TSH levels remained normal during goiter progression.\n2.  **Normal Iodine Organification:** The context also states iodine organification (tested by perchlorate/thiocyanate discharge) was normal.\n3.  **Key Feature:** Pendred syndrome is characterized by **sensorineural hearing loss, goiter, and impaired iodide organification** (a partial defect in thyroid hormone synthesis). However, despite this defect, patients typically maintain **euthyroidism** (normal levels of circulating thyroid hormones T4 and T3) and consequently have **normal serum TSH levels**.\n4.  **Context Confirmation:** The case report specifically highlights that the goiter progressed *despite* normal TSH and normal organification tests, suggesting an alternative mechanism for goiter development in this specific mutation (p.T537P/p.H723R), but reaffirms the classic finding of **no TSH abnormality** in Pendred syndrome.\n\nTherefore, the characteristic hormonal feature of Pendred syndrome is the **absence of thyroid hormone abnormalities (euthyroidism)** despite the underlying iodide transport/organification defect, reflected in normal TSH levels"}
{"idx": 324, "label_json": "{ \"label\": \"True\" }", "question": "Which fusion protein is involved in the development of Ewing sarcoma?", "gold_answer": "EWS/FLI1", "predicted_answer": "Answer: EWS/FLI1"}
{"idx": 325, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: stroke"}
{"idx": 326, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "Medicarpin", "predicted_answer": "Based on the context, the major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.\n\n**Key evidence from the context:**\n1.  Vestitone reductase is explicitly described as the **\"penultimate enzyme in medicarpin biosynthesis\"**.\n2.  The study focuses on cloning the gene for this enzyme to study **\"pterocarpan biosynthesis\"** (medicarpin is a pterocarpan phytoalexin).\n3.  Increases in vestitone reductase enzyme activity directly precede **\"medicarpin biosynthesis\"** in elicited cell cultures.\n4.  Transcript levels correlate with tissues known for **\"synthesis of medicarpin\"** (roots and root nodules).\n\nAnswer: **medicarpin**"}
{"idx": 327, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke\n\nExplanation: The context explicitly states that the ROSIER scale is a \"stroke recognition instrument\" developed to differentiate acute stroke from stroke mimics in emergency room settings. Key evidence includes:  \n- The study involved patients with \"suspected acute stroke.\"  \n- The instrument was validated for \"initial differentiation of acute stroke from stroke mimics.\"  \n- Results measured sensitivity/specificity in identifying stroke (e.g., \"sensitivity of 93%\").  \n- The conclusion emphasizes its role in improving \"referrals to the stroke team.\""}
{"idx": 328, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 329, "label_json": "{ \"label\": \"False\" }", "question": "Is Rheumatoid Arthritis more common in men or women?", "gold_answer": "women", "predicted_answer": "Based solely on the provided context, the text **does not specify whether Rheumatoid Arthritis (RA) is more common in men or women**. The study focuses on gender differences in disease characteristics and treatment responses in an early RA cohort, but it does not address the prevalence or incidence rates of RA in the general population.\n\n**Key observations from the context:**\n1.  The cohort included both men and women with early RA.\n2.  Baseline disease activity and joint damage were similar between genders.\n3.  Treatment responses and progression differed over time (women had worse progression).\n4.  **No information is given about the relative frequency of RA occurrence in men versus women.**\n\n**Answer:** The provided context does not state whether RA is more common in men or women"}
{"idx": 330, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on medical knowledge of Williams syndrome (WBS), the most common hormone abnormalities are:\n\n1.  **Hypercalcemia (elevated blood calcium):** This is particularly common in infancy and early childhood.\n2.  **Thyroid dysfunction:** Including hypothyroidism (underactive thyroid), as illustrated in the provided context. Both thyroid hypoplasia and functional abnormalities can occur.\n\n**Answer: Hypercalcemia and thyroid dysfunction (including hypothyroidism).**"}
{"idx": 331, "label_json": "{ \"label\": \"True\" }", "question": "Which heat shock protein is found to be upregulated during Hsp90 inhibition?", "gold_answer": "Hsp70", "predicted_answer": "Answer: Hsp70\n\nExplanation: The context states that silencing Hsp70 prevents Hsp90 inhibitor-mediated degradation of Nox5, and identifies Hsp70 (along with its ubiquitin ligase CHIP) as the opposing regulator that promotes Nox protein degradation when Hsp90 is inhibited. This implies Hsp70 is functionally upregulated during Hsp90 inhibition to drive the ubiquitination and degradation process"}
{"idx": 332, "label_json": "{ \"label\": \"False\" }", "question": "What type of enzyme is peroxiredoxin 2 (PRDX2)?", "gold_answer": "antioxidant", "predicted_answer": "Based on the provided context, peroxiredoxin 2 (PRDX2) is not explicitly classified or discussed. The context focuses on genes related to phosphoinositide metabolism (e.g., PIP5K2A, WIPI49, TRB3, SNX14), protein kinase C (PKC), and the MAPK pathway, but does not mention PRDX2's enzyme type or function. Therefore, the context does not specify the enzyme type for PRDX2.\n\n**Answer:** Not specified in the context"}
{"idx": 333, "label_json": "{ \"label\": \"True\" }", "question": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?", "gold_answer": "Inhibitor 1", "predicted_answer": "Based on the context, the main inhibitor of protein phosphatase 1 (PP1) is **inhibitor-1 (I-1)**. \n\nKey evidence from the context:\n1. \"Nonphosphorylated I-1 is inactive, whereas **phosphorylated I-1 is a potent PP1 inhibitor**.\"\n2. \"NCLK-phosphorylated I-1 and I-1(T35A) **inhibited PP1** with IC₅₀ values...\"\n3. The study explicitly identifies I-1 as the PP1 inhibitor whose activity is regulated by phosphorylation at Thr35 and Ser67.\n\nAnswer: **inhibitor-1 (I-1)**"}
{"idx": 334, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: alpha-synuclein"}
{"idx": 335, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 336, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)"}
{"idx": 337, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "The synonym for Lubag disease is **X-linked Dystonia-Parkinsonism (XDP)**.  \n\nThis is directly indicated by the context's reference to \"Lubag carrying the **XDP haplotypes**\" and the description of its clinical spectrum (dystonia, parkinsonism, etc.)"}
{"idx": 338, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nThe evidence:\n1. ZnMP induces HO-1 expression by degrading BACH1 protein.\n2. Degradation of BACH1 (a reduction in its levels) leads to **up-regulation** of HO-1 transcription.\n3. This inverse relationship (reduction of BACH1 → increase in HO-1 expression) clearly indicates that BACH1 normally functions to repress HO-1 transcription.\n\n**Answer: Repressor**"}
{"idx": 339, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Based on the context provided, the mutation associated with McLeod syndrome is in the **XK** gene.\n\n**Answer: XK**"}
{"idx": 340, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "The synonym for Lubag disease is **X-linked dystonia-parkinsonism (XDP)**.  \n\nThis is directly stated in the context: \"X-linked dystonia-parkinsonism/Lubag disease\""}
{"idx": 341, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits clotting factor Xa.\n\nAnswer: Factor Xa"}
{"idx": 342, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "Based on the context, the synonym for \"lubag\" disease is **X-linked dystonia-parkinsonism**.\n\nAnswer: X-linked dystonia-parkinsonism"}
{"idx": 343, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium pump of the sarcoplasmic reticulum?", "gold_answer": "SERCA", "predicted_answer": "Answer: SERCA (sarco/endoplasmic reticulum Ca²⁺-ATPase)  \n\n**Key evidence from context:**  \n1. Explicitly states: \"Seipin physically interacts with the **sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA)**\"  \n2. Confirms SERCA's role in calcium handling within the ER/SR compartment.  \n\nThis identifies SERCA as the primary calcium pump responsible for transporting Ca²⁺ from the cytosol into the sarcoplasmic/endoplasmic reticulum"}
{"idx": 344, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nThe text explicitly states:\n1. \"the transcriptional repressor BACH1\"\n2. \"BACH1 binds ARE-like enhancers... and antagonizes NRF2 binding\"\n3. HMOX1 induction \"follows inactivation of BACH1\"\n4. BACH1 inactivation permits pre-existing NRF2 to bind the promoter.\n\nThese points confirm BACH1 functions as a repressor that blocks gene expression until inactivated by oxidative stress.\n\nAnswer: repressor"}
{"idx": 345, "label_json": "{ \"label\": \"True\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "fungi", "predicted_answer": "Answer: Fungi"}
{"idx": 346, "label_json": "{ \"label\": \"False\" }", "question": "What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?", "gold_answer": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility", "predicted_answer": "Based on the provided context, the reason for narcolepsy cases developing after H1N1 influenza vaccination is **likely to be autoimmune**, though definitive evidence (such as specific antibodies or T-cell involvement) is currently lacking.\n\nAnswer: autoimmune"}
{"idx": 347, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 348, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)\n\n**Explanation:**  \nWhile the provided context focuses on PPADS, KB-R7943, and SN-6 as NCX reverse mode inhibitors, SEA0400 is a well-established, potent, and selective inhibitor of the Na⁺/Ca²⁺ exchanger (NCX), particularly its reverse mode (NCX_REV). This is consistent with the class of inhibitors discussed in the context"}
{"idx": 349, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "Answer: X-linked dystonia-parkinsonism"}
{"idx": 350, "label_json": "{ \"label\": \"True\" }", "question": "Where is the histone variant CENPA preferentially localized?", "gold_answer": "centromeres", "predicted_answer": "Based on the context and established knowledge of centromere biology:\n\n**Answer: Centromeres**  \n\nThe context explicitly states that CENPC (another centromere protein) is located at the inner kinetochore plate of mammalian centromeres. While the text does not explicitly restate the localization for CENPA, it identifies the *Cenpa* gene and its product as a homolog of human CENPA. It is universally established in molecular biology that the histone variant CENP-A (encoded by *CENPA* genes) is specifically incorporated into nucleosomes at **centromeres**, forming the foundation of the kinetochore. The context discussing the structure of the *Cenpa* gene reinforces its role in centromere function"}
{"idx": 351, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is targeted by Evolocumab?", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "predicted_answer": "Answer: proprotein convertase subtilisin/kexin type 9 (PCSK9)"}
{"idx": 352, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies is **alpha-synuclein**.\n\nKey evidence from the context:\n1. Alpha-synucleinopathies are defined by abnormal alpha-synuclein deposition in neurons/glial cells.\n2. Lewy bodies (in Parkinson's disease and dementia with Lewy bodies) are explicitly identified as inclusions containing alpha-synuclein.\n3. The text states: \"In Parkinson disease and dementia with Lewy bodies, alpha-synuclein is the main component of Lewy bodies and Lewy neurites.\"\n\nAnswer: **alpha-synuclein**"}
{"idx": 353, "label_json": "{ \"label\": \"True\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based on the context, APOBEC3B functions as a **DNA cytosine deaminase** that directly causes mutations (C-to-T transitions) in genomic DNA. Its enzymatic activity requires nuclear localization to access and deaminate cytosines in the genome. The evidence of genome-wide mutations, TP53 inactivation, DNA fragmentation, and γ-H2AX accumulation (a marker of nuclear DNA damage) confirms its primary activity occurs in the nucleus.  \n\n**Answer: Nuclear**"}
{"idx": 354, "label_json": "{ \"label\": \"True\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "tofacitinib", "predicted_answer": "Tofacitinib"}
{"idx": 355, "label_json": "{ \"label\": \"True\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based on the context:\n\nAPOBEC3B is **nuclear**.\n\n**Explanation:**  \nThe context states that APOBEC3G is cytoplasmic, while APOBEC3B has a distinct subcellular localization. Key evidence:  \n- The Y19D mutation in APOBEC3G (substituting tyrosine with APOBEC3B's aspartic acid at position 19) causes mislocalization.  \n- This indicates that the residue at position 19 in APOBEC3B contributes to a localization pattern different from APOBEC3G.  \n- Since APOBEC3G is cytoplasmic and the APOBEC3B-mimicking mutation disrupts this, APOBEC3B is inferred to be predominantly nuclear (consistent with established biological knowledge).  \n\nThus, APOBEC3B's primary localization is nuclear, contrasting with APOBEC3G's cytoplasmic localization.  \n\n**Answer: Nuclear**"}
{"idx": 356, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "Based on the context provided, the gene mutated in neurofibromatosis type 1 is:\n\n**NF1**\n\nThe context explicitly states: \"Analysis of mutations of **neurofibromatosis type 1 gene**\" and consistently refers to it as the **NF1 gene** throughout the text"}
{"idx": 357, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "JNK", "predicted_answer": "Answer: JNK (c-Jun N-terminal kinase)  \n\n**Explanation:**  \nWhile the context discusses ERK and p38 MAPK pathways in relation to STAT3 inhibition, it does not specify which MAP kinase phosphorylates c-Jun. Based on established molecular biology:  \n- **JNK** is the primary MAP kinase responsible for phosphorylating the transcription factor c-Jun at residues Ser63/Ser73, activating it for transcriptional regulation.  \n- ERK primarily phosphorylates Elk-1, and p38 phosphorylates ATF-2/MSK1.  \n\nThus, the answer is derived from foundational knowledge, not the provided context"}
{"idx": 358, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Answer: antiparallel\n\nExplanation: The context explicitly states that the spectrin repeat (R16) folds into a left-handed antiparallel triple-helical coiled-coil. It further describes the assembly of the spectrin tetramer, where the heterodimer forms by the association of the C-terminal partial repeat of the beta-chain (containing two helices) with the N-terminal partial repeat of the alpha-chain (containing one helix). This end-to-end association of opposite termini (C-term of beta with N-term of alpha) confirms an **antiparallel** arrangement between the alpha-spectrin and beta-spectrin subunits in the heterodimer"}
{"idx": 359, "label_json": "{ \"label\": \"True\" }", "question": "Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?", "gold_answer": "calcineurin", "predicted_answer": "Based on the context, the calcium/calmodulin-dependent protein phosphatase involved in NFAT activation is **calcineurin**.  \n\nThe context explicitly states:  \n> \"The importance of the **Ca(2+)/calcineurin/NFAT** signalling pathway for lymphocyte activation...\"  \n\nCalcineurin is a calcium/calmodulin-dependent serine/threonine phosphatase. Upon activation by calcium-bound calmodulin, it dephosphorylates NFAT transcription factors, enabling their nuclear translocation and transcriptional activity. The defective CRAC channel function in SCID patients disrupts this pathway by impairing calcineurin activation, leading to failed NFAT-mediated immune responses.  \n\n**Answer: Calcineurin**"}
{"idx": 360, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context provided:\n\n**Answer: repressor**\n\n**Explanation:**  \nThe context explicitly states that BACH1 is a \"transcriptional repressor\" and describes its induction by Nrf2 as a \"feedback-inhibitory mechanism\" for ARE-mediated gene regulation. This confirms BACH1 functions to repress transcription"}
{"idx": 361, "label_json": "{ \"label\": \"False\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "The gene responsible for Mowat-Wilson syndrome is **ZEB2**.\n\n**Answer: ZEB2**"}
{"idx": 362, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is explicitly identified as a **repressor**.  \n\nKey evidence:  \n1. Directly stated: \"Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1.\"  \n2. Functional role: BACH1 inactivation is necessary for HMOX1 gene induction, confirming its repressive function.  \n3. Contrast with NRF2: NRF2 is the activator, while BACH1 represses basal expression until oxidative stress inactivates it.  \n\n**Answer: Repressor**"}
{"idx": 363, "label_json": "{ \"label\": \"True\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "Tofacitinib", "predicted_answer": "Answer: tofacitinib\n\nThe context explicitly states:  \n\"**Tofacitinib** is an oral treatment option for RA patients...\"  \nand refers to it as a JAK inhibitor through its mechanism (targeting JAK pathways for RA treatment). The alternative names listed (tasocitinib, CP-690550) also confirm this identification. No other JAK inhibitors are mentioned in the provided text"}
{"idx": 364, "label_json": "{ \"label\": \"False\" }", "question": "Rindopepimut is an analog of which growth factor?", "gold_answer": "EGFRvIII", "predicted_answer": "Based on the context, rindopepimut is an analog of **Epidermal Growth Factor Receptor (EGFR)**, specifically targeting the EGFRvIII mutant variant.\n\n**Answer: Epidermal Growth Factor Receptor (EGFR)**"}
{"idx": 365, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "Bcr-Abl", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia chromosome-positive chronic myelogenous leukemia is **Bcr-Abl**.  \n\n**Key evidence from the context:**  \n- The study explicitly involves patients with \"Bcr-Abl(+) malignancies\" (e.g., chronic myelogenous leukemia or Philadelphia chromosome-positive acute leukemia).  \n- Imatinib is described as a tyrosine kinase inhibitor (TKI) targeting Bcr-Abl, with reference to \"second-generation Bcr-Abl TKIs\" in the conclusions.  \n\n**Answer: Bcr-Abl**"}
{"idx": 366, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Secukinumab?", "gold_answer": "interleukin-17A", "predicted_answer": "Answer: IL-17A (interleukin-17A)  \n\nThe context explicitly states: \"Blockade of IL-17A by secukinumab...\" confirming that secukinumab targets IL-17A"}
{"idx": 367, "label_json": "{ \"label\": \"True\" }", "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?", "gold_answer": "LepChorionDB", "predicted_answer": "Answer: LepChorionDB  \n\n(Note: This is the specific relational database described in the context for identifying and classifying Lepidopteran chorion proteins. It is freely accessible at http://bioinformatics.biol.uoa.gr/LepChorionDB.)"}
{"idx": 368, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is involved in CADASIL?", "gold_answer": "NOTCH3 gene", "predicted_answer": "The gene involved in CADASIL is **NOTCH3**.  \n\n*(Note: While the provided context describes CADASIL's clinical features and pathophysiology, it does not explicitly name the gene. The answer reflects established biomedical knowledge that CADASIL is caused by mutations in the NOTCH3 gene on chromosome 19, leading to cerebral small vessel disease.)*"}
{"idx": 369, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "DNMT1", "predicted_answer": "DNMT1"}
{"idx": 370, "label_json": "{ \"label\": \"True\" }", "question": "Do archaeal genomes contain one or multiple origins of replication?", "gold_answer": "multiple", "predicted_answer": "Based on the context, archaeal genomes can contain **multiple origins of replication**.  \n\n**Evidence from the context:**  \n1. The text explicitly states that genes in *Sulfolobus islandicus* are grouped by their proximity to \"**one of the three origins (O1, O2, O3)**\".  \n2. It further compares evolutionary rates of genes near these distinct origins (e.g., \"genes near O1 evolved faster than those near O2 and O3\").  \n\nThis confirms that in this archaeal species, replication initiates from **three distinct origins**.  \n\n**Answer:** Multiple origins of replication"}
{"idx": 371, "label_json": "{ \"label\": \"True\" }", "question": "Which thyroid hormone transporter is implicated in thyroid hormone resistance syndrome?", "gold_answer": "MCT8", "predicted_answer": "Based on the context provided:\n\n**Answer: MCT8 (Monocarboxylate Transporter 8)**\n\n**Explanation:**\nThe context explicitly states that syndromes of reduced sensitivity to thyroid hormone involve defects in three major steps:\n1. **Hormone receptors** (specifically TH receptor beta, causing RTH)\n2. **Cell transporters**\n3. **Deiodination** (via SECISBP2 gene mutations)\n\nWhile the text names the receptor defect (RTH/THRB) and the deiodination defect (SECISBP2), it does not explicitly name the transporter gene in the provided excerpt. However, the established genetic defect causing thyroid hormone resistance due to a transporter mutation is in the **SLC16A2 gene**, which encodes the **MCT8 (Monocarboxylate Transporter 8)** protein. Mutations in MCT8 cause a specific syndrome of severe X-linked psychomotor retardation and abnormal thyroid hormone levels. This is the transporter implicated in the \"cell transporters\" category mentioned in the context"}
{"idx": 372, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban belongs to the class of **oral direct factor Xa inhibitors**. Therefore, it inhibits **factor Xa**.  \n\n**Answer: factor Xa**"}
{"idx": 373, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", "gold_answer": "aryl hydrocarbon receptor interacting protein", "predicted_answer": "Answer: AIP\n\nThe context identifies AIP (Aryl hydrocarbon receptor interacting protein) gene mutations as germline events in patients with sporadic parathyroid adenomas, suggesting a predisposition role. This gene is specifically implicated in familial isolated pituitary adenoma (FIPA)"}
{"idx": 374, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Based on the context, Gevokizumab targets **interleukin-1β (IL-1β)**.  \n\nKey evidence from the context:  \n1. The study explicitly states that metabolic activation governed by IL-1β contributes to β-cell failure in type 2 diabetes.  \n2. Gevokizumab is described as a **\"novel IL-1β-neutralizing antibody\"** in the conclusions.  \n3. Its mechanism involves neutralizing IL-1β to improve glycemia and reduce inflammation.  \n\nAnswer: IL-1β"}
{"idx": 375, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "Based on the context, the gene mutated in type 1 neurofibromatosis (NF1) is the **NF1 gene**.  \n\nKey evidence from the context:  \n- The study characterizes \"the **NF1 gene**\" in a patient with NF1.  \n- A mutation (IVS6 888+1, G→A) was identified in this gene, disrupting splicing.  \n- The patient's clinical diagnosis (NF1) and tumors (e.g., neurofibroma) are consistent with NF1 gene dysfunction.  \n\nAnswer: **NF1**"}
{"idx": 376, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa  \n\n**Explanation:**  \nBetrixaban is a direct oral anticoagulant that specifically inhibits **Factor Xa** (part of the coagulation cascade). This mechanism is consistent with other Factor Xa inhibitors (e.g., rivaroxaban, apixaban) mentioned in the broader context of novel anticoagulants for atrial fibrillation.  \n\n*(Note: While the provided context does not explicitly name betrixaban, its classification as a Factor Xa inhibitor is well-established in clinical literature.)*"}
{"idx": 377, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "JNK", "predicted_answer": "Answer: JNK"}
{"idx": 378, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: Stroke\n\nThe ROSIER scale (Recognition of Stroke in the Emergency Room) is a clinical assessment tool specifically designed to help healthcare providers recognize stroke in the prehospital or emergency setting. The context clearly states it was used as a \"stroke recognition tool\" on suspected stroke patients and its performance was compared to another established stroke scale (CPSS). The reference standard diagnosis was stroke or transient ischemic attack (TIA)"}
{"idx": 379, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most common type of pediatric cerebellar tumor?", "gold_answer": "Medulloblastoma", "predicted_answer": "Based on the context, the most common type of pediatric cerebellar tumor is **medulloblastoma (MB)**.\n\n**Key evidence from the context:**\n1.  The entire context focuses on **medulloblastoma (MB)** as the subject of study.\n2.  It discusses genetic alterations (Shh pathway, INK4C/CDKN2C) specifically associated with **MB formation**.\n3.  It describes experiments in mice and human samples investigating **MB tumor suppression**.\n4.  The context explicitly states: \"Methylation of the INK4C (CDKN2C) promoter and complete loss of p18(INK4C) protein expression were detected in a significant fraction of **human MBs** again pointing toward a role for INK4C in suppression of **MB formation**.\"\n\nAnswer: **medulloblastoma**"}
{"idx": 380, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.", "gold_answer": "cerebral hemiatrophy", "predicted_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is **cerebral hemiatrophy** (unilateral atrophy of one cerebral hemisphere).  \n\nThis is directly supported by the context's conclusion: \"male gender and left side involvement are frequent in **cerebral hemiatrophy disease**,\" which refers to Dyke-Davidoff-Masson syndrome.  \n\n**Answer: Cerebral hemiatrophy**"}
{"idx": 381, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "S-adenosylmethionine", "predicted_answer": "Answer: S-adenosylmethionine (AdoMet)"}
{"idx": 382, "label_json": "{ \"label\": \"True\" }", "question": "What histone modification is recognized by the bromodomain?", "gold_answer": "acetylated lysines", "predicted_answer": "Acetylated lysine"}
{"idx": 383, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on established pharmacological knowledge (as betrixaban is not specifically mentioned in the provided context), betrixaban inhibits **Factor Xa (FXa)**.\n\n**Reasoning:**\n1.  **Context Focus:** The provided context discusses *investigational* anticoagulants targeting factors like FVIIa/TF, FIX, FXI, FXII, thrombin, and mentions novel platforms like ASOs and aptamers.\n2.  **Betrixaban Status:** Betrixaban is an approved, commercially available direct oral anticoagulant (DOAC), not an investigational agent in the pipeline.\n3.  **Known Mechanism:** Betrixaban is a well-known, selective, direct inhibitor of Factor Xa (FXa). It prevents the conversion of prothrombin to thrombin by inhibiting FXa within the coagulation cascade.\n\n**Answer: Factor Xa (FXa)**"}
{"idx": 384, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "Medicarpin", "predicted_answer": "Based on the context, the major phytoalexin in alfalfa (*Medicago sativa* L.) is **medicarpin**.  \n\nKey evidence from the context:  \n- The text explicitly states research on \"enzymes involved in **medicarpin** biosynthesis\"  \n- It notes IOMT induction correlates with \"**medicarpin** accumulation\"  \n- Medicarpin is the end-product of the isoflavonoid pathway described, where IOMT catalyzes a key methylation step in its synthesis.  \n\nAnswer: **medicarpin**"}
{"idx": 385, "label_json": "{ \"label\": \"True\" }", "question": "What disease is Velcade (bortezomib) mainly used for?", "gold_answer": "multiple myeloma", "predicted_answer": "Answer: multiple myeloma"}
{"idx": 386, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Answer: CYP17A1"}
{"idx": 387, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "The characteristic hormone abnormality in Pendred syndrome is **hypothyroidism** due to an **organification defect**, where the thyroid gland fails to properly incorporate iodine into thyroglobulin for thyroid hormone synthesis. This results in insufficient production of thyroid hormones (T3/T4). \n\n*(Answer derived from the context's emphasis on dyshormonogenesis as a genetic cause of congenital hypothyroidism, with organification defects specifically mentioned as a recessively inherited mechanism. Pendred syndrome is the most common genetic form of organification defect.)*"}
{"idx": 388, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Answer: The transcribed strand of active genes.\n\nBased on the context:\n- TCR specifically repairs the transcribed strand of actively transcribed genes.\n- The method (strand-specific PCR) targets the transcribed strand of genes like DHFR and c-myc.\n- TCR deficiency (e.g., from Cockayne syndrome B or DNA-PKcs depletion) impairs repair of UV damage on these transcribed strands.\n- TCR's mechanism involves RNA polymerase II, which transcribes the template (non-transcribed) strand, leaving the complementary strand as the transcribed target for repair"}
{"idx": 389, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL tyrosine kinase"}
{"idx": 390, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of Romano Ward long QT syndrome?", "gold_answer": "autosomal dominant", "predicted_answer": "Autosomal dominant"}
{"idx": 391, "label_json": "{ \"label\": \"True\" }", "question": "Which kinase is inhibited by the small molecule KN-93?", "gold_answer": "CaM kinase II", "predicted_answer": "Answer: Ca²⁺/calmodulin-dependent protein kinase II (CaM kinase II)"}
{"idx": 392, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Orteronel inhibits the enzyme **CYP17A1 (17α-hydroxylase/17,20-lyase)**. \n\nThis inhibition suppresses androgen synthesis in the adrenal glands, testes, and tumor tissue, which is central to its mechanism of action in prostate cancer treatment"}
{"idx": 393, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene mutation associated with McLeod syndrome is **XK**.  \n\n**Key evidence from context:**  \n- Presence of the **McLeod phenotype** (characterized by absence of Kx red blood cell antigen and weakened Kell system antigens)  \n- Clinical features: chorea, neuropsychiatric symptoms, acanthocytes, areflexia, and elevated creatine kinase  \n\nMcLeod syndrome is an X-linked disorder caused by mutations in the *XK* gene, which encodes the XK protein essential for Kell antigen expression and neuronal integrity.  \n\nAnswer: XK"}
{"idx": 394, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Answer: Huntington disease\n\nThe context explicitly states:  \n- \"patients with Huntington disease\"  \n- \"investigate the metabolic changes in patients with Huntington disease\"  \n- \"clinical assessments using the Unified Huntington's Disease Rating Scale\"  \n- \"targets a Huntington disease-related metabolic activity pattern\"  \n\nThus, pridopidine was tested for treating **Huntington disease**"}
{"idx": 395, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone deficiency is implicated in the Costello syndrome ?", "gold_answer": "growth hormone", "predicted_answer": "Cortisol deficiency. \n\nThe context explicitly states: \"The hypoglycemia is deemed to be due to cortisol deficiency\" and identifies this as the second published case of cortisol deficiency in Costello syndrome"}
{"idx": 396, "label_json": "{ \"label\": \"True\" }", "question": "Which type of lung cancer is the most strongly associated with Lambert-Eaton syndrome?", "gold_answer": "small-cell lung cancer", "predicted_answer": "Answer: Small Cell Lung Cancer (SCLC)\n\nThe context explicitly states that experiments were performed on \"H146 SCLC cells\" (Small Cell Lung Cancer cells) and concludes that P-type Ca²⁺ channels in **SCLC cells** trigger the autoantibody production characteristic of Lambert-Eaton syndrome (LES). This establishes SCLC as the lung cancer type most strongly associated with LES"}
{"idx": 397, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.", "gold_answer": "cerebral hemiatrophy", "predicted_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is **cerebral hemiatrophy** (unilateral cerebral atrophy), which is consistently demonstrated on imaging studies. This is accompanied by secondary findings:\n- Ipsilateral calvarial thickening\n- Hyperpneumatization of the paranasal sinuses\n- Elevation of the petrous ridge\n- Dilatation of the ipsilateral lateral ventricle\n\nThese features result from chronic brain injury during early development, leading to the clinical triad of seizures, contralateral hemiparesis, and developmental delay/intellectual disability"}
{"idx": 398, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits clotting factor Xa.  \n\n**Answer:** Factor Xa"}
{"idx": 399, "label_json": "{ \"label\": \"False\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Answer: Cytoplasmic"}
{"idx": 400, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZEB2", "predicted_answer": "Answer: ZEB2  \n\n**Key evidence from the context:**  \n- The context explicitly states that Mowat-Wilson syndrome (MWS) is caused by mutations in the **ZEB2 gene**.  \n- Molecular testing confirmed mutations (nonsense, frameshift, splice site) or deletions in **ZEB2** across all 27 patients diagnosed with MWS.  \n- The study's title and analysis focus on \"comprehensive ZEB2 gene analysis\" for MWS diagnosis"}
{"idx": 401, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context, [18F]altanserin is used to evaluate **5-HT2A receptors (serotonin 2A receptors)**.\n\nThis is explicitly stated in the purpose (\"determine 5-HT2A receptor availability\") and conclusion (\"reliable tool for in vivo quantification of 5-HT2AR availability\"). The abbreviation \"5-HT2AR\" stands for 5-HT2A receptor.\n\n**Answer: 5-HT2A receptors**"}
{"idx": 402, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: Stroke"}
{"idx": 403, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)"}
{"idx": 404, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "S-adenosylmethionine", "predicted_answer": "Answer: S-adenosylmethionine (AdoMet)"}
{"idx": 405, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK gene"}
{"idx": 406, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits factor Xa (FXa).\n\nAnswer: Factor Xa"}
{"idx": 407, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic domain of histone methyltransferases?", "gold_answer": "SET domain", "predicted_answer": "Answer: SET domain"}
{"idx": 408, "label_json": "{ \"label\": \"True\" }", "question": "Which is the histone residue methylated by MLL1?", "gold_answer": "H3K4", "predicted_answer": "Based on the context, the histone residue methylated by MLL1 is **H3 lysine 4 (H3K4)**.  \n\n**Key Evidence from Context:**  \n1. MLL1 is identified as a **histone methyltransferase** regulating MDR1 transcription.  \n2. MLL1 is specifically known (from established biomedical knowledge) to methylate **histone H3 at lysine 4 (H3K4)**.  \n3. The study links MLL1’s enzymatic activity to MDR1 promoter regulation, consistent with H3K4 methylation’s role in gene activation.  \n\n**Answer:** H3 lysine 4 (H3K4)"}
{"idx": 409, "label_json": "{ \"label\": \"True\" }", "question": "Which is the molecular target of the immunosuppressant drug Rapamycin?", "gold_answer": "mTOR", "predicted_answer": "Answer: mTOR (mechanistic target of rapamycin)"}
{"idx": 410, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, Pendred syndrome is characterized by **mild thyroid dysfunction**, specifically involving abnormalities in **thyroid hormone production**. \n\nThe context explicitly states:  \n*\"The mild thyroid dysfunction in these patients suggests that PS should be considered in all patients with congenital or early-onset hearing impairment.\"*  \n\nThis dysfunction is linked to defects in thyroid hormone organification (detected via the perchlorate discharge test mentioned in the methods), leading to impaired synthesis of thyroid hormones (e.g., thyroxine/T4).\n\n**Answer: Thyroid hormone abnormalities (specifically impaired synthesis/organification).**"}
{"idx": 411, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "The gene mutated in neurofibromatosis type 1 (NF1) is **NF1**, which encodes the tumor suppressor protein neurofibromin.  \n\n**Direct evidence from the context**:  \n*\"the tumor suppressor protein neurofibromin, which is mutated in NF1\"*  \n*\"neurofibromin, which is mutated in NF1\"*  \n\nThis confirms the **NF1 gene** is the mutated locus responsible for the disorder"}
{"idx": 412, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context and general medical knowledge of Williams syndrome (WBS):\n\n**Answer: Hypercalcemia (elevated blood calcium levels) is the most common hormone/electrolyte abnormality in Williams syndrome.**\n\n**Explanation:**\n1.  **Context:** The provided context specifically describes a case of **congenital hypothyroidism** (low thyroid hormone levels) in an infant with WBS. This highlights that thyroid dysfunction *can* occur in WBS.\n2.  **General Knowledge:** While thyroid issues like hypothyroidism *can* be associated with WBS, the **most characteristic and frequent endocrine abnormality** is **hypercalcemia**, often presenting in infancy. This is caused by dysregulation of vitamin D metabolism and/or calcium absorption.\n3.  **Answer:** Therefore, the most common hormone/electrolyte abnormality is **hypercalcemia**. The context correctly illustrates that thyroid abnormalities (like hypothyroidism) are also important to monitor for in WBS patients"}
{"idx": 413, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 414, "label_json": "{ \"label\": \"True\" }", "question": "Which is the human selenoprotein that contains several Se-Cys residues?", "gold_answer": "selenoprotein P", "predicted_answer": "Answer: selenoprotein P"}
{"idx": 415, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 416, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.", "gold_answer": "cerebral hemiatrophy", "predicted_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome (DDMS) is **unilateral cerebral hemiatrophy**, as evidenced by:\n- The context's repeated reference to \"right-sided DDMS\" in all patients\n- Neuroimaging confirmation of unilateral involvement\n- Lateralized neuropsychological deficits (e.g., visuospatial impairments linked to right hemisphere damage)\n- Interictal EEG abnormalities localized to the affected hemisphere\n\nThis unilateral cerebral atrophy drives the syndrome's core manifestations, including contralateral neurological deficits, seizures, and cognitive impairments specific to the damaged hemisphere.\n\nAnswer: Unilateral cerebral hemiatrophy"}
{"idx": 417, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "DNMT1", "predicted_answer": "Based on the context, the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNMT1**.  \n\n**Key evidence from the context**:  \n1. The study specifically analyzes the role of **DNMT1** in methylation imprint maintenance during spermatogenesis.  \n2. A loss-of-function mutation in *Dnmt1* causes aberrant hypermethylation of the *Snrpn* DMR (a region that should be unmethylated in sperm), indicating DNMT1's direct role in maintaining correct methylation patterns.  \n3. This defect is absent in *Dnmt3a* mutant models, confirming DNMT1's distinct function in **maintenance** (vs. de novo methylation by DNMT3 enzymes).  \n\n**Answer: DNMT1**"}
{"idx": 418, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 419, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Based on the provided context and consistent with the prior example, JTV519 is a derivative of **1,4-benzothiazepine**.\n\nAnswer: 1,4-benzothiazepine"}
{"idx": 420, "label_json": "{ \"label\": \"True\" }", "question": "How many tissue kallikrein genes are present in the human genome?", "gold_answer": "15", "predicted_answer": "Based on the context provided, the human tissue kallikrein gene family consists of **15 genes**.\n\n**Key points supporting this:**\n1. The context discusses \"kallikrein 13\" as one member and references \"PSA\" (kallikrein 3), indicating a numbered series.\n2. It explicitly refers to the \"kallikrein gene family\" and mentions \"novel kallikreins,\" implying multiple members beyond the originally known ones.\n3. Biomedical knowledge confirms the human kallikrein family comprises 15 genes (KLK1 to KLK15), which aligns with the context's focus on kallikrein 13 and the broader family implications in cancer.\n\nThe context does not explicitly state the number, but the reference to kallikrein 13 (within a numbered series) and the term \"gene family\" universally indicates the established 15-member human kallikrein family in current biomedicine"}
{"idx": 421, "label_json": "{ \"label\": \"False\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "Dnmt1", "predicted_answer": "Based on the context, the enzyme involved in the maintenance of DNA methylation for specific germ line genes is **Dnmt3b**. \n\nKey evidence from the context:  \n1. Dnmt1 alone is insufficient for perfect maintenance methylation.  \n2. Dnmt3b remains bound to promoter regions of germ line genes in somatic cells.  \n3. Maintenance of methylation and silencing of these genes **requires Dnmt3b but not Dnmt1**.  \n\nAnswer: **Dnmt3b**"}
{"idx": 422, "label_json": "{ \"label\": \"False\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Based on the provided context:\n\n**Answer: Stroke and transient ischaemic attack (TIA)**\n\n**Explanation:** The context explicitly states that the ROSIER scale was assessed for its ability to identify patients with \"a diagnosis of acute stroke or TIA\" in the emergency department setting. It is compared to the FAST scale for this purpose"}
{"idx": 423, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: stroke"}
{"idx": 424, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: alpha-synuclein"}
{"idx": 425, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Answer: Huntington disease"}
{"idx": 426, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa**.\n\n**Explanation:**  \nThe context states:  \n* \"These drugs include the **factor Xa inhibitors** and IIa (thrombin) inhibitors.\"  \n* Betrixaban is a well-established **direct factor Xa inhibitor** (though not explicitly named in this excerpt, it falls under this class).  \n\nThus, betrixaban targets clotting **factor Xa**"}
{"idx": 427, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Based on the provided context, the molecule targeted by Gevokizumab is **Interleukin-1β (IL-1β)**.  \n\nKey evidence from the context:  \n1. Gevokizumab negatively modulates **IL-1β signaling** via an allosteric mechanism.  \n2. It decreases the binding affinity of **IL-1β** for the IL-1RI signaling receptor.  \n3. The drug alters the electrostatic surface potential of **IL-1β**, directly interacting with it to reduce association rates.  \n\nAnswer: **IL-1β**"}
{"idx": 428, "label_json": "{ \"label\": \"True\" }", "question": "What is the definitive treatment for low pressure headache?", "gold_answer": "epidural blood patch", "predicted_answer": "The definitive treatment for low-pressure headache (post-dural puncture headache) is **autologous epidural blood patch**.  \n\n**Answer: Autologous epidural blood patch**"}
{"idx": 429, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "Bcr-Abl", "predicted_answer": "Answer: Bcr-Abl tyrosine kinase"}
{"idx": 430, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", "gold_answer": "aryl hydrocarbon receptor interacting protein", "predicted_answer": "Answer: AIP"}
{"idx": 431, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone deficiency is implicated in the Costello syndrome ?", "gold_answer": "Growth hormone", "predicted_answer": "The hormone deficiency implicated in Costello syndrome is **Growth Hormone (GH) deficiency**.  \n\n**Answer: Growth Hormone (GH)**"}
{"idx": 432, "label_json": "{ \"label\": \"False\" }", "question": "How many genera comprise the Flaviviridae family?", "gold_answer": "three", "predicted_answer": "The Flaviviridae family comprises **4** genera: *Flavivirus*, *Pestivirus*, *Hepacivirus*, and *Pegivirus*"}
{"idx": 433, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZEB2", "predicted_answer": "The gene responsible for Mowat-Wilson syndrome (MWS) is **ZEB2**.  \n\n**Key evidence from the context**:  \n- The patient's 2q22.3 deletion involves two genes: **ZEB2** and GTDC1.  \n- MWS is defined by pathogenic variants or deletions in **ZEB2**, which is the established causal gene for the syndrome.  \n\n**Additional clarification**:  \nWhile the deletion includes both genes, MWS pathogenesis is specifically attributed to **ZEB2** haploinsufficiency. GTDC1 is not implicated in the core features of MWS.  \n\nAnswer: **ZEB2**"}
{"idx": 434, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium pump of the sarcoplasmic reticulum?", "gold_answer": "SERCA", "predicted_answer": "Based on the context, the main calcium pump of the sarcoplasmic reticulum is:\n\n**SERCA (Sarco/Endoplasmic Reticulum Ca²⁺-ATPase)**  \n\nThis is explicitly stated in the context, which discusses the modulation of \"rabbit muscle sarcoplasmic reticulum **Ca(2+)-ATPase** activity\" (SERCA) by quercetin derivatives. SERCA is the primary pump responsible for transporting calcium ions back into the sarcoplasmic reticulum during muscle relaxation"}
{"idx": 435, "label_json": "{ \"label\": \"True\" }", "question": "Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?", "gold_answer": "BRG1", "predicted_answer": "Based on the context, the SWI/SNF protein complex subunit demonstrated to interact with the FANCA gene product is **BRG1**.\n\nKey evidence from the context:\n1.  \"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"\n2.  \"BRG1 is a subunit of the SWI/SNF complex.\"\n3.  \"We demonstrated co-localization in the nucleus between transfected FANCA and BRG1.\"\n\nAnswer: BRG1"}
{"idx": 436, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL"}
{"idx": 437, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based on the context, **1** TAp73 isoform has been identified in humans.  \nThe context explicitly lists \"all 5 N-terminal isoforms\" as:  \n- **TAp73**  \n- DeltaNp73  \n- DeltaN'p73  \n- Ex2p73  \n- Ex2/3p73  \n\nTAp73 is specified as a single distinct isoform among these five.  \n\n**Answer: 1**"}
{"idx": 438, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 439, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Mepolizumab?", "gold_answer": "interleukin-5", "predicted_answer": "Based on the context of eosinophilic oesophagitis (EE) and its eosinophil-driven pathology:\n**Answer: Interleukin-5 (IL-5)**\n\n**Explanation:**  \nWhile the context does not explicitly mention Mepolizumab, it describes EE as an eosinophil-mediated disorder. Mepolizumab is a monoclonal antibody that specifically targets and neutralizes **interleukin-5 (IL-5)**, a cytokine critical for eosinophil maturation, activation, and survival. By inhibiting IL-5, Mepolizumab reduces eosinophil levels and is used clinically for eosinophilic diseases like EE"}
{"idx": 440, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the characteristic hormone abnormality in Pendred syndrome is:  \n**Thyroid hormone deficiency**  \n\nThis results specifically from:  \n- **Partial iodide organification defect** (impaired thyroid hormone synthesis) due to reduced iodide efflux into the thyroid follicular lumen caused by pendrin dysfunction.  \n\nThe context does not indicate abnormalities in other hormone systems"}
{"idx": 441, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 442, "label_json": "{ \"label\": \"False\" }", "question": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.", "gold_answer": "cerebral hemiatrophy", "predicted_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is **contralateral atrophy** (affecting the trunk and extremities), resulting from unilateral cerebral hemiatrophy. This manifests as facial asymmetry, hemiparesis, and other neurological deficits.\n\nAnswer: Contralateral atrophy"}
{"idx": 443, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Based on the context, the tyrosine kinase targeted by Imatinib (Gleevec/STI571) is:\n\n**BCR-ABL**\n\n**Explanation:**  \nThe context explicitly states the study involves \"BCR-ABL positive cell lines\" and \"primary patient-derived BCR-ABL cells\" in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Imatinib (referred to as STI571 in the text) is a tyrosine kinase inhibitor designed to specifically target the BCR-ABL fusion protein, which is the oncogenic driver of CML resulting from the Philadelphia chromosome translocation"}
{"idx": 444, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "predicted_answer": "The gene implicated in familial isolated pituitary adenoma is **AIP**.\n\nAnswer: AIP"}
{"idx": 445, "label_json": "{ \"label\": \"False\" }", "question": "How many genera comprise the Flaviviridae family?", "gold_answer": "three", "predicted_answer": "Answer: 4"}
{"idx": 446, "label_json": "{ \"label\": \"False\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: PTEN\n\nBased on the context:\n1.  The title explicitly states: \"PTEN: a new guardian of the genome.\"\n2.  The abstract concludes: \"Thus, we propose that PTEN is a new guardian of the genome.\"\n3.  While p53 is mentioned as the *most frequently mutated* gene in human cancer, the context specifically designates PTEN as the \"new guardian of the genome\" due to its role in maintaining chromosomal stability and protecting the genome from instability"}
{"idx": 447, "label_json": "{ \"label\": \"True\" }", "question": "Which deficiency is the cause of restless leg syndrome?", "gold_answer": "Iron", "predicted_answer": "Based on the context, the deficiency implicated in restless legs syndrome is **iron deficiency**. The context explicitly links iron to restless legs syndrome in the title (\"Iron, brain and restless legs syndrome\") and discusses iron's critical role in metabolic processes, emphasizing that iron imbalance (including deficiency) is associated with neurological conditions like RLS. \n\nAnswer: **Iron deficiency**"}
{"idx": 448, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 449, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the provided context, the hormone abnormality common in Williams syndrome is:\n\n**Thyroid dysfunction, specifically subclinical hypothyroidism.**\n\nKey evidence from the context:\n1.  Thyroid function tests were performed and monitored.\n2.  The prevalence of subclinical hypothyroidism was \"significantly higher in the younger patients.\"\n3.  Yearly monitoring of thyroid function is recommended.\n4.  Treatment is suggested for overt hypothyroidism or progressive deterioration.\n\nTherefore, thyroid abnormalities, particularly subclinical hypothyroidism, are identified as a common issue in this patient population"}
{"idx": 450, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "The characteristic hormone abnormalities in Pendred syndrome are **thyroid hormone deficiencies**, specifically **hypothyroidism** resulting from impaired thyroid hormone synthesis (dyshormonogenesis). This is often accompanied by elevated TSH levels due to the pituitary gland's compensatory response.\n\n*Source: Context identifies \"congenital hypothyroidism caused by organification defects\" as a form of dyshormonogenesis, which is the category Pendred syndrome belongs to.*"}
{"idx": 451, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?", "gold_answer": "ret", "predicted_answer": "Based on the context, the gene frequently mutated in both Multiple Endocrine Neoplasia Type 2 (MEN2) and Hirschsprung disease (HSCR) is:\n\n**RET**\n\n**Explanation:**  \n- The context explicitly states molecular analysis was performed on the **ret and GDNF genes** in a family with MEN2A and HSCR.  \n- It highlights a silent mutation in exon 2 of the **RET gene (A45A)** in the patient with both conditions.  \n- While GDNF was scanned, **no mutation was found**, implicating RET as the primary mutated gene in this family.  \n- Clinically, RET mutations are well-established drivers of MEN2 syndromes and are also the most common genetic cause of HSCR"}
{"idx": 452, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the specific number of TAp73 isoforms identified in humans is **not stated**.\n\nThe context refers to \"TAp73 isoforms\" in plural and discusses their function and regulation compared to ΔNp73 isoforms, but it does not enumerate how many distinct TAp73 isoforms exist. The focus is on the functional difference between the two *types* (TAp73 vs ΔNp73) and the regulation of their ratio.\n\n**Answer:** The context does not specify the number of TAp73 isoforms identified in humans"}
{"idx": 453, "label_json": "{ \"label\": \"True\" }", "question": "Which bone protein is used in archaelogy for dating and species identification?", "gold_answer": "collagen", "predicted_answer": "Answer: collagen"}
{"idx": 454, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 455, "label_json": "{ \"label\": \"True\" }", "question": "What is the target of the drug Olaparib?", "gold_answer": "PARP", "predicted_answer": "The target of the drug Olaparib is Poly (ADP-ribose) polymerase (PARP).  \n\n**Answer: Poly (ADP-ribose) polymerase**"}
{"idx": 456, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Answer: 5-HT2A receptors (5-HT2AR)  \n\nThe context explicitly states:  \n- \"PURPOSE:\" involves determining \"5-HT2A receptor availability\"  \n- \"CONCLUSION:\" confirms \"[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability\"  \n- Validation methods (PET and autoradiography) specifically target 5-HT2A receptors.  \n\nNo other receptors are mentioned in relation to [18F]altanserin in this context"}
{"idx": 457, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Answer: repressor"}
{"idx": 458, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "yroidis", "predicted_answer": "Based on the context provided, the common hormone abnormality in Williams syndrome is:\n\n**Hypercalcemia** (elevated blood calcium levels).\n\nKey evidence from the context:\n1.  **Explicit mention**: \"Treatment of hypercalcemia may include diet modification, oral corticosteroids, and/or intravenous pamidronate.\"\n2.  **Management focus**: Referral to a nephrologist is recommended for \"persistent hypercalcemia and/or hypercalciuria\".\n3.  **Surveillance**: Children under two require serum calcium testing every 4-6 months, and all individuals need serum calcium measured every two years. Urine calcium/creatinine ratios are also monitored annually.\n4.  **Avoidance**: Pediatric multivitamins are to be avoided \"because all pediatric multivitamin preparations contain vitamin D\", implicating dysregulation in calcium/vitamin D metabolism as a core issue.\n\nWhile the context mentions managing early puberty with a gonadotropin-releasing hormone agonist, it does not explicitly state that early puberty or its hormonal drivers (like gonadotropins or sex steroids) are *common* abnormalities. The primary and consistently highlighted hormonal abnormality is hypercalcemia"}
{"idx": 459, "label_json": "{ \"label\": \"True\" }", "question": "Which bone protein is used in archaelogy for dating and species identification?", "gold_answer": "collagen", "predicted_answer": "Based on the context, the bone protein used in archaeology for dating and species identification is **collagen**.  \n\n**Key evidence from the context:**  \n1. Collagen is explicitly mentioned as the primary structural protein in bone matrix.  \n2. The study analyzes collagen crosslinks (pyridinoline/deoxypyridinoline), confirming collagen's central role.  \n3. Collagen's stability in mineralized tissues allows long-term preservation, enabling radiocarbon dating and species-specific peptide sequencing in archaeological samples.  \n\n*Note: While osteopontin and osteocalcin are discussed as noncollagenous proteins, collagen is the established protein for archaeological applications due to its durability and species-specific molecular signatures.*  \n\n**Answer: collagen**"}
{"idx": 460, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Based on the context provided, the tumor suppressor referred to as \"the guardian of the genome\" is:\n\n**p53**\n\n*   The context explicitly states: \"Tumor suppressor p53 functions as a 'guardian of the genome' to prevent cells from transformation.\""}
{"idx": 461, "label_json": "{ \"label\": \"True\" }", "question": "Which protein is causing Netherton syndrome?", "gold_answer": "LEKTI", "predicted_answer": "Answer: LEKTI"}
{"idx": 462, "label_json": "{ \"label\": \"False\" }", "question": "Rindopepimut is an analog of which growth factor?", "gold_answer": "EGFRvIII", "predicted_answer": "Answer: Epidermal Growth Factor Receptor (EGFR)  \n\nKey points from the context:  \n- Rindopepimut targets **EGFRvIII**, a mutant variant of the Epidermal Growth Factor Receptor.  \n- It is explicitly described as a peptide vaccine against EGFRvIII.  \n- EGFRvIII is a tumor-specific antigen derived from EGFR, making rindopepimut an analog targeting this receptor.  \n\nThus, rindopepimut is an analog of the Epidermal Growth Factor Receptor"}
{"idx": 463, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa\n\nThe context identifies betrixaban as a direct factor Xa inhibitor, meaning it directly targets and inhibits clotting factor Xa"}
{"idx": 464, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Factor Xa"}
{"idx": 465, "label_json": "{ \"label\": \"False\" }", "question": "Rindopepimut is an analog of which growth factor?", "gold_answer": "EGFRvIII", "predicted_answer": "Answer: epidermal growth factor"}
{"idx": 466, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 467, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Answer: Huntington disease"}
{"idx": 468, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Based on the context, the transcript directly responsible for X-chromosome inactivation is **Xist**.\n\n**Key evidence from the context:**\n1.  Tsix (via its antisense action) represses **Xist**.\n2.  X-chromosome inactivation (XCI) choice is determined by asymmetric expression of Tsix, which directly controls the repression of **Xist**.\n3.  The mechanism described involves regulators (Xite, Tsix) controlling **Xist** expression, where **Xist** is the effector transcript that initiates and carries out the silencing of the X chromosome"}
{"idx": 469, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZEB2", "predicted_answer": "Based solely on the provided context, **Mowat-Wilson syndrome is not mentioned**. The context exclusively discusses **Rubinstein-Taybi syndrome (RSTS)** and its genetic causes (CREBBP, EP300, and potential novel candidates like TWIST1). \n\n**However**, to directly answer your question from established biomedical knowledge (outside the provided context):  \n**Mowat-Wilson syndrome is caused by mutations in the ZEB2 gene.**\n\n*(The context does not contain information about Mowat-Wilson syndrome or ZEB2.)*"}
{"idx": 470, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "The gene mutated in type 1 neurofibromatosis is **NF1**.  \n\n**Key evidence from the context:**  \n- The text explicitly references \"NF1 multiexonic deletion\" and \"NF1 mutations\" throughout.  \n- It describes molecular characterization of a deletion in the \"NF1 gene\" and states that multiexonic deletions represent \"2% of NF1 mutations.\"  \n- The protein product \"neurofibromin\" is mentioned, which is encoded by the *NF1* gene.  \n\n**Answer: NF1**"}
{"idx": 471, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine  \n\n**Explanation:**  \nThe context explicitly refers to K201 (the alternative name for JTV519) and describes structural modifications to its chemical framework. The base compound JTV519/K201 is identified as a **1,4-benzothiazepine derivative** in prior literature (as confirmed in the provided example context). This classification remains consistent, as the current text discusses synthesizing a \"dioxole congener\" of K201 to enhance its electron donor properties, further validating its origin from the 1,4-benzothiazepine group"}
{"idx": 472, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 473, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the hormone abnormalities common in Williams syndrome (WS) are related to thyroid function, specifically:\n\n1.  **TSH hypersecretion**: An exaggerated and prolonged TSH response to TRH injection.\n2.  **Reduced TSH bioactivity**: A low TSH bioactivity to immunoreactivity ratio (TSH B/I).\n\nThese abnormalities indicate a pattern of **subclinical hypothyroidism**, similar to that seen in hypothalamic hypothyroidism"}
{"idx": 474, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Answer: The context does not specify the number of TAp73 isoforms identified in humans. It only distinguishes between the two major isoform groups: TA and ΔN"}
{"idx": 475, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL"}
{"idx": 476, "label_json": "{ \"label\": \"True\" }", "question": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?", "gold_answer": "Inhibitor 1", "predicted_answer": "Based on the context, the main inhibitor of protein phosphatase 1 (PP1) is **phosphatase inhibitor-1 (I-1)**. \n\nKey evidence from the context:  \n- \"Non-phosphorylated I-1 is inactive, whereas I-1 phosphorylated by protein kinase A (PKA) at Thr35 is a potent PP1 inhibitor.\"  \n- The experiments directly measure I-1's role in inhibiting PP1 activity, particularly when phosphorylated at Thr35.  \n\n**Answer: phosphatase inhibitor-1 (I-1)**"}
{"idx": 477, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "JNK", "predicted_answer": "Answer: JNK  \n\n**Key evidence from context:**  \nThe text explicitly states: \"DHA treatment... attenuating **JNK phosphorylation, c-Jun phosphorylation** and AP-1 activation.\"  \n- **JNK** (c-Jun N-terminal kinase) is a member of the MAP kinase family.  \n- It directly phosphorylates the transcription factor **c-Jun**, as indicated by the parallel phrasing in the context.  \n\nThis aligns with established molecular biology where JNK phosphorylates c-Jun to regulate AP-1 transcriptional activity"}
{"idx": 478, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Based on the context, SEA0400 is an inhibitor of **NCX1 (the Na⁺/Ca²⁺ exchanger isoform 1)**.\n\n**Key evidence from the context:**\n1. The study examines the role of **NCX** (specifically **NCX1**) in retinal cell death.\n2. **SEA0400** reduces retinal damage in models involving NMDA injection, ischemia-reperfusion, and oxygen-glucose deprivation (OGD).\n3. SEA0400 reverses damage exacerbated by ouabain (which inhibits Na⁺/K⁺-ATPase, leading to Na⁺ overload and subsequent NCX1-mediated Ca²⁺ influx).\n4. The conclusion explicitly states: \"NCX1 may play a role in retinal cell death...\", and SEA0400's efficacy directly targets this mechanism"}
{"idx": 479, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies is **alpha-synuclein**.  \n\nKey evidence from the text:  \n- Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.  \n- Inclusion bodies formed by synphilin-1A recruit alpha-synuclein, resembling Lewy bodies.  \n- Lewy bodies are defined by their accumulation of alpha-synuclein, a hallmark of Parkinson's disease.  \n\nAnswer: **alpha-synuclein**"}
{"idx": 480, "label_json": "{ \"label\": \"True\" }", "question": "Which is the database of molecular recognition features in membrane proteins?", "gold_answer": "mpMoRFsDB", "predicted_answer": "The database of molecular recognition features (MoRFs) in membrane proteins is **mpMoRFsDB**.  \n\n**Answer: mpMoRFsDB**"}
{"idx": 481, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "PLN", "predicted_answer": "Based on the context, the main regulatory molecule of SERCA2A function in cardiac muscle is **phospholamban (PLN)**.  \n\n**Key evidence from the context:**  \n1. \"Dephosphorylated PLN inhibits SERCA2a.\"  \n2. Phosphorylation of PLN (at Ser16 or Thr17) relieves SERCA2a inhibition.  \n3. The entire review focuses on PLN's role in regulating SERCA2a under pathophysiological conditions.  \n\n**Answer: Phospholamban (PLN)**"}
{"idx": 482, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies is **alpha-synuclein**. \n\nThe text explicitly states:  \n*\"DLB is characterized by the widespread distribution of Lewy bodies... Accumulating evidence suggests that [alpha-synuclein] aggregation constitutes one of the first steps preceding Lewy body formation.\"*  \nIt further emphasizes therapeutic strategies targeting *alpha-synuclein aggregation* to prevent Lewy body formation.  \n\nNo other components are mentioned as primary constituents"}
{"idx": 483, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 484, "label_json": "{ \"label\": \"True\" }", "question": "Which is the database of molecular recognition features in membrane proteins?", "gold_answer": "mpMoRFsDB", "predicted_answer": "Answer: mpMoRFsDB"}
{"idx": 485, "label_json": "{ \"label\": \"True\" }", "question": "What is the average diameter of intermediate filaments?", "gold_answer": "10 nm", "predicted_answer": "Based on the context, the average diameter of intermediate filaments is **10 nm**.\n\nThis is explicitly stated in the sentence: \"...the axis of both the **10 nm filaments** and protofilaments.\" The \"10 nm filaments\" refer to the fully assembled intermediate filaments"}
{"idx": 486, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "zfhx1b", "predicted_answer": "Answer: zfhx1b  \n\nThe context explicitly states: \"mutations involving zfhx1b may lead to biliary developmental anomalies\" in a patient with Mowat-Wilson syndrome, directly linking the syndrome to mutations in this gene"}
{"idx": 487, "label_json": "{ \"label\": \"True\" }", "question": "Which is the process that Conserved noncoding elements mostly regulate?", "gold_answer": "development", "predicted_answer": "Based on the context, conserved noncoding elements (specifically HCNEs - Highly Conserved Noncoding Elements) mostly regulate **developmental genes**.  \n\nThis is directly indicated by:  \n1. The study examines \"56 large **HCNE-rich loci**\" associated with \"key **developmental genes**\".  \n2. Bivalent domains (marked by H3K27me3 and H3K4me3) in these HCNE-rich regions silence **developmental genes** while keeping them poised for activation.  \n3. These domains maintain **pluripotency** in embryonic stem cells, a state intrinsically linked to developmental potential.  \n\nThus, HCNEs primarily regulate genes controlling **development**.\n\n**Answer: developmental genes**"}
{"idx": 488, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: sodium-calcium exchanger (NCX)"}
{"idx": 489, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 490, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Answer: 5-HT2A receptors\n\nThe context explicitly states:  \n\"PURPOSE: ... determine 5-HT2A receptor availability...\"  \nand  \n\"CONCLUSION: [18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability...\"  \n\n(5-HT2AR is the abbreviation for 5-hydroxytryptamine 2A receptor, commonly known as serotonin 2A receptor.)"}
{"idx": 491, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most prevalent form of arrhythmia worldwide?", "gold_answer": "AF", "predicted_answer": "Based on the context, the most prevalent form of arrhythmia discussed is **atrial fibrillation (AF)**. The context explicitly studies a \"pacing-induced in vivo model of AF in rats\" and evaluates antiarrhythmic effects on \"AF duration.\" This aligns with global epidemiological data identifying atrial fibrillation as the most common sustained cardiac arrhythmia worldwide.\n\nAnswer: Atrial fibrillation"}
{"idx": 492, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets the **transcribed strand**.\n\n**Key evidence from the context:**\n1.  TCR is described as repairing \"transcription blocking lesions\".\n2.  TCR is explicitly stated to be responsible for the \"repair of transcribed strands\".\n3.  The mechanism involves recognizing a stalled RNA polymerase on the actively transcribed strand.\n\nAnswer: transcribed strand"}
{"idx": 493, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Based on the context, the disease associated with the ectopic expression of the protein encoded by the gene **DUX4** is **FSHD** (Facioscapulohumeral Muscular Dystrophy).\n\n**Answer: FSHD**"}
{"idx": 494, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Based on the context, the drug Gevokizumab targets **Interleukin-1β (IL-1β)**.  \n\nAnswer: Interleukin-1β (IL-1β)"}
{"idx": 495, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "The transcribed strand of active genes is targeted by transcription-coupled repair (TCR).  \n\n**Answer:** Transcribed strand"}
{"idx": 496, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits clotting factor Xa. \n\n**Answer: Factor Xa**"}
{"idx": 497, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits Factor Xa.\n\nAnswer: Factor Xa"}
{"idx": 498, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "dermatitis herpetiformis", "predicted_answer": "Answer: Dermatitis herpetiformis  \n\n**Explanation:**  \nThe context explicitly states that dermatitis herpetiformis is a gluten-dependent skin disease associated with gluten-sensitive enteropathy (celiac disease). It describes the rash as the hallmark manifestation of gluten sensitivity in the skin, characterized by IgA deposits targeting epidermal transglutaminase. No other rash is mentioned in association with gluten"}
{"idx": 499, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "The disease associated with ectopic expression of the protein encoded by the gene DUX4 is **Facioscapulohumeral Muscular Dystrophy (FSHD)**.  \n\n**Key evidence from the context:**  \n- The context explicitly states: \"**FSHD-causing D4Z4 array**\" and \"levels of endogenous sense and antisense D4Z4 transcripts were upregulated in **FSHD myotubes**.\"  \n- It describes DUX4 expression as dependent on the D4Z4 macrosatellite array configuration, which is the genetic basis of FSHD pathogenesis.  \n- The study focuses on transcriptional regulation mechanisms underlying the **characteristic muscle weakness in FSHD**.  \n\nAnswer: **FSHD (Facioscapulohumeral Muscular Dystrophy)**"}
{"idx": 500, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "Phospholamban", "predicted_answer": "Based on the context, the main regulatory molecule of SERCA2a function in cardiac muscle is:\n\n**Phospholamban**\n\nThe context explicitly states:  \n- *\"phospholamban regulation of SERCA2a\"*  \n- *\"functional saturation of SERCA2a by phospholamban\"*  \n- *\"a higher fraction of SERCA2a pumps are regulated by phospholamban\"*  \n\nThis directly identifies phospholamban as the key regulator of SERCA2a activity in cardiac muscle"}
{"idx": 501, "label_json": "{ \"label\": \"True\" }", "question": "Which is the third subunit of the TSC1-TSC2 complex upstream of mTORC1?", "gold_answer": "TBC1D7", "predicted_answer": "Answer: TBC1D7\n\nThe context explicitly states:  \n*\"the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex\"*  \nand confirms TBC1D7 as the third subunit through functional validation (e.g., its knockdown disrupts complex integrity and Rheb-GAP activity)"}
{"idx": 502, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies in dementia with Lewy bodies (DLB) is **alpha-synuclein**. This is explicitly referenced in the context:  \n*\"whether any of the APP isoforms is instrumental in* **alpha-synuclein deposition** *in dementia with Lewy bodies (DLB)\"*.  \n\nLewy bodies are pathological aggregates primarily composed of misfolded alpha-synuclein protein, which defines DLB and related synucleinopathies.  \n\n**Answer: alpha-synuclein**"}
{"idx": 503, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most common type of pediatric cerebellar tumor?", "gold_answer": "medulloblastoma", "predicted_answer": "Based on the context provided, the most common type of pediatric cerebellar tumor is **medulloblastoma (MB)**.\n\n**Key evidence from the context:**\n1.  The study explicitly focuses on a \"mouse **medulloblastoma** model\".\n2.  It discusses \"MB initiation and growth\", \"early MBs\", and \"MB progression\".\n3.  The tumor model used is a \"Patched-1 (Ptch1) conditional knockout (CKO) model\", which is a well-established genetic model for studying **medulloblastoma**.\n4.  The goal is \"early in vivo detection and longitudinal imaging of **MB** progression in the mouse brain\".\n\nAnswer: **medulloblastoma**"}
{"idx": 504, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits factor Xa.  \n\n**Answer:** Factor Xa"}
{"idx": 505, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Based on the context, the ROSIER scale is used for **acute stroke**.\n\nKey evidence from the context:\n1. The instrument was developed to differentiate \"acute stroke from stroke mimics in the ER\".\n2. It was validated on \"suspected acute stroke\" patients.\n3. The study explicitly states: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics\".\n4. All validation metrics (sensitivity, specificity) refer to stroke diagnosis"}
{"idx": 506, "label_json": "{ \"label\": \"True\" }", "question": "Which drug should be used as an antidote in benzodiazepine overdose?", "gold_answer": "Flumazenil", "predicted_answer": "Based on the context, the benzodiazepine antagonist **flumazenil** is discussed as a treatment for hepatic encephalopathy. While the context focuses on hepatic encephalopathy, flumazenil is clinically recognized as the specific antidote for benzodiazepine overdose. It works by competitively inhibiting benzodiazepines at the GABA receptor, reversing sedation.\n\n**Answer: flumazenil**"}
{"idx": 507, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: Stroke"}
{"idx": 508, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa"}
{"idx": 509, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene mutated in the Gaucher disease?", "gold_answer": "glucocerebrosidase", "predicted_answer": "The gene mutated in Gaucher disease is **GBA** (glucocerebrosidase gene).  \n\n**Key points from the context:**  \n- The mutation described (259T) occurs in exon 3 of the cDNA (genomic position 1763), which is part of the *GBA* gene.  \n- Gaucher disease is caused by mutations in *GBA*, leading to deficient glucocerebrosidase enzyme activity.  \n- The context confirms the mutation's location and phenotypic impact without explicitly naming the gene, but *GBA* is universally recognized as the affected gene in Gaucher disease.  \n\nAnswer: **GBA**"}
{"idx": 510, "label_json": "{ \"label\": \"True\" }", "question": "Abnormality in which vertebral region is important in the Bertolotti's syndrome?", "gold_answer": "Lumbosacral", "predicted_answer": "Answer: lumbosacral region (specifically L5 vertebra)  \n\n**Explanation:**  \nThe context describes an \"anomalous enlargement of the left transverse process of the fifth lumbar vertebra\" (L5) forming a pseudarthrosis with the sacrum. This abnormality at the **lumbosacral junction** (L5-S1 level) defines Bertolotti's syndrome"}
{"idx": 511, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Answer: antiparallel  \n\nThe context explicitly states that α-actinin forms an antiparallel dimer and uses this to explain the properties of spectrin isoforms, indicating that spectrin heterodimers (αIβI and αIIβII) follow a similar antiparallel arrangement"}
{"idx": 512, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the number of TAp73 isoforms in humans is **not explicitly stated**.\n\nThe context:\n1.  Mentions \"all TAp73 and DeltaNp73 isoforms\" collectively.\n2.  Focuses specifically on the generation and function of DeltaNp73-deficient mice and the role of the DeltaNp73 isoform itself.\n3.  Does not list or enumerate the specific TAp73 isoforms that exist in humans or mice.\n\nTherefore, the exact number of TAp73 isoforms identified in humans cannot be determined from the given text.\n\n**Answer:** The number of TAp73 isoforms in humans is not specified in the provided context"}
{"idx": 513, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 514, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium binding protein of the sarcoplasmic reticulum?", "gold_answer": "Calsequestrin", "predicted_answer": "Based on the context, the main calcium binding protein of the sarcoplasmic reticulum is **calsequestrin**.  \n\nKey evidence from the context:  \n- The study identifies a 60,000-Da protein as frog cardiac calsequestrin.  \n- It is localized in the lumen of the sarcoplasmic reticulum (SR).  \n- Its presence supports the SR's ability to store Ca²⁺, a core function of calsequestrin.  \n- It shares biochemical and sequence similarities with mammalian cardiac calsequestrin.  \n\nAnswer: **calsequestrin**"}
{"idx": 515, "label_json": "{ \"label\": \"True\" }", "question": "To the ligand of which receptors does Denosumab (Prolia) bind?", "gold_answer": "RANKL", "predicted_answer": "Answer: RANKL  \n\n**Explanation:**  \n- Denosumab (Prolia) is a monoclonal antibody that specifically binds to RANKL (Receptor Activator of Nuclear Factor-kappa B Ligand).  \n- This binding inhibits RANKL from interacting with its receptor RANK on osteoclasts, thereby suppressing bone resorption.  \n- The context explicitly states that RANKL stimulates osteoclast activity, while OPG inhibits RANKL; Denosumab mimics OPG's action by targeting RANKL directly"}
{"idx": 516, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", "gold_answer": "aryl hydrocarbon receptor interacting protein", "predicted_answer": "Answer: AIP"}
{"idx": 517, "label_json": "{ \"label\": \"True\" }", "question": "Mutations in which gene determine response to both erlotinib and gefitinib?", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "predicted_answer": "Answer: epidermal growth factor receptor (EGFR) gene  \n\nThe context explicitly states that the method detects mutations and deletions in the EGFR gene, and these mutations (e.g., exon 19 deletions, L858R, T790M) are clinically relevant for predicting response to EGFR-targeted therapies like erlotinib and gefitinib in non-small-cell lung cancer"}
{"idx": 518, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Answer: repressor"}
{"idx": 519, "label_json": "{ \"label\": \"False\" }", "question": "What is the average diameter of intermediate filaments?", "gold_answer": "10 nm", "predicted_answer": "Based on the provided context, the average diameter of intermediate filaments **is not explicitly stated**. The text only indicates that \"as the temperature increased, both the average diameter and average length of particles in the supernatant increased\" but does not provide specific numerical values for the diameter.\n\n**Answer:** The context does not specify the average diameter"}
{"idx": 520, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most prevalent form of arrhythmia worldwide?", "gold_answer": "af", "predicted_answer": "Answer: Atrial fibrillation"}
{"idx": 521, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 522, "label_json": "{ \"label\": \"False\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "tofacitinib", "predicted_answer": "Based solely on the provided context, **no specific JAK inhibitor is named as approved for rheumatoid arthritis**. The context discusses:\n1.  Activity in expanding JAK inhibitors for autoimmune diseases.\n2.  Development of more selective JAK inhibitors.\n3.  Progress with Syk inhibitors (specifically naming fostamatinib, a Syk inhibitor).\n4.  General progress of kinase inhibitors beyond phase 2 trials for RA.\n5.  New treatment options emerging for RA patients.\n\nIt does not explicitly state the name of any approved JAK inhibitor for rheumatoid arthritis.\n\n**Answer:** The context does not specify which JAK inhibitor is approved for treatment of rheumatoid arthritis"}
{"idx": 523, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 524, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits Factor Xa.  \n\nAnswer: Factor Xa"}
{"idx": 525, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based on the context, **one** TAp73 isoform is explicitly identified. The text states:  \n\"The p73 gene... is expressed as **TA** and **ΔN** isoforms.\"  \n\nThis identifies two broad isoform categories (TA and ΔN), with TAp73 referenced as a single entity distinct from ΔNp73. No subdivisions or variants of TAp73 are mentioned.  \n\n**Answer: 1**"}
{"idx": 526, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 527, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-Synuclein", "predicted_answer": "Answer: alpha-synuclein"}
{"idx": 528, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most common cause of sudden cardiac death in young athletes?", "gold_answer": "hypertrophic cardiomyopathy", "predicted_answer": "Based on the context and established medical knowledge referenced in the study, the most common cause of sudden cardiac death in young athletes is **hypertrophic cardiomyopathy (HCM)**. The study confirms its findings align with prior reports, where HCM is consistently identified as the leading cardiac cause.\n\nAnswer: Hypertrophic cardiomyopathy"}
{"idx": 529, "label_json": "{ \"label\": \"True\" }", "question": "Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?", "gold_answer": "calcineurin", "predicted_answer": "Answer: calcineurin"}
{"idx": 530, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context, [18F]altanserin is explicitly identified as a PET ligand for the **5-HT2A receptor**.\n\n**Answer: 5-HT2A receptors**"}
{"idx": 531, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Answer: Repressor\n\n**Explanation from context:**  \n1. Bach1 binds to the NF-E2/AP-1 (NA) site in the HS-40 enhancer.  \n2. Inhibiting heme (with SA) **increases** Bach1 binding to the NA site, **decreasing** alpha-globin transcription.  \n3. Adding hemin **reduces** Bach1 binding and **restores** alpha-globin expression.  \n4. Heme disrupts Bach1's repressive interaction with the NA site, inducing transcription.  \nThe text explicitly states Bach1 is a \"transcriptional repressor\" and its nuclear accumulation (during repression) correlates with reduced alpha-globin expression"}
{"idx": 532, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: alpha-synuclein  \n\n**Explanation:**  \nThe context explicitly states that alpha-synucleinopathies are defined by abnormal deposits of alpha-synuclein in neurons or glial cells. Lewy bodies (characteristic of Parkinson's disease and dementia with Lewy bodies) are a type of neuronal inclusion in this group. The text confirms that all alpha-synucleinopathies share fibrillar alpha-synuclein accumulations, making it the primary component of Lewy bodies"}
{"idx": 533, "label_json": "{ \"label\": \"True\" }", "question": "Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?", "gold_answer": "beta-Trcp", "predicted_answer": "Based on the context, the E3 ubiquitin ligase mediating IFNAR1 ubiquitination is **β-Trcp**. This is inferred from the mention of IFNAR1's \"destruction motif\" (a characteristic feature targeted by β-Trcp) and the explicit reference to Tyk2 stabilization being independent of β-Trcp binding, confirming β-Trcp's role in the degradation pathway.\n\nAnswer: β-Trcp"}
{"idx": 534, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Mepolizumab?", "gold_answer": "interleukin-5", "predicted_answer": "The monoclonal antibody Mepolizumab targets **interleukin-5 (IL-5)**.  \n\nThis is explicitly stated in the context:  \n*\"Mepolizumab blocks human IL-5 from binding to the α-chain of the IL-5 receptor complex...\"*"}
{"idx": 535, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 536, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "Thyroid", "predicted_answer": "Based on the provided context, **no characteristic hormone abnormalities were detected** in this study of Pendred syndrome. Specifically:\n\n1.  **\"Hormone analysis was normal\"** in all cases.\n2.  **\"Perchlorate test negative\"** in all cases.\n\nWhile Pendred syndrome is classically associated with thyroid abnormalities (particularly goiter and a positive perchlorate discharge test indicating a thyroid organification defect), this study found no evidence of these abnormalities in the examined Tunisian families.\n\n**Answer:** The context reports no detected hormone abnormalities (normal hormone analysis and negative perchlorate test)"}
{"idx": 537, "label_json": "{ \"label\": \"True\" }", "question": "Which drug is benserazide usually co-administered with?", "gold_answer": "L-dopa", "predicted_answer": "Benserazide is usually co-administered with **levodopa (L-dopa)**.  \n\n**Key evidence from the context**:  \n- The text explicitly states that levodopa is administered \"in combination with a peripheral decarboxylase inhibitor (PDI)\" (where benserazide is a PDI).  \n- It references \"Madopar treatment\", a branded combination of **levodopa and benserazide**.  \n- The study compares groups receiving levodopa alone versus levodopa + PDI, confirming benserazide's role as a co-therapy with levodopa.  \n\nAnswer: **Levodopa**"}
{"idx": 538, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 539, "label_json": "{ \"label\": \"True\" }", "question": "Which residue of alpha-synuclein was found to be phosphorylated in Lewy bodies?", "gold_answer": "serine 129", "predicted_answer": "Answer: Ser129"}
{"idx": 540, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban is a **direct factor Xa inhibitor**, meaning it targets clotting **factor Xa**.  \n\n**Answer: factor Xa**"}
{"idx": 541, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 542, "label_json": "{ \"label\": \"False\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based solely on the provided context, the subcellular localization (cytoplasmic or nuclear) of APOBEC3B is **not specified**. The text describes its functional role in inhibiting L1 retrotransposition via a DNA deamination-independent mechanism and a \"preintegration barrier,\" but does not address its cellular compartmentalization.\n\n**Answer:** Not specified in the context"}
{"idx": 543, "label_json": "{ \"label\": \"True\" }", "question": "Which is the human selenoprotein that contains several Se-Cys residues?", "gold_answer": "selenoprotein P", "predicted_answer": "Based on the context, the human selenoprotein containing several selenocysteine (Se-Cys) residues is **selenoprotein P**.\n\n**Key evidence from the context:**\n1.  The cloned bovine protein displays \"high homology to rat and human selenoprotein P cDNA\".\n2.  The discussion centers on this protein and its relation to \"selenoprotein P mRNA\".\n3.  Selenocysteines are encoded by TGA codons within the open reading frame, and the human selenoprotein P cDNA contains these (specifically noted to have 10 in the context, compared to the bovine clone's 12).\n\nAnswer: **selenoprotein P**"}
{"idx": 544, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa**.\n\n**Key evidence from the context:**\n1.  Betrixaban is explicitly classified as one of the \"direct thrombin and **factor Xa inhibitors**\".\n2.  It is referred to as having \"anti-Xa activity\" in the section discussing the potential reversal agent PRT4445"}
{"idx": 545, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL"}
{"idx": 546, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits Factor Xa.\n\nAnswer: Factor Xa"}
{"idx": 547, "label_json": "{ \"label\": \"True\" }", "question": "Is Rheumatoid Arthritis more common in men or women?", "gold_answer": "women", "predicted_answer": "Based on the context, Rheumatoid Arthritis (RA) is more common in women in the Latin American and Caribbean (LAC) population. The study specifically highlights worse outcomes and higher risks for women (e.g., early onset, polyautoimmunity, abdominal obesity, high disability rates), and the conclusion attributes the \"high rates of disability and worse prognosis\" to women in LAC. This implies a higher prevalence and burden among women.\n\n**Answer: Women**"}
{"idx": 548, "label_json": "{ \"label\": \"True\" }", "question": "PBT2 has been tested for which disorder?", "gold_answer": "Alzheimer's disease", "predicted_answer": "Based on the context, PBT2 has been tested for **Alzheimer's disease**.\n\n**Reasoning:**  \nThe context focuses on the \"Metals Hypothesis of Alzheimer's disease\" and describes PBT2 as a compound developed to correct metal-related abnormalities in this disorder. It specifically links amyloid-beta aggregation (a hallmark of Alzheimer's) to zinc/copper dysregulation and positions PBT2 as a therapeutic agent addressing this mechanism"}
{"idx": 549, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on standard pharmacological knowledge (as betrixaban is not explicitly mentioned in the provided context):\n\n**Answer: Factor Xa**\n\n**Explanation:**  \nBetrixaban is a **direct factor Xa (FXa) inhibitor**. It selectively blocks factor Xa in the coagulation cascade, preventing thrombin generation and clot formation. While the context discusses investigational anticoagulants targeting other factors (e.g., FXI, FXII), betrixaban is an established FXa inhibitor used for venous thromboembolism prophylaxis"}
{"idx": 550, "label_json": "{ \"label\": \"False\" }", "question": "What memory problems are reported in the \" Gulf war syndrome\"", "gold_answer": "memory loss", "predicted_answer": "Based solely on the provided context, **no specific memory problems (or any specific symptoms) are reported or detailed for \"Gulf War syndrome\" (GWS).**\n\nThe context states:\n1.  GWV reported higher rates of general ill health and more new medical symptoms/diseases since 1990 compared to NGWV.\n2.  6% of GWV believed they had GWS, and this belief was associated with the highest symptom reporting.\n3.  **Crucially, the study explicitly states: \"This study was the first to use a questionnaire which did not focus specifically on the veterans' symptoms themselves.\"**\n\nTherefore, while the study confirms increased ill health and symptom reporting among GWV (especially those believing they have GWS), it **does not list, describe, or specify any particular symptoms, including memory problems.** The context only provides statistics on the *prevalence* and *number* of symptoms reported, not their nature"}
{"idx": 551, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits **Factor Xa**.  \n\nAnswer: Factor Xa"}
{"idx": 552, "label_json": "{ \"label\": \"True\" }", "question": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?", "gold_answer": "Chaperone-mediated autophagy (CMA)", "predicted_answer": "Answer: chaperone-mediated autophagy"}
{"idx": 553, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: factor Xa"}
{"idx": 554, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Based on established knowledge of spectrin structure and the described lateral association process in the context:\n\nAlpha-spectrin and beta-spectrin subunits form **antiparallel heterodimers**.\n\n**Explanation:**\n1.  Spectrin heterodimers are formed by the side-by-side association of alpha and beta chains running in opposite directions (N-terminus of one aligns with C-terminus of the other).\n2.  The context describes the initiation site near the actin-binding end (the \"head\" region, involving the N-terminus of beta-spectrin and the C-terminus of alpha-spectrin), which is characteristic of the antiparallel arrangement.\n3.  While the specific text snippet doesn't explicitly state \"antiparallel,\" the description of the dimer nucleation site and the established molecular architecture of spectrin heterodimers confirm the antiparallel orientation"}
{"idx": 555, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: Stroke\n\nBased on the context:\n1.  The ROSIER is explicitly compared to the Cincinnati Prehospital Stroke Scale (CPSS).\n2.  Both scales were used on \"suspected stroke patients\".\n3.  The reference standard was the \"final discharge diagnosis of stroke or transient ischemic attack\".\n4.  The results discuss diagnostic accuracy for identifying stroke.\n5.  The conclusion emphasizes its use for \"potential stroke patients\" and that it cannot replace comprehensive assessment for \"stroke as a diagnosis\""}
{"idx": 556, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the following hormone abnormalities are common in Williams syndrome (WBS):\n1.  **Hypercalcemia (elevated blood calcium levels)** - This is a well-known feature of Williams syndrome, particularly in infancy.\n2.  **Thyroid dysfunction** - As described in the case, congenital hypothyroidism due to thyroid hypoplasia can occur, necessitating regular monitoring of thyroid morphology and function (TSH, FT4) even if neonatal screening is negative.\n\n**Answer: Hypercalcemia and thyroid dysfunction.**"}
{"idx": 557, "label_json": "{ \"label\": \"True\" }", "question": "Which protein is causing Netherton syndrome?", "gold_answer": "LEKTI", "predicted_answer": "Answer: LEKTI"}
{"idx": 558, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-Synuclein", "predicted_answer": "The main component of Lewy bodies is **alpha-synuclein**.  \n\n**Key evidence from the context**:  \n- Lewy bodies (LBs) are the pathological hallmark of dementia with Lewy bodies (DLB).  \n- The study directly investigates alpha-synuclein isoforms (112 and 140) in DLB patients, confirming their dysregulation in this disease.  \n- Alpha-synuclein aggregation is the defining feature of Lewy bodies in neurodegenerative disorders like DLB.  \n\n**Answer**: alpha-synuclein"}
{"idx": 559, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 560, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the text refers to \"TAp73\" as a single category or form (\"transcriptionaly active TAp73\") distinct from \"DeltaNp73\". It does not specify the number of individual TAp73 isoforms identified in humans.\n\n**Answer: The context does not specify a number.** It presents TAp73 as one functional form (transcriptionally active) compared to DeltaNp73 (dominant-negative)"}
{"idx": 561, "label_json": "{ \"label\": \"True\" }", "question": "Which is the E3 ubiquitin ligase which ubiquitinates IkB leading to its proteasomal degradation?", "gold_answer": "beta-TrCP", "predicted_answer": "The E3 ubiquitin ligase that ubiquitinates phosphorylated IkBα (inhibitor of kappa B alpha) is **SCF<sup>β-TrCP</sup>** (Skp1–Cullin1–F-box protein complex with β-TrCP as the substrate-recognition component). \n\n**Key points:**  \n1. Upon stimulation (e.g., TNF-α), IκBα is phosphorylated by the IKK complex.  \n2. Phosphorylated IκBα is recognized by β-TrCP, the F-box protein in the SCF E3 ubiquitin ligase complex.  \n3. SCF<sup>β-TrCP</sup> polyubiquitinates IκBα, targeting it for proteasomal degradation.  \n\n*Note: While the context discusses clusterin's role in regulating NF-κB by interacting with phospho-IκBα, it does not name the E3 ligase. The answer is derived from established knowledge of the NF-κB pathway.*"}
{"idx": 562, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic domain of histone methyltransferases?", "gold_answer": "SET domain", "predicted_answer": "Answer: SET domain"}
{"idx": 563, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 functions as a **repressor**. \n\nKey evidence:\n1. Bach1 deficiency leads to **impaired osteoclastogenesis** (reduced OC formation).\n2. Bach1 deficiency causes **resistance to RANKL-dependent HO-1 reduction**, resulting in sustained HO-1 expression that suppresses osteoclast differentiation.\n3. Knocking down HO-1 in Bach1-deficient cells **restores osteoclastogenesis**, confirming HO-1 as a key target repressed by BACH1.\n4. Bach1 deletion reduces expression of osteoclast-promoting genes (RANK, TRAF6/c-Fos/NF-ATc1, Blimp1), indicating it represses pathways required for osteoclast formation.\n\nAnswer: **Repressor**"}
{"idx": 564, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 565, "label_json": "{ \"label\": \"True\" }", "question": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?", "gold_answer": "Nestin", "predicted_answer": "Based on the context, the intermediate filament protein used as a non-specific marker for neuronal precursor cells is **Nestin**.  \n\nThis is explicitly stated in the context:  \n> \"only **Prominin-1/Nestin double-positive cells** fulfilled the defining stem cell criteria\"  \n\nNestin is a well-established intermediate filament marker for neural stem/progenitor cells in neurogenic niches like the subventricular zone and subgranular zone. Its expression identifies undifferentiated, proliferative precursor cells.  \n\n**Answer: Nestin**"}
{"idx": 566, "label_json": "{ \"label\": \"True\" }", "question": "Which deficiency is the cause of restless leg syndrome?", "gold_answer": "iron", "predicted_answer": "Answer: Iron deficiency"}
{"idx": 567, "label_json": "{ \"label\": \"True\" }", "question": "What is the inheritance pattern of Li–Fraumeni syndrome?", "gold_answer": "autosomal dominant", "predicted_answer": "Answer: Autosomal dominant\n\nBased on the context:\n- Tumors arise in heterozygotes\n- They display loss of heterozygosity (LOH)\n- This follows Knudson's two-hit hypothesis, which is a hallmark of human autosomal dominant cancer syndromes\n- The zebrafish p53 mutant allele shows dominant-negative activity in vivo"}
{"idx": 568, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 569, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Based on the context, the ROSIER scale is used for **stroke**, including transient ischemic attack (TIA). \n\n**Key evidence from the context:**  \n1. The study explicitly evaluates ROSIER as a \"stroke recognition tool\" in suspected stroke patients.  \n2. The reference standard diagnosis was \"stroke or transient ischemic attack\" made by neurologists.  \n3. Performance metrics (sensitivity, specificity, etc.) are reported for diagnosing these conditions.  \n4. The conclusion emphasizes its use in prehospital settings for potential stroke patients.  \n\nAnswer: **stroke**"}
{"idx": 570, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Answer: Xist (X inactive-specific transcript)\n\n**Key evidence from the context:**  \n1. The study explicitly analyzes \"**Xist transcription** and the onset of X chromosome inactivation.\"  \n2. Xist expression precedes late X-chromosome replication, a hallmark of inactivation.  \n3. The authors conclude that the pattern is \"compatible with a possible role of **bovine Xist** in the initiation of X chromosome inactivation.\"  \n\n*(Note: \"Xist\" is the standardized abbreviation for the X-inactive specific transcript responsible for silencing one X chromosome in female mammals.)*"}
{"idx": 571, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "XIST", "predicted_answer": "Based on the context, the transcript responsible for X-chromosome inactivation is **XIST**.  \n\n**Key evidence from the context:**  \n1. The text explicitly states: \"elucidating a function for **XIST** in the process of X inactivation.\"  \n2. It describes evolutionary studies of \"the human and murine **XIST** genes\" and their role in X inactivation.  \n3. Features like transcription start sites and methylation patterns specific to **XIST** are conserved across species.  \n4. The mouse homolog is referred to as **Xist** (e.g., \"Xist conserved 5' repeats\").  \n\n**Answer:** XIST"}
{"idx": 572, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\n**Evidence from the context:**\n1. Bach1-deficient mice (Bach1(-/-)) showed **significantly higher HO-1 mRNA expression** than wild-type mice (Bach1(+/+)) in all brain sites.\n2. Higher HO-1 induction occurred after cold injury in Bach1(-/-) mice compared to controls.\n3. The study concludes Bach1 regulates HO-1 expression by suppressing it constitutively and inducibly.\n\nThese findings indicate BACH1 **represses** HO-1 transcription, as its absence (in knockout mice) leads to increased HO-1 expression"}
{"idx": 573, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "SAM", "predicted_answer": "Answer: S-adenosyl-l-methionine (SAM)"}
{"idx": 574, "label_json": "{ \"label\": \"True\" }", "question": "Which is the histone residue methylated by MLL1?", "gold_answer": "H3K4", "predicted_answer": "Answer: H3K4 (histone H3 lysine 4)  \n\nThe context explicitly states: \"we identified a molecular mechanism by which the recruitment of a **H3K4 histone methyltransferase complex** on the promoter...\", and identifies MLL1 as part of this complex. MLL1 is a well-established methyltransferase specific for H3K4 methylation"}
{"idx": 575, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the pharmacological class of betrixaban and related anticoagulants discussed in the context:\n\n**Answer: Factor Xa**  \n\n*(Note: Betrixaban is a direct Factor Xa inhibitor, consistent with the class of \"new oral anticoagulants\" (e.g., rivaroxaban) referenced in the context, though betrixaban itself is not explicitly named.)*"}
{"idx": 576, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Answer: transcribed strand"}
{"idx": 577, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of Wilson's disease?", "gold_answer": "autosomal recessive", "predicted_answer": "Answer: Autosomal recessive  \n\nThe context explicitly states that Wilson's disease is among the conditions considered in the differential diagnosis but does not detail its inheritance. However, Wilson's disease is universally recognized in biomedicine as an **autosomal recessive disorder** caused by mutations in the *ATP7B* gene. This aligns with standard medical knowledge, consistent with the context's discussion of recessive inheritance for other disorders like HSD"}
{"idx": 578, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 579, "label_json": "{ \"label\": \"True\" }", "question": "Mutations in which gene determine response to both erlotinib and gefitinib?", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "predicted_answer": "Based on the context, mutations in the **EGFR** (epidermal growth factor receptor) gene determine response to both erlotinib and gefitinib.  \n\nKey evidence from the context:  \n1. Mutations in the **EGFR tyrosine kinase (TK) domain** (specifically exon 19 deletions and exon 21 point mutations) were found in gefitinib-sensitive and erlotinib-sensitive tumors.  \n2. No mutations were detected in tumors refractory to either drug.  \n3. Functional studies (immunoblotting) confirmed these EGFR mutations alter drug sensitivity.  \n\n**Answer: EGFR**"}
{"idx": 580, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of  long QT  Jervell and Lange-Nielsen syndrome?", "gold_answer": "autosomal recessive", "predicted_answer": "Based on the context, Jervell and Lange-Nielsen syndrome (JLNS) has an **autosomal recessive** mode of inheritance.  \n\nKey evidence from the context:  \n1. JLNS requires mutations in both alleles of either *KCNQ1* or *KCNE1* genes.  \n2. Heterozygous carriers (one mutated allele) may exhibit prolonged QTc or LQTS symptoms but do not develop the full JLNS phenotype (which includes congenital deafness).  \n3. The text explicitly contrasts JLNS (recessive) with other forms of LQTS that can be autosomal dominant.  \n\nAnswer: Autosomal recessive"}
{"idx": 581, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?", "gold_answer": "Clostridium botulinum", "predicted_answer": "The bacterium responsible for botulism (sausage-poisoning) is *Clostridium botulinum*.  \n\n**Answer:** *Clostridium botulinum*"}
{"idx": 582, "label_json": "{ \"label\": \"True\" }", "question": "Which protein phosphatase has been found to interact with the heat shock protein, HSP20?", "gold_answer": "PP1", "predicted_answer": "Answer: protein phosphatase-1"}
{"idx": 583, "label_json": "{ \"label\": \"True\" }", "question": "What is generic name of drug Adempas?", "gold_answer": "Riociguat", "predicted_answer": "Answer: Riociguat"}
{"idx": 584, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "The ROSIER scale is used for identifying **stroke or transient ischemic attack (TIA)** in emergency department settings.  \n\n**Answer: Stroke or transient ischemic attack**"}
{"idx": 585, "label_json": "{ \"label\": \"True\" }", "question": "Which drug is benserazide usually co-administered with?", "gold_answer": "l-DOPA", "predicted_answer": "Based on standard pharmacological knowledge for Parkinson's disease treatment:\n\n**Answer: L-DOPA**\n\n**Explanation:**  \nBenserazide is a peripheral aromatic L-amino acid decarboxylase inhibitor (AAADI). It is **routinely co-administered with L-DOPA** (e.g., in the combination drug *Madopar* or *co-beneldopa*) to prevent the peripheral breakdown of L-DOPA into dopamine. This allows more L-DOPA to cross the blood-brain barrier, enhancing central dopamine synthesis while reducing peripheral side effects like nausea and hypotension. The context focuses on L-DOPA therapy, reinforcing this standard combination"}
{"idx": 586, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia chromosome-positive chronic myelogenous leukemia is **BCR-ABL**. \n\nThis fusion kinase results from the reciprocal translocation between chromosomes 9 and 22 (t(9;22)), which generates the Philadelphia chromosome and drives uncontrolled myeloid cell proliferation in CML. Imatinib specifically inhibits BCR-ABL's constitutive tyrosine kinase activity"}
{"idx": 587, "label_json": "{ \"label\": \"True\" }", "question": "What disease is Velcade (bortezomib) mainly used for?", "gold_answer": "multiple myeloma", "predicted_answer": "Velcade (bortezomib) is mainly used for **multiple myeloma**.\n\nAnswer: multiple myeloma"}
{"idx": 588, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context provided, betrixaban inhibits **Factor Xa**.\n\n**Explanation:**\n1.  The context explicitly states that newer anticoagulants include \"the factor Xa inhibitors\".\n2.  It further explains that these include \"Direct and indirect factor Xa inhibitors\".\n3.  While betrixaban is not specifically named in the provided text, its name follows the established convention for **direct** Factor Xa inhibitors (ending in \"-xaban\", like rivaroxaban, apixaban, edoxaban).\n4.  Therefore, betrixaban belongs to the class of drugs described as \"direct factor Xa inhibitors\" and inhibits clotting Factor Xa"}
{"idx": 589, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the exact number of TAp73 isoforms identified in humans is **not specified**. The context refers to \"the pro-apoptotic TAp73 isoforms\" (plural) but does not quantify them. The study focuses on transcriptional regulation via promoter methylation rather than isoform enumeration.\n\nAnswer: The context does not specify the number"}
{"idx": 590, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "JNK", "predicted_answer": "Based on the context and general biochemical knowledge:\n\n**JNK** (c-Jun N-terminal kinase) phosphorylates the transcription factor c-jun.\n\nThe context explicitly mentions JNK (\"the phosphorylation of p38MAPK and **JNK**\"), and JNK is the specific MAP kinase known to phosphorylate c-jun at its N-terminal activation domain"}
{"idx": 591, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa  \n\n**Explanation:**  \nThe context states that \"factor Xa inhibitors rivaroxaban and apixaban\" are oral anticoagulants. Betrixaban belongs to the same class of direct factor Xa inhibitors, targeting clotting factor Xa to prevent thrombus formation. While betrixaban isn't explicitly named, the class mechanism is clearly defined in the provided text.  \n\n</fin>"}
{"idx": 592, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "SAM", "predicted_answer": "Based on the context, the methyl donor for histone methyltransferases is **S-adenosylmethionine (SAMe)**. \n\nKey evidence from the context:\n- SAMe is explicitly described as modulating histone methylation.\n- The study focuses on SAMe's role in inhibiting LPS-induced gene expression via histone methylation changes.\n- SAMe is the universal methyl donor for biological methylation reactions, including histone methylation"}
{"idx": 593, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Answer: Interleukin-1β (IL-1β)  \n\nThe context explicitly states:  \n- \"gevokizumab negatively modulates IL-1β signaling\"  \n- \"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor\"  \n- \"gevokizumab is a unique inhibitor of IL-1β signaling\"  \n\nThus, Gevokizumab directly targets IL-1β"}
{"idx": 594, "label_json": "{ \"label\": \"True\" }", "question": "Which bone protein is used in archaelogy for dating and species identification?", "gold_answer": "collagen", "predicted_answer": "Answer: bone collagen"}
{"idx": 595, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "PLN", "predicted_answer": "Based on the context, the main regulatory molecule of SERCA2A function in cardiac muscle is **phospholamban (PLN)**.  \n\nKey evidence from the context:  \n- Dephosphorylated PLN inhibits SERCA2a.  \n- Phosphorylation of PLN (at Ser16 or Thr17) relieves this inhibition, enhancing SR Ca²⁺ uptake.  \n- The review specifically focuses on PLN's role in regulating SERCA2a activity under pathophysiological conditions.  \n\n**Answer: Phospholamban**"}
{"idx": 596, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Mepolizumab?", "gold_answer": "interleukin-5", "predicted_answer": "Answer: Interleukin-5 (IL-5)  \n\nThe context explicitly states:  \n- \"Mepolizumab is an **anti-interleukin-5 monoclonal antibody**\"  \n- \"Interleukin-5 stimulates the production... of eosinophils\"  \n- It is described as an \"**anti-IL-5 monoclonal antibody**\" in multiple instances.  \n\nThus, Mepolizumab specifically targets the cytokine **Interleukin-5**"}
{"idx": 597, "label_json": "{ \"label\": \"True\" }", "question": "Which drug should be used as an antidote in benzodiazepine overdose?", "gold_answer": "flumazenil", "predicted_answer": "Based on the context, the antidote for benzodiazepine overdose is:  \n**Flumazenil**.  \n\n**Key evidence from the context**:  \n1. Flumazenil is explicitly used to reverse chlordiazepoxide (a benzodiazepine) toxicity.  \n2. Continuous infusion of flumazenil prevented resedation and respiratory insufficiency in the case.  \n3. The text states that continuous-infusion flumazenil is warranted for benzodiazepine toxicity to restore respiratory function and mental awareness.  \n\nAnswer: **Flumazenil**"}
{"idx": 598, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "adenosylmethionine", "predicted_answer": "Answer: S-adenosyl methionine (SAM)  \n\nHistone methyltransferases universally use **S-adenosyl methionine (SAM)** as the methyl group donor. This is consistent with the general mechanism described in the context, where methionine-derived methyl groups are transferred to target residues (e.g., lysine in cytochrome c)"}
{"idx": 599, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic domain of histone methyltransferases?", "gold_answer": "SET domain", "predicted_answer": "The characteristic domain of histone methyltransferases is the **SET domain**.\n\nAnswer: SET domain"}
{"idx": 600, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Based on the context, Orteronel inhibits the enzyme **CYP17A1**, specifically targeting its **17,20-lyase** activity more potently than its 17α-hydroxylase activity.\n\n**Key evidence from the context:**\n1.  Explicitly identified as a \"17,20-lyase inhibitor\".\n2.  Inhibits \"CYP17A1 enzymatic activity\".\n3.  Suppresses androgen production (DHEA, testosterone) dependent on CYP17A1.\n4.  Inhibits \"17,20-lyase activity 5.4 times more potently than 17-hydroxylase activity\" in enzyme assays.\n5.  Inhibits DHEA production (17,20-lyase dependent) 27 times more potently than cortisol production (17α-hydroxylase dependent) in human adrenal cells.\n\n**Answer: CYP17A1**"}
{"idx": 601, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "medicarpin", "predicted_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.  \n\n**Key evidence from the context:**  \n- Isoflavone reductase (IFR) is explicitly described as \"the penultimate enzyme in **medicarpin biosynthesis**.\"  \n- The accumulation of medicarpin is directly linked to IFR induction kinetics.  \n- Medicarpin glucoside accumulates in healthy plant parts, confirming its role as the core phytoalexin compound.  \n\nAnswer: **medicarpin**"}
{"idx": 602, "label_json": "{ \"label\": \"True\" }", "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?", "gold_answer": "LepChorionDB", "predicted_answer": "Answer: LepChorionDB"}
{"idx": 603, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: Bcr-Abl"}
{"idx": 604, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nKey evidence from the context:\n1. Directly states: \"Bach1 heterodimerizes with small Maf proteins to **repress** Maf recognition element (MARE)-dependent gene expression.\"\n2. Bach1 binding to MARE increases when heme is depleted (SA treatment), correlating with reduced beta-globin expression.\n3. Heme blocks Bach1-MARE binding, reversing repression and restoring beta-globin transcription.\n4. Mutated Bach1 lacking heme-binding sites constitutively represses the beta-globin promoter, eliminating heme responsiveness.\n\nThe mechanism confirms heme positively regulates beta-globin expression by *inactivating* the repressor Bach1.\n\nAnswer: Repressor"}
{"idx": 605, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies is **alpha-synuclein**.  \n\nThe context explicitly states:  \n> *\"The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons\"*  \nand further clarifies that Lewy bodies (a hallmark of Parkinson's disease and dementia with Lewy bodies) are neuronal inclusions composed of aggregated alpha-synuclein.  \n\n**Answer: alpha-synuclein**"}
{"idx": 606, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context, [18F]altanserin is used to evaluate **5-HT2A receptors (5-HT2AR)**.\n\nAnswer: 5-HT2A receptors"}
{"idx": 607, "label_json": "{ \"label\": \"False\" }", "question": "How is bladder wall thickness measured?", "gold_answer": "ultrasound", "predicted_answer": "Answer: transvaginal ultrasound"}
{"idx": 608, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Based on the context, alpha-spectrin and beta-spectrin subunits form **antiparallel heterodimers**.  \n\nKey evidence from the text:  \n1. \"lie nearly opposite each other on **antiparallel spectrin dimers** of a tetramer.\"  \n2. The fragment HEα4,5 lies opposite the interaction site between the C-terminal of β-spectrin and N-terminal of α-spectrin, confirming an antiparallel orientation.  \n\nThis arrangement is critical for spectrin's flexibility and function in red blood cells.  \n\nAnswer: antiparallel"}
{"idx": 609, "label_json": "{ \"label\": \"False\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "SIP-1", "predicted_answer": "Answer: ZEB2"}
{"idx": 610, "label_json": "{ \"label\": \"True\" }", "question": "Which bone protein is used in archaelogy for dating and species identification?", "gold_answer": "collagen", "predicted_answer": "Collagen"}
{"idx": 611, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the characteristic hormone abnormality associated with Pendred syndrome is:\n\n**An organification defect in the thyroid gland**, identified by a positive potassium perchlorate discharge test. This defect impairs the incorporation of iodine into thyroglobulin, potentially leading to hypothyroidism and goiter.\n\n*   **Supporting Evidence from Context:**\n    *   The study explicitly measured \"iodine organification in the thyroid identified in a test with potassium perchlorate\".\n    *   Pendred syndrome is defined by sensorineural hearing loss, inner ear malformations (like enlarged vestibular aqueduct), and this specific thyroid organification defect. While overt hypothyroidism isn't always present, the organification defect is the hallmark endocrine abnormality"}
{"idx": 612, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Based on the established biomedical context from prior research (as referenced in the initial example provided), JTV519 is a derivative of the **1,4-benzothiazepine** group of chemical compounds.\n\n**Answer: 1,4-benzothiazepine**"}
{"idx": 613, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 614, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "FSHD (Facioscapulohumeral Muscular Dystrophy) is associated with the ectopic expression of the protein encoded by the gene DUX4.  \n\nAnswer: FSHD"}
{"idx": 615, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-Synuclein", "predicted_answer": "The main component of Lewy bodies is **alpha-synuclein**.  \n\n**Answer:** alpha-synuclein"}
{"idx": 616, "label_json": "{ \"label\": \"True\" }", "question": "Which drug is benserazide usually co-administered with?", "gold_answer": "L-Dopa", "predicted_answer": "Answer: L-Dopa\n\nBased on the context, benserazide is consistently co-administered with L-Dopa (Levodopa) as part of the combination \"L-Dopa/benserazide\" to treat Parkinson's disease. This is explicitly stated in the text:  \n*\"L-Dopa/benserazide increased locomotion and improved parkinsonism\"* and  \n*\"Co-administration of JL-18... with L-Dopa/benserazide\"*.  \n\nBenserazide is a peripheral decarboxylase inhibitor that enhances L-Dopa's efficacy by preventing its peripheral breakdown, making L-Dopa the primary drug it is paired with"}
{"idx": 617, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets the **transcribed strand**.\n\nThe context explicitly states:  \n*\"An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage\"* and later refers to TCR occurring in the *\"transcribed strand\"*.  \n\nAnswer: **transcribed strand**"}
{"idx": 618, "label_json": "{ \"label\": \"True\" }", "question": "How is myotonic dystrophy inherited?", "gold_answer": "autosomal dominant", "predicted_answer": "Myotonic dystrophy is inherited in an **autosomal dominant** pattern.  \n\nThis means:  \n- A single copy of the mutated gene (from either parent) is sufficient to cause the disorder.  \n- Affected individuals have a 50% chance of passing the mutation to each child.  \n- The condition shows variable expressivity and anticipation (worsening severity across generations), consistent with the described \"clinical polymorphism.\"  \n\n*(Answer derived from the context's emphasis on genetic inheritance studies and established biomedical knowledge of myotonic dystrophy pathogenesis.)*"}
{"idx": 619, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the common hormone abnormalities in Williams syndrome are related to thyroid dysfunction, specifically:\n\n1.  **Subclinical hypothyroidism** (15% prevalence)\n2.  **Overt hypothyroidism** (10% prevalence)\n\nAnswer: Subclinical hypothyroidism and overt hypothyroidism"}
{"idx": 620, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "Based on the context, the gene responsible for Mowat-Wilson syndrome is **Zfhx1b**.  \n\nAnswer: Zfhx1b"}
{"idx": 621, "label_json": "{ \"label\": \"False\" }", "question": "Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?", "gold_answer": "phosphatase 2B", "predicted_answer": "The calcium/calmodulin-dependent protein phosphatase involved in NFAT activation is **calcineurin (CaN)**.  \n\nThis is directly stated in the context:  \n- \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization\"  \n- Current immunosuppressants like cyclosporin A and FK506 \"block CaN activity\"  \n- BTP compounds do not directly inhibit \"dephosphorylation of NFAT by CaN in vitro\"  \n\nCalcineurin dephosphorylates NFAT, enabling its nuclear translocation and subsequent cytokine gene transcription"}
{"idx": 622, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "medicarpin", "predicted_answer": "Answer: Medicarpin  \n\n**Explanation from Context:**  \n- The text explicitly identifies medicarpin as the phytoalexin in alfalfa, stating:  \n  > *\"During elicitation, [(14)C]phenylalanine was incorporated predominantly into **medicarpin**...\"*  \n  > *\"...suggesting that the **phytoalexin** [medicarpin] could be released from a preformed conjugate...\"*  \n- Medicarpin is induced by elicitors (stressors), consistent with its role as a phytoalexin, while afrormosin conjugates are constitutive and unaffected by elicitation"}
{"idx": 623, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.", "gold_answer": "cerebral hemiatrophy", "predicted_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is **cerebral hemiatrophy** (unilateral cerebral atrophy), typically accompanied by compensatory changes such as:\n- Ipsilateral calvarial thickening\n- Hyperpneumatization of the frontal sinuses\n- Elevation of the petrous ridge\n- Contralateral hemiplegia\n\nThis structural asymmetry is the defining radiological and pathological hallmark of the syndrome, resulting from early brain injury (congenital or acquired).\n\n*Answered based on the clinical presentation of spastic hemiplegia and associated neurological deficits in the case.*"}
{"idx": 624, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets the **transcribed strand** of active genes.  \n\n**Key evidence from the context:**  \n1. TCR is explicitly defined as the repair pathway for \"active genes.\"  \n2. This contrasts with \"bulk DNA repair\" (which handles inactive DNA).  \n3. CS cells (deficient in TCR) cannot repair active genes but retain bulk DNA repair.  \n4. XP-C cells (proficient in TCR) retain the ability to repair active genes despite deficient bulk repair.  \n\nThe \"transcribed strand\" is the DNA strand used as a template for RNA synthesis, where damage blocks transcription and triggers TCR"}
{"idx": 625, "label_json": "{ \"label\": \"True\" }", "question": "How is myotonic dystrophy inherited?", "gold_answer": "autosomal dominant", "predicted_answer": "Myotonic dystrophy (including both DM1 and DM2) is inherited in an **autosomal dominant** pattern. This means a single copy of the mutated gene from either parent is sufficient to cause the disorder.\n\n**Explanation from the context:**  \nWhile the provided text describes clinical features of DM2 in a specific patient group (Jewish European ancestry), it does not explicitly state the inheritance pattern. However, the established genetic basis of myotonic dystrophy (DM1 and DM2) is autosomal dominant inheritance, which is consistent with the observed familial transmission patterns in broader medical literature"}
{"idx": 626, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, thyroid hormone abnormalities—specifically **subclinical hypothyroidism** with an exaggerated/prolonged TSH response to TRH and reduced TSH bioactivity—are observed in Williams syndrome (WS), though they are not routinely investigated. These abnormalities resemble hypothalamic hypothyroidism and may relate to genes at 7q11.23 (contiguous to the WS deletion region) affecting thyroid development.  \n\n**Answer:** Subclinical hypothyroidism with abnormal TSH dynamics and reduced TSH bioactivity"}
{"idx": 627, "label_json": "{ \"label\": \"True\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "tofacitinib", "predicted_answer": "Based on the provided context, the JAK inhibitor approved for treatment of rheumatoid arthritis is **tofacitinib**.  \n\nThe context explicitly states:  \n*\"tofacitinib, an oral Janus kinase (JAK) inhibitor\"*  \nand references its clinical use in rheumatoid arthritis (RA) patients across phase 2 studies. Tofacitinib (marketed as **Xeljanz®**) is FDA-approved for RA.  \n\n**Answer: tofacitinib**"}
{"idx": 628, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban is a new oral anticoagulant with a pharmacological profile similar to the other mentioned agents (dabigatran, rivaroxaban, apixaban, endoxaban). While the context does not explicitly name the inhibited clotting factor, it groups betrixaban with drugs known to inhibit **Factor Xa** (rivaroxaban, apixaban, endoxaban).\n\n**Answer: Factor Xa**"}
{"idx": 629, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 630, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic domain of histone methyltransferases?", "gold_answer": "SET domain", "predicted_answer": "The characteristic domain of histone methyltransferases is the **SET domain**.  \n\nThis is explicitly stated in the context:  \n> *\"SUV39H1 utilizes both the chromodomain and the **SET domain** for catalysis.\"*  \n\nWhile histone methyltransferases may contain additional domains (e.g., chromodomains), the **SET domain** is the conserved catalytic domain responsible for methyltransferase activity"}
{"idx": 631, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone deficiency is implicated in the Costello syndrome ?", "gold_answer": "growth hormone", "predicted_answer": "Based solely on the provided context, **no hormone deficiency is mentioned or implicated in Costello syndrome.**\n\nThe context explicitly states:\n1.  Costello syndrome is caused by **germline HRAS mutations**.\n2.  The key differences discussed are genetic (mutations in HRAS vs. BRAF/MEK1/MEK2), clinical features (patterns of congenital heart defects, hypertrophic cardiomyopathy, tachycardia), and tumor risk/histology.\n3.  There is **no reference** to any hormone, endocrine pathway, or hormone deficiency in the description of Costello syndrome or its comparison to CFC syndrome.\n\nTherefore, the provided text does not associate any hormone deficiency with Costello syndrome. The defect is solely attributed to the HRAS mutation and its effects on the MAP kinase pathway"}
{"idx": 632, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 633, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Answer: 1  \n\nThe context identifies five N-terminal isoforms of p73: **TAp73**, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73. TAp73 is explicitly listed as one distinct isoform among these five. No additional TAp73 variants are mentioned, confirming that a single TAp73 isoform was measured in this study.  \n\n**Key evidence from context**:  \n> \"The expression of all 5 N-terminal isoforms (**TAp73**, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured...\""}
{"idx": 634, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\"", "gold_answer": "delta-distance", "predicted_answer": "The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is the **delta-distance**.  \n\nAnswer: delta-distance"}
{"idx": 635, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "Na(+)/Ca(2+) exchanger", "predicted_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)"}
{"idx": 636, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?", "gold_answer": "Clostridium botulinum", "predicted_answer": "The bacterium responsible for botulism (sausage-poisoning) is **Clostridium botulinum**.  \n\n**Key points from the context:**  \n- The context explicitly references \"botulinum neurotoxin (BoNT) intoxication,\" which is produced by *Clostridium botulinum*.  \n- Botulism is historically termed \"sausage-poisoning\" (*botulus* = sausage in Latin), originating from outbreaks linked to contaminated meat products.  \n- *Clostridium botulinum* produces the botulinum toxin, the deadliest known toxin (lethal dose ~1 ng/kg).  \n\n**Answer:** Clostridium botulinum"}
{"idx": 637, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "Medicarpin", "predicted_answer": "Based on the context, the major phytoalexin in alfalfa (*Medicago sativa L.*) is **medicarpin**. \n\nThis is directly supported by the text, which states:  \n- *\"IOMT transcripts are rapidly induced... prior to the increase in IOMT activity and* **medicarpin accumulation**.\"  \n- The entire study focuses on enzymes (like IOMT) involved in **medicarpin biosynthesis**"}
{"idx": 638, "label_json": "{ \"label\": \"False\" }", "question": "Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?", "gold_answer": "SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)", "predicted_answer": "Answer: beta-Trcp\n\nBased on the context:\n- The text explicitly states: \"the ability of IFNAR1 to recruit beta-Trcp\" is essential for its ubiquitination and degradation.\n- It further concludes: \"IFNAR1, which is a beta-Trcp substrate\".\n\nTherefore, the E3 ubiquitin ligase mediating IFNAR1 ubiquitination and degradation is **beta-Trcp**"}
{"idx": 639, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "Based on the context provided:  \n**ZFHX1B** is the gene responsible for Mowat-Wilson syndrome.  \n\nAnswer: ZFHX1B"}
{"idx": 640, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL"}
{"idx": 641, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 642, "label_json": "{ \"label\": \"True\" }", "question": "Inhibition of which transporter is the mechanism of action of drug Canagliflozin?", "gold_answer": "sodium glucose co-transporter 2", "predicted_answer": "Answer: Sodium glucose co-transporter 2 (SGLT2)  \n\n**Directly from the context:**  \n\"Sodium glucose co-transporter 2 inhibition is a novel mode of treatment for type 2 diabetes mellitus (T2DM).\"  \nThe drug assessed in the study is **canagliflozin**, confirming its mechanism of action targets SGLT2"}
{"idx": 643, "label_json": "{ \"label\": \"False\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "Fungi", "predicted_answer": "Based on the context, microsporidia (specifically referred to as \"formerly microsporidian metchnikovellids\") are classified within the phylum **Sporozoa**, which belongs to the kingdom **Protozoa**.\n\n**Answer: Protozoa**"}
{"idx": 644, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL tyrosine kinase"}
{"idx": 645, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "Jnk", "predicted_answer": "Answer: Jnk"}
{"idx": 646, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: Acute stroke"}
{"idx": 647, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 648, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is targeted by Evolocumab?", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "predicted_answer": "Evolocumab targets **PCSK9 (proprotein convertase subtilisin/kexin type 9)**.  \n\nThis monoclonal antibody inhibits PCSK9, enhancing LDL receptor recycling on hepatocytes and significantly reducing LDL-C levels, as described in the context.\n\nAnswer: PCSK9"}
{"idx": 649, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 650, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "c-Jun NH2-terminal kinase", "predicted_answer": "Based on the context and biological knowledge, the MAP kinase that phosphorylates the transcription factor c-jun is **JNK (c-Jun N-terminal kinase)**.\n\n**Key reasoning:**\n1.  c-jun is a core component of the **AP-1** transcription factor complex.\n2.  The context discusses inhibition of **AP-1 activation** by E2/E2-BSA.\n3.  While the context focuses on *p38 MAPK's role* in LPS-induced NO production and mentions its inhibition by E2 affects AP-1 activation, **the direct kinase responsible for phosphorylating and activating c-jun itself is JNK**.\n4.  JNK specifically phosphorylates c-jun on serine residues 63 and 73 within its transactivation domain, enhancing its transcriptional activity.\n\n**Answer: JNK**"}
{"idx": 651, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "The ROSIER scale is used for **acute stroke**.\n\nAnswer: acute stroke"}
{"idx": 652, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban is a **direct inhibitor of factor Xa**.  \n\nAnswer: Factor Xa"}
{"idx": 653, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa\n\nExplanation: The context explicitly states that betrixaban is \"an oral factor Xa inhibitor\" in the first sentence. This directly identifies the specific clotting factor it inhibits"}
{"idx": 654, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene associated with McLeod syndrome is **XK**.  \n\n**Key evidence from the context**:  \n1. The title explicitly states \"McLeod phenotype associated with a **XK missense mutation**\".  \n2. The syndrome is described as **X-linked**, consistent with the XK gene's location on the X chromosome.  \n3. Immunohematology and Western blotting confirmed the McLeod phenotype, which is defined by mutations in the XK gene.  \n\nThis mutation disrupts the XK protein, leading to the characteristic McLeod phenotype and associated neuroacanthocytosis syndrome"}
{"idx": 655, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Secukinumab?", "gold_answer": "interleukin-17A", "predicted_answer": "Secukinumab targets interleukin-17A (IL-17A)"}
{"idx": 656, "label_json": "{ \"label\": \"False\" }", "question": "Which is the most widely used model for the study of multiple sclerosis (MS)?", "gold_answer": "Experimental Autoimmune Encephalomyelitis (EAE)", "predicted_answer": "Answer: EAE+Cyclosporine  \n\nThe context explicitly identifies \"EAE+Cyclosporine\" as the most robust model in the study, validated for both behavioral and pharmacological characterization of MS-related sensory abnormalities"}
{"idx": 657, "label_json": "{ \"label\": \"False\" }", "question": "What does mTOR stands for?", "gold_answer": "mammalian target of rapamycin", "predicted_answer": "Answer: mechanistic target of rapamycin"}
{"idx": 658, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "dermatitis herpetiformis", "predicted_answer": "The typical rash associated with gluten is **dermatitis herpetiformis**.  \n\n**Answer:** dermatitis herpetiformis"}
{"idx": 659, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "The receptors that can be evaluated with [18F]altanserin are **5-HT2A receptors**.  \n\n**Answer: 5-HT2A receptors**"}
{"idx": 660, "label_json": "{ \"label\": \"True\" }", "question": "What does mTOR stands for?", "gold_answer": "mammalian target of rapamycin", "predicted_answer": "Answer: Mammalian Target of Rapamycin  \n\nSource: The context explicitly states \"Mammalian target of rapamycin complex 2 (mTORC2)\" in the opening sentence"}
{"idx": 661, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Answer: Huntington disease"}
{"idx": 662, "label_json": "{ \"label\": \"True\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based on the context, APOBEC3B (A3B) is **nuclear**.\n\nThe context explicitly states:\n1.  \"A3B **nuclear import** is an active process\"\n2.  It requires a specific N-terminal motif (containing Val54) analogous to the nuclear localization determinant of AID (which is nuclear).\n3.  It interacts with the same importin proteins as AID, facilitating nuclear transport.\n4.  The text discusses mechanisms guiding these enzymes *\"after nuclear import\"* to their substrates and preventing DNA damage, confirming its presence in the nucleus.\n\nAnswer: Nuclear"}
{"idx": 663, "label_json": "{ \"label\": \"True\" }", "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?", "gold_answer": "LepChorionDB", "predicted_answer": "Answer: LepChorionDB"}
{"idx": 664, "label_json": "{ \"label\": \"True\" }", "question": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?", "gold_answer": "nestin", "predicted_answer": "Answer: Nestin"}
{"idx": 665, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits Factor Xa.  \n\nAnswer: Factor Xa"}
{"idx": 666, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK gene"}
{"idx": 667, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets the **transcribed strand** of an active gene.  \n\nThis is directly stated in the context:  \n*\"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\"*  \n\nTCR specifically repairs lesions in the transcribed strand (where active transcription occurs), while global genomic repair (GGR) handles the non-transcribed strand and genome-wide damage. The context confirms that Elc1 is essential for GGR (non-transcribed strand repair) but dispensable for TCR (transcribed strand repair).  \n\n**Answer: transcribed strand**"}
{"idx": 668, "label_json": "{ \"label\": \"True\" }", "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?", "gold_answer": "LepChorionDB", "predicted_answer": "Answer: LepChorionDB"}
{"idx": 669, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "Answer: X-linked dystonia-parkinsonism"}
{"idx": 670, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Answer: Interleukin-1β (IL-1β)  \n\n**Key evidence from context:**  \n- Directly states: \"gevokizumab negatively modulates IL-1β signaling\"  \n- Describes mechanism: \"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor\"  \n- Confirms specificity: targets IL-1β, not the decoy receptor (IL-1RII)  \n- Structural basis: alters IL-1β's electrostatic surface to inhibit receptor binding  \n\nThis aligns with gevokizumab's classification as an anti-IL-1β monoclonal antibody"}
{"idx": 671, "label_json": "{ \"label\": \"True\" }", "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?", "gold_answer": "LepChorionDB", "predicted_answer": "Answer: LepChorionDB  \n\nThe database specifically designed for identifying and classifying Lepidopteran chorion proteins is **LepChorionDB**, accessible at http://bioinformatics.biol.uoa.gr/LepChorionDB"}
{"idx": 672, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "The receptor that can be evaluated with [18F]altanserin is the **serotonin 5-HT2A receptor**.  \n\nAnswer: serotonin 5-HT2A receptor"}
{"idx": 673, "label_json": "{ \"label\": \"True\" }", "question": "How is myotonic dystrophy inherited?", "gold_answer": "autosomal dominant", "predicted_answer": "Based on the context and established biomedical knowledge:\n\n**Myotonic Dystrophy Type 1 (DM1) is inherited in an autosomal dominant pattern.**\n\nThis means:\n1.  Only one copy of the mutated gene (from either parent) is sufficient to cause the disease.\n2.  The mutation (CTG triplet repeat expansion in the *DMPK* gene) is passed directly from parent to child.\n3.  The context confirms this intergenerational transmission and the expansion of the mutation size between generations, which is characteristic of autosomal dominant triplet repeat disorders"}
{"idx": 674, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene most commonly mutated in Tay-Sachs disease?", "gold_answer": "HEXA", "predicted_answer": "The gene most commonly mutated in Tay-Sachs disease is **HEXA**.  \n\n**Key evidence from the context:**  \n- Tay-Sachs disease (TSD) is defined by enzyme assay, which directly measures hexosaminidase A deficiency caused by **HEXA** mutations.  \n- The described mutations (G749T, C1351G) are located in the **HEXA** gene, as they are found in TSD carriers and linked to polymorphic markers on chromosome 15 (where **HEXA** resides).  \n- References to \"Jewish\" mutations (e.g., Ashkenazi founder variants) historically affect the **HEXA** gene.  \n\n**Answer: HEXA**"}
{"idx": 675, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context and established biological knowledge, **BACH1 is a transcriptional repressor**.\n\n**Key supporting evidence from the context:**\n1.  The context describes Bach1's role in \"transduc[ing] metabolic activity into gene expression\" via heme-regulated nuclear export.\n2.  Bach1 forms heterodimers with MafK, a classic characteristic of Bach1 acting as a repressor complex.\n3.  Nuclear accumulation of Bach1 (when heme is low) correlates with its functional state. Its subsequent nuclear *exclusion* by heme (mediated by Crm1) allows for the *derepression* (activation) of its target genes (e.g., heme oxygenase-1).\n\nTherefore, BACH1 functions as a repressor when localized in the nucleus"}
{"idx": 676, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "5-HT2A receptors  \n\n**Explanation from Context:**  \nThe context explicitly states that [18F]altanserin uptake reflects \"specific 5-HT2A receptor binding\" and that age-related reductions \"directly reflect the loss of specific 5-HT2A receptors.\" No other receptors are mentioned in relation to this tracer"}
{"idx": 677, "label_json": "{ \"label\": \"True\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "fungi", "predicted_answer": "Answer: Fungi"}
{"idx": 678, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the provided context, the characteristic hormone abnormality in Pendred syndrome is:\n\n**Impaired thyroid hormone synthesis**, specifically a defect in **iodine organification** in the thyroid gland. This is identified by the positive **potassium perchlorate discharge test** mentioned in the diagnostic procedures.\n\nWhile the context does not explicitly state altered serum levels of thyroid hormones (T3/T4), the diagnostic focus on iodine organification confirms the underlying biochemical defect in thyroid hormone production is a hallmark of Pendred syndrome.\n\nAnswer: **Defect in iodine organification (impaired thyroid hormone synthesis)**"}
{"idx": 679, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits **Factor Xa**.\n\nThis is directly stated in the context: \"betrixaban, an oral **factor Xa inhibitor**\""}
{"idx": 680, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa**.\n\nKey evidence from the text:\n1.  Betrixaban is classified as a \"novel oral anticoagulant\" alongside \"direct thrombin and factor Xa inhibitors\".\n2.  It is described as having \"anti-Xa activity\".\n3.  The reversal agent PRT4445 is mentioned as potentially reversing \"all anticoagulants with anti-Xa activity\", which includes betrixaban.\n4.  Its mechanism (direct factor Xa inhibition) is implied by its comparison to other novel anticoagulants in this class and the discussion of reversal agents specific to anti-Xa drugs.\n\nAnswer: **factor Xa**"}
{"idx": 681, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context provided, [18F]altanserin is used to evaluate **5-HT2A receptors**.\n\n**Explanation:**\nThe context explicitly states that \"[18F]altanserin uptake\" reflects \"specific 5-HT2A receptor binding\" and that the reduction in uptake \"directly reflects the loss of specific 5-HT2A receptors with age.\" This confirms that [18F]altanserin is a radioligand specifically targeting serotonin 5-HT2A receptors for PET imaging"}
{"idx": 682, "label_json": "{ \"label\": \"True\" }", "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?", "gold_answer": "LepChorionDB", "predicted_answer": "Based on the provided context, the database available for identifying chorion proteins in Lepidopteran proteomes is:  \n**LepChorionDB**.  \n\nAnswer: LepChorionDB"}
{"idx": 683, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 684, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene associated with McLeod syndrome is **XK**.  \nThis is inferred from the context:  \n- McLeod syndrome involves the absence of the red-blood-cell Kell antigen (Kx), a phenotype directly linked to XK gene mutations.  \n- The mapped critical region (Xp21, 150–380 kb) aligns with the XK gene locus, and CpG islands identified are candidate sites for this gene.  \n\n**Answer: XK**"}
{"idx": 685, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-synuclein", "predicted_answer": "The antibody used for immunostaining of Lewy bodies is raised against **alpha-synuclein**, as Lewy bodies are pathologically defined by aggregated alpha-synuclein protein. This is standard in neuropathological diagnosis of Lewy body-related disorders, including the cases described in the context (PSP/LBD and pure LBD).\n\nAnswer: alpha-synuclein"}
{"idx": 686, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: facioscapulohumeral muscular dystrophy (FSHD)"}
{"idx": 687, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, thyroid hormone concentrations (specifically T3) are typically altered in Allan-Herndon-Dudley syndrome (AHDS), **but the context highlights important variability**:  \n\n1. **Thyroid hormones (T3/T4)** are the primary hormones affected due to impaired transport via the MCT8 transporter.  \n2. **However**, the context explicitly states that one male patient with the mutation had **normal serum T3 levels**, and heterozygous females also showed **normal thyroid hormone levels**.  \n\nThus, while thyroid hormone abnormalities are characteristic of AHDS, **normal thyroid hormone levels can occur in some patients**, complicating diagnosis solely based on biochemical tests.  \n\n**Answer: Thyroid hormones (T3/T4), though they can be normal in some patients.**"}
{"idx": 688, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most widely used model for the study of multiple sclerosis (MS)?", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "predicted_answer": "The most widely used model for studying multiple sclerosis (MS), as referenced in the context, is **Experimental Autoimmune Encephalomyelitis (EAE)**. The context explicitly states:  \n> \"acute EAE Lewis rats were treated...\"  \n> \"...treating EAE animals...\"  \n> \"...therapeutic avenue for treating EAE and MS.\"  \n\nEAE is an established animal model (typically induced in rodents) that replicates key features of MS, including inflammation, demyelination, and axonal damage.  \n\n**Answer: EAE (Experimental Autoimmune Encephalomyelitis)**"}
{"idx": 689, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 690, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 691, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the number of TAp73 isoforms identified in humans is **not specified**.\n\nThe context states:  \n*\"p73, a p53 family tumor suppressor, is expressed as **TA and ΔN isoforms**\"*  \nand later refers to *\"knockdown of **TAp73**\"*.\n\nWhile it confirms the existence of TAp73 isoforms (plural), it does **not** provide a specific count of how many TAp73 isoforms have been identified in humans. The answer to the question is not explicitly stated in the given text"}
{"idx": 692, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium binding protein of the sarcoplasmic reticulum?", "gold_answer": "calsequestrin", "predicted_answer": "Based on the context, the main calcium binding protein of the sarcoplasmic reticulum is **calsequestrin (specifically CASQ2)**. \n\nThe context explicitly states:  \n*\"Our data suggest that the arrhythmogenic CASQ2(D307H) mutation impairs SR Ca²⁺ storing and release functions... by reducing the effective Ca²⁺ buffering inside the SR\"*,  \nidentifying calsequestrin as the key calcium-buffering protein within the sarcoplasmic reticulum"}
{"idx": 693, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the provided context, [18F]altanserin is used to evaluate **5-HT2A receptors (5-HT2AR)**.\n\nAnswer: 5-HT2A receptors"}
{"idx": 694, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa**.\n\n**Explanation from the context:**\n1.  The context explicitly states it is discussing \"direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban\".\n2.  It refers to them collectively as \"these four oral direct factor Xa inhibitors\".\n3.  Betrixaban is included in this group of drugs that directly target factor Xa.\n\nAnswer: **factor Xa**"}
{"idx": 695, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Answer: antiparallel"}
{"idx": 696, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "SAM", "predicted_answer": "Answer: S-adenosylmethionine (SAMe)"}
{"idx": 697, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Answer: transcribed strands"}
{"idx": 698, "label_json": "{ \"label\": \"True\" }", "question": "Which protein is affected by dusp8 activation?", "gold_answer": "JNK", "predicted_answer": "Based on the context, DUSP8 (M3/6) activation affects **JNK isoforms** (specifically JNK1α, JNK1β, JNK2α, and JNK3). \n\n**Answer: JNK**"}
{"idx": 699, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia chromosome-positive chronic myeloid leukemia is **BCR-ABL**. \n\nThis fusion protein results from the t(9;22) translocation (Philadelphia chromosome) and drives the pathogenesis of CML. Imatinib specifically inhibits its tyrosine kinase activity"}
{"idx": 700, "label_json": "{ \"label\": \"True\" }", "question": "Which drug should be used as an antidote in benzodiazepine overdose?", "gold_answer": "flumazenil", "predicted_answer": "The antidote for benzodiazepine overdose is **flumazenil**.  \n\n**Direct Answer:** Flumazenil"}
{"idx": 701, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium binding protein of the sarcoplasmic reticulum?", "gold_answer": "calsequestrin", "predicted_answer": "Based on the context, the main calcium binding protein of the sarcoplasmic reticulum is **calsequestrin (CASQ2)**. \n\nThe context explicitly states:  \n*\"Our data suggest that the arrhythmogenic CASQ2(D307H) mutation impairs SR Ca²⁺ storing and release functions... by reducing the effective Ca²⁺ buffering inside the SR\"*  \nand identifies CASQ2 as the protein mutated in catecholaminergic polymorphic ventricular tachycardia (CPVT). Calsequestrin is the primary Ca²⁺-buffering protein within the SR lumen"}
{"idx": 702, "label_json": "{ \"label\": \"True\" }", "question": "Which fusion protein is involved in the development of Ewing sarcoma?", "gold_answer": "EWS/FLI1", "predicted_answer": "Answer: EWS/FLI1"}
{"idx": 703, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by a drug fostamatinib?", "gold_answer": "spleen tyrosine kinase", "predicted_answer": "Answer: Syk kinase"}
{"idx": 704, "label_json": "{ \"label\": \"False\" }", "question": "From which tissue was the NCI-H520 cell-line derived?", "gold_answer": "squamous cell carcinoma", "predicted_answer": "Based solely on the provided context, the origin of the NCI-H520 cell line is **not specified**.\n\nAnswer: The context does not state the tissue origin of the NCI-H520 cell line.\n\n*(Note: While external knowledge confirms NCI-H520 is a human lung squamous cell carcinoma line, the answer must be derived solely from the provided text, which does not mention this information.)*"}
{"idx": 705, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium binding protein of the sarcoplasmic reticulum?", "gold_answer": "CASQ", "predicted_answer": "Based solely on the provided context, the main calcium binding protein of the sarcoplasmic reticulum is **calsequestrin (CASQ2)**.\n\n**Evidence from the context:**\n1.  The study explicitly focuses on \"calsequestrin\" (CASQ2).\n2.  It states that the CASQ2(D307H) mutation \"reduced the Ca2+ storing capacity of the SR\".\n3.  It concludes that the mutation \"impairs SR Ca2+ storing and release functions\" and specifically impairs SR Ca2+ buffering (\"by reducing the effective Ca2+ buffering inside the SR\").\n4.  CASQ2 is described as the protein whose function is to store/buffer calcium within the SR lumen"}
{"idx": 706, "label_json": "{ \"label\": \"True\" }", "question": "What is generic name of drug Adempas?", "gold_answer": "Riociguat", "predicted_answer": "Answer: riociguat"}
{"idx": 707, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 708, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.", "gold_answer": "cerebral hemiatrophy", "predicted_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is **unilateral cerebral hemiatrophy** (atrophy of one cerebral hemisphere), typically associated with compensatory calvarial changes such as:\n- Thickening of the calvarium\n- Enlargement of the diploic space\n- Hyperpneumatization of the frontal sinuses\n- Elevation of the petrous ridge on the affected side\n\nThis cerebral hemiatrophy underlies the classic clinical triad of:\n1. Contralateral hemiparesis/hemiplegia\n2. Seizures\n3. Developmental delay/intellectual disability\n\n(Source: Original 1933 description by Dyke, Davidoff, and Masson based on skull radiographic findings)"}
{"idx": 709, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Answer: The transcribed strand.  \n\nTranscription-coupled repair (TCR) specifically targets the transcribed strand of active genes, as it is initiated by RNA polymerase II stalling at DNA lesions on this strand. The context confirms TCR is distinct from the broader global repair pathway and is \"superimposed\" upon NER in transcriptionally active domains"}
{"idx": 710, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on established biomedical knowledge (though not explicitly stated in the context), the main component of Lewy bodies is:\n\n**Alpha-synuclein**\n\n*   The context mentions \"alpha-synuclein deposition in dementia with Lewy bodies (DLB)\", confirming that Lewy bodies are composed of aggregated alpha-synuclein protein. This is a well-known pathological hallmark of DLB and related disorders like Parkinson's disease"}
{"idx": 711, "label_json": "{ \"label\": \"False\" }", "question": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?", "gold_answer": "p16Ink4", "predicted_answer": "Answer: p16Ink4a"}
{"idx": 712, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most abundant membrane protein on Earth?", "gold_answer": "Light-harvesting pigment-protein complex of Photosystem II", "predicted_answer": "Based on the context, the most abundant membrane protein on Earth is **LHCII** (Light-Harvesting Complex II). This protein is central to photosynthesis in plants and algae, serving as the primary antenna complex for photosystem II. Its global prevalence in photosynthetic organisms makes it the most abundant membrane protein.\n\nAnswer: LHCII"}
{"idx": 713, "label_json": "{ \"label\": \"True\" }", "question": "Which is the third subunit of the TSC1-TSC2 complex upstream of mTORC1?", "gold_answer": "TBC1D7", "predicted_answer": "Answer: TBC1D7  \n\n**Key points from the context:**  \n- The functional complex is explicitly named the **TSC1-TSC2-TBC1D7 (TSC-TBC) complex**.  \n- TBC1D7 stabilizes the association between TSC1 and TSC2.  \n- Knockdown of TBC1D7 disrupts TSC1-TSC2 binding and reduces Rheb-GAP activity.  \n- The context confirms TBC1D7 is the third subunit of this complex upstream of mTORC1.  \n\nThus, TBC1D7 is the third subunit"}
{"idx": 714, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits factor Xa.  \n\nAnswer: Factor Xa"}
{"idx": 715, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Answer: Huntington disease"}
{"idx": 716, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "Medicarpin", "predicted_answer": "The major phytoalexin in alfalfa (*Medicago sativa* L.) is **medicarpin**.  \n\n**Key evidence from the context:**  \n- The study focuses on an enzyme (isoflavone 7-O-methyltransferase, IOMT) induced during **medicarpin biosynthesis**.  \n- IOMT activity and transcript induction precede **medicarpin accumulation** in elicited alfalfa.  \n- Medicarpin is explicitly named as the target phytoalexin whose biosynthesis involves the characterized enzyme.  \n\nAnswer: **medicarpin**"}
{"idx": 717, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context provided:\n\n**Answer: Factor Xa**\n\n**Explanation:**  \nThe context explicitly states that rivaroxaban, apixaban, edoxaban, and betrixaban are all \"direct inhibitors of factor Xa\" and collectively refers to them as \"oral direct factor Xa inhibitors.\" Betrixaban is included in this group of drugs targeting Factor Xa"}
{"idx": 718, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits clotting factor Xa.  \n\nAnswer: Factor Xa"}
{"idx": 719, "label_json": "{ \"label\": \"True\" }", "question": "Is the long non- coding RNA malat-1 up or downregulated in cancer?", "gold_answer": "upregulated", "predicted_answer": "Based on the context, MALAT-1 is **upregulated** in bladder cancer.  \n\nKey evidence:  \n1. The study evaluates MALAT-1 expression in bladder cancer tissues.  \n2. Silencing MALAT-1 (via siRNA) impairs cancer cell migration and reduces EMT markers (ZEB1/ZEB2/Slug), while increasing E-cadherin.  \n3. The need to experimentally *downregulate* MALAT-1 to inhibit metastasis implies it is naturally elevated in cancer.  \n\n**Answer: Upregulated**"}
{"idx": 720, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "DNMT1", "predicted_answer": "Answer: DNA methyltransferase 1 (DNMT1)  \n\nThe context explicitly states:  \n- DMAP1 \"stimulates DNA methylation\" and is \"a DNMT1 interacting protein\"  \n- DMAP1 depletion causes \"reduction in methylated CpGs\"  \n- DMAP1 \"activates DNMT1 preferentially at sites of HR repair\"  \nDNMT1 is the enzyme responsible for maintaining DNA (cytosine-5-)-methylation patterns during DNA replication and repair"}
{"idx": 721, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.  \n\n**Key reasons for this designation:**  \n1. **DNA Damage Response:** p53 halts the cell cycle upon detecting DNA damage, allowing repair.  \n2. **Apoptosis Induction:** If DNA damage is irreparable, p53 triggers programmed cell death to prevent mutation propagation.  \n3. **Genomic Stability:** It suppresses tumor formation by preventing the accumulation of genetic errors.  \n\n*(Note: While the context discusses genomic stability in iPSCs, it does not explicitly name p53. The answer reflects established biological knowledge.)*  \n\n**Answer: p53**"}
{"idx": 722, "label_json": "{ \"label\": \"True\" }", "question": "Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?", "gold_answer": "beta-TrCP", "predicted_answer": "Based on the provided context, the specific E3 ubiquitin ligase mediating IFNAR1 ubiquitination and degradation is **β-TrCP (beta-transducin repeat-containing protein)**.\n\n**Reasoning:**\n1.  The context states that Tyk2 catalytic activity is required for \"ligand-induced IFNAR1 serine phosphorylation, ubiquitination and efficient lysosomal proteolysis.\"\n2.  While the context excerpt itself does not explicitly name the E3 ligase, the described mechanism (serine phosphorylation leading to ubiquitination and lysosomal degradation) is the canonical pathway mediated by the **SCF<sup>β-TrCP</sup>** E3 ubiquitin ligase complex.\n3.  β-TrCP specifically recognizes IFNAR1 after it is phosphorylated on specific serine residues (S535 in humans), triggering its ubiquitination and subsequent lysosomal degradation.\n\n**Answer: β-TrCP**"}
{"idx": 723, "label_json": "{ \"label\": \"True\" }", "question": "The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?", "gold_answer": "PD-1", "predicted_answer": "The antibodies MK-3475 (pembrolizumab) and CT-011 target the **PD-1 protein**.  \n\nThis is directly supported by the context:  \n- The study focuses on the **PD-1/PD-L1 pathway** as a key mechanism of immune suppression.  \n- **CT-011** is explicitly mentioned to block PD-1, enhancing T-cell responses to DC/tumor fusions.  \n- **MK-3475** (though not named in the text) is clinically established as an anti-PD-1 antibody, aligning with the pathway discussed.  \n\n**Answer: PD-1**"}
{"idx": 724, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) specifically targets the **transcribed strand** of DNA. This is inferred from the contrast with differentiation-associated repair (DAR), which proficiently repairs both DNA strands within active genes, while TCR is described as a specialized subpathway superimposed upon global NER that responds to RNA polymerase II encountering lesions on the transcribed strand.\n\nAnswer: transcribed strand"}
{"idx": 725, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?", "gold_answer": "RET", "predicted_answer": "Answer: RET proto-oncogene\n\nThe context explicitly states:  \n* \"Systematic analysis for **germline mutations of the RET proto-oncogene** was performed...\"  \n* \"...germline mutation in RET codon 620, which previously has been shown to be responsible for MEN 2...\"  \n* \"**The presence of a germline mutation in the RET proto-oncogene** in a patient with MTC indicates heritable disease.\"  \n\nThis confirms RET as the gene mutated in MEN2 syndromes. While Hirschsprung disease isn't mentioned in this excerpt, established biomedical knowledge confirms RET mutations are also a primary cause of Hirschsprung disease"}
{"idx": 726, "label_json": "{ \"label\": \"False\" }", "question": "How many genera comprise the Flaviviridae family?", "gold_answer": "three", "predicted_answer": "Answer: 4\n\nThe Flaviviridae family comprises four genera: *Flavivirus*, *Hepacivirus*, *Pestivirus*, and *Pegivirus*. While the context mentions Flaviviridae and specifically identifies Yellow Fever Virus as a Flavivirus (one genus), it does not explicitly state the total number of genera. This answer relies on standard virological classification knowledge"}
{"idx": 727, "label_json": "{ \"label\": \"False\" }", "question": "Which is the main calcium pump of the sarcoplasmic reticulum?", "gold_answer": "SERCA", "predicted_answer": "Answer: SERCA2a"}
{"idx": 728, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits **factor Xa**.  \n\nThis is directly indicated in the context:  \n- Betrixaban is classified as a **novel oral anticoagulant** targeting factor Xa, alongside other drugs in this class.  \n- The context explicitly references a \"factor Xa decoy\" (PRT4445) under evaluation as a reversal agent for betrixaban, confirming its mechanism as a **factor Xa inhibitor**.  \n\nAnswer: Factor Xa"}
{"idx": 729, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: Facioscapulohumeral Muscular Dystrophy (FSHD)  \n\nThe context explicitly states:  \n- \"DUX4 and its target genes contribute to the global dysregulation of gene expression observed in **FSHD**\"  \n- \"DUX4c was increased [...] in **FSHD** muscle biopsies\"  \n- \"changes in [DUX4c] expression could contribute to the **FSHD** pathology\"  \n\nFSHD is the disease linked to ectopic DUX4 expression"}
{"idx": 730, "label_json": "{ \"label\": \"True\" }", "question": "Which medication should be administered when managing patients with suspected acute opioid overdose?", "gold_answer": "naloxone", "predicted_answer": "Answer: naloxone  \n\n**Explanation:**  \n- The context explicitly identifies **naloxone** as the medication proposed for peer administration to reverse heroin overdoses.  \n- Naloxone is a competitive opioid receptor antagonist, clinically approved for rapidly reversing respiratory depression and other life-threatening effects of opioid overdose.  \n- This aligns with medical guidelines (e.g., WHO, CDC, and clinical protocols) that universally recommend naloxone as the first-line treatment for suspected acute opioid overdose.  \n\n*Note: The context focuses on distributing naloxone to peers for overdose prevention, directly reinforcing its role in managing acute opioid toxicity.*"}
{"idx": 731, "label_json": "{ \"label\": \"False\" }", "question": "Rindopepimut is an analog of which growth factor?", "gold_answer": "EGFRvIII", "predicted_answer": "Based on the context, rindopepimut is an analog targeting **EGFRvIII**, a mutant variant of the epidermal growth factor receptor (EGFR). Therefore, it is an analog of:  \n**Epidermal Growth Factor (EGF)**.  \n\nAnswer: Epidermal Growth Factor"}
{"idx": 732, "label_json": "{ \"label\": \"True\" }", "question": "Treatment of which disease was investigated in the MR CLEAN study?", "gold_answer": "Acute ischemic stroke", "predicted_answer": "The disease investigated in the MR CLEAN study was **acute ischemic stroke (AIS)**, specifically focusing on endovascular therapies for large vessel occlusion (LVO).  \n\n**Answer: Acute ischemic stroke**"}
{"idx": 733, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene mutated in the Gaucher disease?", "gold_answer": "glucocerebrosidase", "predicted_answer": "Based on the context, the gene mutated in Gaucher disease is the **glucocerebrosidase gene**.  \n\nAnswer: glucocerebrosidase"}
{"idx": 734, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Based on the context, the molecule targeted by the drug Gevokizumab is **Interleukin-1β (IL-1β)**.  \n\n**Key evidence from the context**:  \n- Gevokizumab \"negatively modulates IL-1β signaling through an allosteric mechanism.\"  \n- It \"decreases the binding affinity of IL-1β for the IL-1 receptor\" by altering IL-1β's electrostatic surface potential.  \n- The drug specifically inhibits IL-1β interactions with its signaling receptor (IL-1RI), not the decoy receptor.  \n\n**Answer: Interleukin-1β (IL-1β)**"}
{"idx": 735, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "PLN", "predicted_answer": "The main regulatory molecule of SERCA2A function in cardiac muscle is **phospholamban (PLN)**.  \n\n**Key evidence from the context:**  \n- The text explicitly describes the \"PLN/SERCA interactome\" as central to regulating SR Ca²⁺-cycling.  \n- PLN directly interacts with SERCA2a to fine-tune SR Ca²⁺-uptake, storage, and release.  \n- Genetic variants in PLN and associated proteins (e.g., I-1, Hsp20, HAX1) disrupt SERCA2a activity, leading to contractile dysfunction.  \n\n**Answer: Phospholamban**"}
{"idx": 736, "label_json": "{ \"label\": \"True\" }", "question": "What does mTOR stands for?", "gold_answer": "mammalian Target of Rapamycin", "predicted_answer": "Answer: Mammalian Target of Rapamycin"}
{"idx": 737, "label_json": "{ \"label\": \"True\" }", "question": "What is the average diameter of intermediate filaments?", "gold_answer": "10 nm", "predicted_answer": "Answer: 10 nanometers"}
{"idx": 738, "label_json": "{ \"label\": \"True\" }", "question": "Neurostimulation of which nucleus is used for treatment of dystonia?", "gold_answer": "globus pallidus internus", "predicted_answer": "Answer: globus pallidus internus (GPi)"}
{"idx": 739, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?", "gold_answer": "Clostridium botulinum", "predicted_answer": "The most known bacterium responsible for botulism (including sausage-poisoning) is **Clostridium botulinum**.  \n\n**Reasoning:**  \n- The context discusses botulinum neurotoxin serotypes (BoNT/C, BoNT/D, and BoNT/CD mosaic), all produced by *Clostridium botulinum*.  \n- Historically, botulism outbreaks from contaminated sausages (\"sausage-poisoning\") are caused by toxins from *Clostridium botulinum*.  \n- While other clostridia (e.g., *C. butyricum*, *C. baratii*) can produce botulinum toxins, *C. botulinum* remains the primary and most recognized pathogen.  \n\n**Answer: Clostridium botulinum**"}
{"idx": 740, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine  \n\n**Explanation:**  \nThe context refers to \"K201 (JTV519)\" as the same compound studied in the prior example, which explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine. This classification remains consistent across both contexts"}
{"idx": 741, "label_json": "{ \"label\": \"False\" }", "question": "How many genes outside of the MHC locus have been genetically associated to Rheumatoid Arthritis through GWAS?", "gold_answer": "more than 30", "predicted_answer": "Based on the context, eight non-HLA genes have been genetically associated with Rheumatoid Arthritis (RA) through GWAS:  \n**PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4**.  \n\nAnswer: 8"}
{"idx": 742, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)"}
{"idx": 743, "label_json": "{ \"label\": \"True\" }", "question": "Name a method for enrichment of arginine-methylated peptides.", "gold_answer": "immunoaffinity purification", "predicted_answer": "The method for enrichment of arginine-methylated peptides is **immunoaffinity enrichment**.  \n\n**Answer: Immunoaffinity enrichment**"}
{"idx": 744, "label_json": "{ \"label\": \"False\" }", "question": "Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?", "gold_answer": "beta-Trcp", "predicted_answer": "Based solely on the provided context, the specific E3 ubiquitin ligase mediating IFNAR1 ubiquitination and degradation **is not explicitly named**. The text describes the phosphorylation events (Ser532 priming by PERK, followed by CK1α phosphorylation at Ser535) that trigger ubiquitination and degradation, but it does not identify the responsible E3 ligase.\n\nTherefore, the answer cannot be determined from the given context"}
{"idx": 745, "label_json": "{ \"label\": \"False\" }", "question": "What kind of enzyme is encoded by the proto-oncogene ABL1?", "gold_answer": "nonreceptor tyrosine kinase", "predicted_answer": "Answer: kinase"}
{"idx": 746, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: sodium-calcium exchanger (NCX)"}
{"idx": 747, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: alpha-synuclein"}
{"idx": 748, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: NACP/alpha-synuclein"}
{"idx": 749, "label_json": "{ \"label\": \"True\" }", "question": "How many tissue kallikrein genes are present in the human genome?", "gold_answer": "15", "predicted_answer": "The human genome contains 15 tissue kallikrein genes (KLK1 to KLK15).  \n\n**Answer:** 15"}
{"idx": 750, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "Na(+)/Ca(2+) exchanger", "predicted_answer": "Answer: Na(+)/Ca(2+) exchanger"}
{"idx": 751, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa**.\n\n**Reasoning:** The context explicitly states that \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development\" and that they work by \"the inhibition of factor Xa\". Betrixaban is a member of this class of direct factor Xa inhibitors"}
{"idx": 752, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Based on the context, the transcript responsible for X-chromosome inactivation is **Xist**.  \n\n**Answer: Xist**  \n\nThe context explicitly states:  \n> *\"providing a powerful theoretical framework for the study of X-chromosome inactivation and other events mediated by ribonucleoprotein associations\"*  \nand focuses on *\"Xist associations\"* with proteins involved in epigenetic regulation. Xist is a long non-coding RNA that initiates and maintains X-chromosome silencing"}
{"idx": 753, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 acts as a **repressor**. \n\nThis is evident because:\n1. Heme *induces* Hmox-1 expression by **inhibiting BACH1's binding** to enhancers.\n2. BACH1 **represses Hmox-1 transcription** under basal conditions, and heme relieves this repression by triggering BACH1 nuclear export and DNA-binding inhibition.\n\nThe mechanism confirms BACH1's role as a heme-sensitive transcriptional repressor of Hmox-1.\n\nAnswer: **repressor**"}
{"idx": 754, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "phospholamban", "predicted_answer": "The main regulatory molecule of SERCA2A function in cardiac muscle is **phospholamban (PLN)**.  \n\n**Key evidence from the context:**  \n- The text explicitly refers to the \"PLN/SERCA interactome\" as central to regulating SR Ca²⁺ cycling.  \n- Phospholamban directly interacts with SERCA2a to fine-tune calcium uptake into the sarcoplasmic reticulum.  \n- Genetic variants in PLN are highlighted to depress contractility, underscoring its regulatory role.  \n\n*Other proteins (e.g., I-1, Hsp20, HAX1) associate with PLN but do not replace it as the primary regulator of SERCA2a.*  \n\n**Answer: Phospholamban (PLN)**"}
{"idx": 755, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 756, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "bcr-abl", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) is **Abl kinase**, specifically the BCR-ABL fusion protein resulting from the Philadelphia chromosome translocation.  \n\n**Answer: Abl kinase**"}
{"idx": 757, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Answer: 5-HT(2A) receptors  \n\nThe context explicitly states:  \n1. \"5-HT(2A) displacement studies\" validate cerebellar nonspecific binding.  \n2. Ketanserin (a selective 5-HT(2A) antagonist) displaces [18F]altanserin binding.  \n3. The conclusion confirms: \"5-HT(2A) receptor studies can be conducted...\".  \n\nThus, [18F]altanserin specifically evaluates **5-HT(2A) receptors**"}
{"idx": 758, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most common type of pediatric cerebellar tumor?", "gold_answer": "Medulloblastoma", "predicted_answer": "Based on the context provided, the most common type of pediatric cerebellar tumor is **medulloblastoma (MB)**. The text explicitly focuses on medulloblastoma formation, its genetic drivers (e.g., Shh pathway, p18Ink4c loss), and its relevance in human and mouse models.  \n\n**Answer: medulloblastoma**"}
{"idx": 759, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Based on the context, Gevokizumab targets **Interleukin-1β (IL-1β)**.  \n\nKey evidence:  \n1. Gevokizumab is described as an inhibitor of **IL-1β signaling**.  \n2. It directly binds to IL-1β, altering its electrostatic surface potential and reducing its affinity for the signaling receptor IL-1RI.  \n3. The mechanism involves allosteric modulation of IL-1β itself, not the receptors.  \n\n**Answer: IL-1β**"}
{"idx": 760, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Based on the provided context, Orteronel inhibits the enzyme **CYP17A1**.\n\n**Key evidence from the context:**\n1.  Orteronel is explicitly described as an \"investigational CYP17A1 inhibitor\".\n2.  The mechanism of action for suppressing estrogen and androgen synthesis is attributed to \"selective inhibition of CYP17A1 activity\".\n3.  The context contrasts this with aromatase inhibition (anastrozole), confirming Orteronel does *not* inhibit aromatase directly"}
{"idx": 761, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by a drug fostamatinib?", "gold_answer": "spleen tyrosine kinase", "predicted_answer": "Answer: spleen tyrosine kinase (Syk)"}
{"idx": 762, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "zfhx1b", "predicted_answer": "Answer: zfhx1b"}
{"idx": 763, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 764, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 765, "label_json": "{ \"label\": \"True\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "tofacitinib", "predicted_answer": "Based on the context, the JAK inhibitor discussed and approved for rheumatoid arthritis treatment is **tofacitinib**.  \n\n**Answer: tofacitinib**"}
{"idx": 766, "label_json": "{ \"label\": \"True\" }", "question": "Which is the methyl donor of histone methyltransferases?", "gold_answer": "SAM", "predicted_answer": "The methyl donor for histone methyltransferases is **S-adenosylmethionine (SAMe)**.  \n\n**Key evidence from the context:**  \n- SAMe is a substrate for methylation reactions, and its metabolites (MTA, SAH) modulate histone methylation.  \n- The study directly links SAMe to histone methylation by showing its inhibition of H3K4 trimethylation at gene promoters.  \n- Biochemical principles confirm SAMe is the universal methyl donor for methyltransferases, including those modifying histones.  \n\n**Answer:** S-adenosylmethionine (SAMe)"}
{"idx": 767, "label_json": "{ \"label\": \"True\" }", "question": "Do archaeal genomes contain one or multiple origins of replication?", "gold_answer": "Multiple", "predicted_answer": "Based on the context:  \n**Archaeal genomes can contain multiple origins of replication.**  \n\nKey evidence from the context:  \n1. Initially, only *Pyrococcus abyssi* was confirmed to have a single origin.  \n2. Recent findings demonstrate that some archaeal species have **multiple origins**, confirmed experimentally.  \n3. This discovery impacts research on DNA replication mechanisms and evolution in archaea.  \n\nAnswer: Multiple origins"}
{"idx": 768, "label_json": "{ \"label\": \"False\" }", "question": "Rindopepimut is an analog of which growth factor?", "gold_answer": "EGFRvIII", "predicted_answer": "Answer: Epidermal Growth Factor Receptor (EGFR)  \n\nThe context specifies that rindopepimut is a vaccine targeting **EGFRvIII**, a mutant variant of the Epidermal Growth Factor Receptor. Thus, it is an analog derived from EGFR"}
{"idx": 769, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa**.\n\n**Reasoning:**\n1.  The context explicitly states that rivaroxaban, apixaban, edoxaban, and betrixaban are \"direct inhibitors of factor Xa\".\n2.  It groups all four drugs together as \"these four oral direct factor Xa inhibitors\".\n3.  The entire context focuses on comparing these direct factor Xa inhibitors, confirming that betrixaban shares this mechanism of action"}
{"idx": 770, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 771, "label_json": "{ \"label\": \"True\" }", "question": "Which is the most widely used model for the study of multiple sclerosis (MS)?", "gold_answer": "experimental autoimmune encephalomyelitis (EAE)", "predicted_answer": "Answer: experimental autoimmune encephalomyelitis (EAE)"}
{"idx": 772, "label_json": "{ \"label\": \"True\" }", "question": "Which receptors can be evaluated with the [18F]altanserin?", "gold_answer": "5-HT2A", "predicted_answer": "Based on the context, the receptors evaluated with [18F]altanserin are **5-HT2A receptors (5-HT2AR)**. The study explicitly uses [18F]altanserin to assess frontal cortex 5-HT2A receptor binding in relation to trait aggression and impulsivity.\n\nAnswer: 5-HT2A receptors"}
{"idx": 773, "label_json": "{ \"label\": \"False\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based solely on the provided context, the subcellular localization (cytoplasmic or nuclear) of APOBEC3B protein is **not specified**. The text describes its function in inhibiting L1 retrotransposition but does not mention its cellular distribution.\n\n**Answer:** The context does not specify whether APOBEC3B is predominantly cytoplasmic or nuclear"}
{"idx": 774, "label_json": "{ \"label\": \"True\" }", "question": "Which medication should be administered when managing patients with suspected acute opioid overdose?", "gold_answer": "naloxone", "predicted_answer": "Answer: naloxone"}
{"idx": 775, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context and pharmacological classification of the new oral anticoagulants:\n\n**Answer: Factor Xa**\n\n**Explanation:**  \nBetrixaban belongs to the class of direct oral anticoagulants (DOACs) ending in \"-xaban\" (e.g., rivaroxaban, apixaban), which are **selective direct Factor Xa inhibitors**. These drugs directly block Factor Xa in the coagulation cascade, preventing thrombin generation and clot formation. The context groups betrixaban with other \"-xaban\" agents, confirming its mechanism aligns with this class"}
{"idx": 776, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "The characteristic hormone abnormality in Pendred syndrome is **hypothyroidism** due to impaired thyroid hormone synthesis. This results from mutations in the *PDS* gene (encoding a chloride-iodide transporter), which disrupt iodide transport into thyroid follicular cells, leading to defective organification of iodide and reduced production of thyroxine (T₄) and triiodothyronine (T₃).\n\n**Answer: Hypothyroidism**"}
{"idx": 777, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL tyrosine kinase\n\nThe Philadelphia chromosome results from the t(9;22) translocation, creating the *BCR-ABL* fusion gene. This gene encodes the constitutively active BCR-ABL tyrosine kinase, which is the direct target of Imatinib (Gleevec)"}
{"idx": 778, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?", "gold_answer": "thyroid", "predicted_answer": "Answer: Thyroid hormone concentrations, specifically elevated serum T3 (triiodothyronine) and reduced T4 (thyroxine).\n\n**Explanation:**  \nAllan–Herndon–Dudley syndrome is caused by mutations in the *SLC16A2* gene encoding the **MCT8 transporter**, critical for cellular uptake of thyroid hormones. This defect impairs T3 entry into target tissues (e.g., brain), leading to:  \n- **Elevated serum T3** (due to reduced tissue uptake and disrupted metabolism)  \n- **Reduced serum T4** (due to increased conversion of T4 to T3 in peripheral tissues)  \n\nThe context explicitly links thyroid hormone transporters (MCT8) to tissue-level regulation of thyroid hormone activity, confirming these alterations"}
{"idx": 779, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine  \n\n**Directly from the context:**  \nThe first sentence explicitly states:  \n*\"a newly synthesized 1,4-benzothiazipine derivative, JTV-519\"*  \n(Note: \"benzothiazipine\" is a typographical variant of \"benzothiazepine,\" consistent with prior literature)"}
{"idx": 780, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 781, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits factor Xa.  \n\n**Key evidence from the context:**  \n1. Directly states betrixaban belongs to a class of \"direct [...] factor Xa inhibitors\".  \n2. References a \"factor Xa decoy, PRT4445\" as a potential reversal agent for betrixaban, confirming its anti-factor Xa mechanism.  \n3. Describes betrixaban as a \"novel oral anticoagulant\" with anti-Xa activity, aligning it with other direct factor Xa inhibitors (e.g., rivaroxaban, apixaban).  \n\n**Answer:** Factor Xa"}
{"idx": 782, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "The transcribed strand of an active gene is targeted by transcription-coupled repair (TCR).  \n\n**Answer:** transcribed strand"}
{"idx": 783, "label_json": "{ \"label\": \"False\" }", "question": "How many clinical trials for off-label drugs in neonates are cited in the literature.", "gold_answer": "0", "predicted_answer": "Based solely on the provided context, the number of clinical trials for off-label drugs in neonates is **not mentioned or cited**. The text discusses Paediatric Investigation Plans (PIPs) and their regulatory outcomes (e.g., waivers, withdrawals), but it does not reference specific clinical trials or off-label use in neonates.\n\n**Answer:** The context does not cite any number of clinical trials for off-label drugs in neonates"}
{"idx": 784, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Based on the context, the tumor suppressor referred to as \"the guardian of the genome\" is **p53**.\n\nAnswer: p53"}
{"idx": 785, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "The main component of Lewy bodies is **alpha-synuclein**.  \n\n**Answer:** alpha-synuclein"}
{"idx": 786, "label_json": "{ \"label\": \"False\" }", "question": "What is the incidence of Edwards syndrom in the european population?", "gold_answer": "1:5000", "predicted_answer": "Based on the provided context, **the incidence of Edwards syndrome (trisomy 18) in the European population is not explicitly stated**. The context only describes:\n1.  The general incidence of **oesophageal atresia** (1:3000-3500 live births).\n2.  The **poor prognosis** of Edwards syndrome (only ~5% survive beyond 1 year).\n3.  That Edwards syndrome is a chromosomal disorder associated with oesophageal atresia in some cases.\n\n**The context does not provide specific incidence data for Edwards syndrome in Europe or elsewhere.**"}
{"idx": 787, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "The ROSIER scale is used for **stroke**.\n\nAnswer: stroke"}
{"idx": 788, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "Bcr-Abl", "predicted_answer": "Answer: BCR-ABL tyrosine kinase"}
{"idx": 789, "label_json": "{ \"label\": \"True\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "fungi", "predicted_answer": "Based on the genomic and evolutionary evidence presented, microsporidia belong to the kingdom **Fungi**. This classification is supported by:  \n- Shared syntenic gene pairs (RPS9-RPL21) with fungi  \n- Conserved gene fusions/architectures (e.g., unfused tRNA synthetase)  \n- Homology of the sex-related locus to zygomycetes (a fungal group)  \n- Phylogenetic analyses confirming their close evolutionary relationship with fungi  \n\nAnswer: Fungi"}
{"idx": 790, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia chromosome-positive chronic myelogenous leukemia (CML) is **BCR-ABL**.  \n\nAnswer: BCR-ABL"}
{"idx": 791, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 792, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by a drug fostamatinib?", "gold_answer": "spleen tyrosine kinase", "predicted_answer": "Answer: Syk"}
{"idx": 793, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 794, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa"}
{"idx": 795, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "Answer: ZFHX1B  \n\n**Key points from context:**  \n1. The text explicitly states: \"molecular genetic analysis of **ZFHX1B** is important for a definite diagnosis of MWS.\"  \n2. Mowat-Wilson syndrome (MWS) is characterized by a wide phenotypic spectrum (e.g., Hirschsprung disease, congenital heart defects, intellectual disability), and ZFHX1B mutations are its primary genetic cause.  \n\n*(Note: ZFHX1B is also known as SIP1 [Smad-interacting protein 1], but the context specifically uses \"ZFHX1B\")*"}
{"idx": 796, "label_json": "{ \"label\": \"True\" }", "question": "What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations?", "gold_answer": "Fanconi anemia", "predicted_answer": "Fanconi anemia\n\n**Answer Explanation:**  \nThe context explicitly states that lymphocytes from **Fanconi anemia (FA) patients** were studied. FA is a genetic disorder characterized by hypersensitivity to DNA crosslinking agents (e.g., mitomycin C, used in the study) and chromosomal instability, leading to a high frequency of aberrations. The hypersensitivity to hydroxyurea further aligns with FA's defective DNA repair pathway"}
{"idx": 797, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: Stroke\n\nThe ROSIER scale is specifically designed for recognizing stroke in emergency room settings, as indicated by its full name \"Recognition of Stroke in the Emergency Room.\" The context evaluates its effectiveness in differentiating acute cerebrovascular events (including ischemic stroke, TIA, and intracerebral hemorrhage) from stroke mimics in suspected stroke patients"}
{"idx": 798, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "medicarpin", "predicted_answer": "Based on the context provided, the major phytoalexin in alfalfa (*Medicago sativa* L.) is **medicarpin**. \n\nKey evidence from the context:\n- Explicitly states IFR is \"the penultimate enzyme in **medicarpin** biosynthesis\"\n- Notes \"accumulation of **medicarpin**\" in elicited cell cultures\n- Mentions healthy plant parts accumulate \"a **medicarpin** glucoside\"\n- Concludes that cloning IFR enables \"genetic manipulation of phytoalexin biosynthesis\" for altering medicarpin stereochemistry\n\nAnswer: **medicarpin**"}
{"idx": 799, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZEB2", "predicted_answer": "The gene responsible for Mowat-Wilson syndrome is **ZEB2**.  \n\n**Answer: ZEB2**"}
{"idx": 800, "label_json": "{ \"label\": \"False\" }", "question": "What histone trimethylation has been associated to RNA splicing?", "gold_answer": "H3K36me3", "predicted_answer": "Based on the provided context, no specific histone trimethylation mark is mentioned or associated with RNA splicing. The context states that preferential nucleosome positioning at exons is **independent of their modification status**, but does not identify any particular histone modifications, including trimethylation marks. \n\nTherefore, the context does not provide information associating any histone trimethylation with RNA splicing. \n\n**Answer:** Not specified in the context"}
{"idx": 801, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Answer: repressor"}
{"idx": 802, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) is **BCR-ABL**, the oncogenic fusion protein resulting from the Philadelphia chromosome in chronic myelogenous leukemia.  \n\nAnswer: BCR-ABL"}
{"idx": 803, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context provided, betrixaban inhibits **factor Xa**.\n\n**Direct Answer:** Factor Xa\n\n**Explanation:**  \nThe context explicitly states that rivaroxaban, apixaban, edoxaban, and betrixaban are all \"direct inhibitors of factor Xa\" and collectively refers to them as \"these four oral direct factor Xa inhibitors.\" Betrixaban is included in this group and shares the same mechanism of action"}
{"idx": 804, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium binding protein of the sarcoplasmic reticulum?", "gold_answer": "Calsequestrin", "predicted_answer": "Based on the context, the main calcium binding protein of the sarcoplasmic reticulum is **calsequestrin (CS)**. \n\nThe context explicitly states:  \n*\"The physiological role of CS in controlling calcium release from the SR\"* and discusses its localization, mutants, and function in calcium regulation within the sarcoplasmic reticulum. No other calcium-binding proteins are mentioned as the focus of this study"}
{"idx": 805, "label_json": "{ \"label\": \"True\" }", "question": "What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?", "gold_answer": "SECIS", "predicted_answer": "Answer: SECIS (Selenocysteine Insertion Sequence)"}
{"idx": 806, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Factor Xa  \n\nBetrixaban is a direct factor Xa inhibitor, as indicated by its classification among the \"factor Xa inhibitors\" discussed in the context"}
{"idx": 807, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "Bcr-Abl", "predicted_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia chromosome-positive chronic myeloid leukemia is **Abl kinase**, specifically the BCR-ABL fusion protein.  \n\nAnswer: Abl kinase"}
{"idx": 808, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?", "gold_answer": "thyroid", "predicted_answer": "Patients with Allan-Herndon-Dudley syndrome exhibit altered **thyroid hormone concentrations**, specifically:  \n- **Elevated serum triiodothyronine (T3)**  \n- **Reduced serum thyroxine (T4)**  \n- **Normal or slightly elevated thyroid-stimulating hormone (TSH)**  \n\nThis pattern results from mutations in the *MCT8* gene, which impairs neuronal uptake of thyroid hormones, leading to peripheral thyroid hormone dysregulation. The thyroid profile is a key diagnostic feature of the syndrome.  \n\n(Source: Syndrome pathophysiology and clinical case descriptions confirm this consistent thyroid hormone alteration pattern.)"}
{"idx": 809, "label_json": "{ \"label\": \"True\" }", "question": "Pridopidine has been tested for treatment of which disorder?", "gold_answer": "Huntington disease", "predicted_answer": "Pridopidine has been tested for the treatment of **Huntington disease**.  \n\n**Answer:** Huntington disease"}
{"idx": 810, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context provided, betrixaban inhibits **factor Xa**.  \n\n**Reasoning:**  \n- The context explicitly states that \"direct factor Xa inhibitors\" comprise a class of oral anticoagulants targeting factor Xa in the coagulation cascade.  \n- Betrixaban is a known member of this class (though not named in the text, its mechanism aligns with the class description).  \n- The text emphasizes that all agents in this class inhibit factor Xa, as seen in trials for apixaban and rivaroxaban.  \n\n**Answer: Factor Xa**"}
{"idx": 811, "label_json": "{ \"label\": \"True\" }", "question": "Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?", "gold_answer": "beta-Trcp", "predicted_answer": "Based on the context provided:\n\nAnswer: β-Trcp (beta-Transducin Repeat Containing Protein)\n\nExplanation:  \nThe context explicitly states that Tyk2 stabilizes IFNAR1 \"in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\" This directly identifies β-Trcp as the E3 ubiquitin ligase responsible for binding IFNAR1 and mediating its ubiquitination and subsequent degradation"}
{"idx": 812, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits **factor Xa**.\n\nAnswer: factor Xa"}
{"idx": 813, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke\n\nBased on the context:\n- The ROSIER scale is explicitly described as a \"stroke recognition instrument\" developed for emergency room settings.\n- It was designed to differentiate \"acute stroke from stroke mimics\" during initial assessment.\n- Validation metrics (sensitivity, specificity, PPV, NPV) are reported for stroke diagnosis.\n- The study excluded asymptomatic TIAs but included stroke patients and symptomatic TIAs in the validation cohort"}
{"idx": 814, "label_json": "{ \"label\": \"True\" }", "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?", "gold_answer": "Tofacitinib", "predicted_answer": "Answer: tofacitinib"}
{"idx": 815, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "Answer: Stroke"}
{"idx": 816, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the exact number of TAp73 isoforms identified in humans is **not explicitly stated**.\n\nThe context discusses \"TAp73 isoforms\" and their functions, but it does not specify how many distinct TAp73 isoforms exist in humans. It focuses on the role and consequences of TAp73 deficiency rather than enumerating the isoforms.\n\nTherefore, the context does not provide the information needed to answer this specific question"}
{"idx": 817, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "The characteristic thyroid hormone abnormality in Pendred syndrome is **defective iodine organification**, detectable by a positive perchlorate discharge test. This reflects impaired incorporation of iodine into thyroglobulin during thyroid hormone synthesis.\n\n*Rationale from the context:*  \n- Patients with SLC26A4 mutations showed significantly greater radioiodine discharge after perchlorate administration (p=0.09) compared to those without mutations.  \n- The perchlorate discharge test directly assesses iodine organification defects.  \n- Abnormal thyroid function tests (including elevated thyroglobulin and thyroid volume) were consistently linked to SLC26A4 mutations, confirming thyroid dyshormonogenesis as a core feature.  \n\nThis organification defect distinguishes Pendred syndrome from other causes of hypothyroidism"}
{"idx": 818, "label_json": "{ \"label\": \"True\" }", "question": "Which drug is benserazide usually co-administered with?", "gold_answer": "L-DOPA", "predicted_answer": "Answer: L-DOPA"}
{"idx": 819, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "The main component of Lewy bodies is **alpha-synuclein**.  \n\n*(Note: While the provided context discusses the role of amyloid precursor protein (APP) isoforms in dementia with Lewy bodies (DLB), it explicitly references \"alpha-synuclein deposition\" as the pathological hallmark of DLB. Lewy bodies are defined histopathologically by aggregated alpha-synuclein protein.)*"}
{"idx": 820, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?", "gold_answer": "RET", "predicted_answer": "Based on the context, the gene frequently mutated in both Multiple Endocrine Neoplasia 2 (MEN2) and Hirschsprung disease (HSCR) is:\n\n**RET proto-oncogene**\n\n**Key evidence from the context:**  \n- The study explicitly focuses on mutations in the \"RET proto-oncogene\" (exon 13 Tyr791Phe mutation).  \n- It screened patients with MEN2-associated conditions (MTC, pheochromocytoma) and HSCR, identifying RET mutations in both groups.  \n- Specific RET mutations (Cys620Phe in MEN2A, Met918Thr in MEN2B) and HSCR-associated RET mutations (Ser649Leu) are cited.  \n- The paper directly questions whether the Tyr791Phe mutation has dual functionality (gain/loss-of-function), consistent with RET's role in both oncogenic (MEN2) and developmental (HSCR) disorders.  \n\nAnswer: RET proto-oncogene"}
{"idx": 821, "label_json": "{ \"label\": \"False\" }", "question": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?", "gold_answer": "craniosynostosis", "predicted_answer": "Based on the context provided, an additional feature included in Shprintzen-Goldberg syndrome (SGS) is **intellectual impairment**.\n\nThe context explicitly states:\n*   \"The degree of reported intellectual impairment ranges from mild to severe.\"\n*   This is listed as one of the \"commonly reported manifestations\" alongside hypotonia and developmental delay.\n\nAnswer: Intellectual impairment"}
{"idx": 822, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "XIST", "predicted_answer": "Answer: XIST/Xist RNA"}
{"idx": 823, "label_json": "{ \"label\": \"True\" }", "question": "To the ligand of which receptors does Denosumab (Prolia) bind?", "gold_answer": "RANKL", "predicted_answer": "Answer: RANKL (Receptor Activator of Nuclear Factor κB Ligand)"}
{"idx": 824, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the hormone abnormality commonly associated with Williams syndrome is:\n\n**Hypothyroidism**, specifically characterized by:\n- Elevated TSH (thyroid-stimulating hormone)\n- Low FT4 (free thyroxine)\n\nThis is evidenced by the infant's thyroid function tests showing:\n- TSH: 42 mIU/l (normal: 0.5-4 mIU/l)\n- FT4: 10.21 pmol/l (normal: 10.29-24.45 pmol/l)\n\nThe context emphasizes that congenital hypothyroidism (due to thyroid hypoplasia) requires regular monitoring in Williams syndrome, even after negative neonatal screening"}
{"idx": 825, "label_json": "{ \"label\": \"False\" }", "question": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?", "gold_answer": "craniosynostosis", "predicted_answer": "Based on the context, the disease included as an additional feature in Goldberg-Shprintzen syndrome (GSS/SGS) is **Marfan syndrome (MFS)**.\n\nAnswer: Marfan syndrome (MFS)"}
{"idx": 826, "label_json": "{ \"label\": \"True\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "fungi", "predicted_answer": "Based on current classification, microsporidia belong to the kingdom **Fungi**.\n\n**Key points supporting this:**\n1.  Molecular phylogenetic studies (especially analysis of ribosomal RNA sequences and other genes) have consistently shown that microsporidia share a common ancestor with fungi.\n2.  While they are highly specialized, obligate intracellular parasites with reduced genomes (as mentioned in the context), their evolutionary lineage places them within the fungal kingdom.\n3.  This reclassification from protozoa to fungi is now widely accepted in modern taxonomy.\n\nAnswer: Fungi"}
{"idx": 827, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?", "gold_answer": "thyroid", "predicted_answer": "In patients with Allan–Herndon–Dudley syndrome (caused by MCT8 mutations), the altered hormone concentrations are:  \n**Elevated serum triiodothyronine (T3)** and **reduced serum thyroxine (T4/free T4)**, with normal or mildly elevated thyrotropin (TSH).  \n\nThis is confirmed in the context:  \n- L-thyroxine (LT4) administration suppressed TSH but **did not change thyroid hormone values** (i.e., persistently high T3 and low T4).  \n- The syndrome exhibits \"characteristic thyroid hormone function tests\" reflecting this imbalance"}
{"idx": 828, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "Medicarpin", "predicted_answer": "Based on the context provided, the major phytoalexin in alfalfa (*Medicago sativa* L.) is **medicarpin**.  \n\nKey evidence from the context:  \n1. The study focuses on an **elicitor-inducible isoflavone 7-O-methyltransferase (IOMT)** enzyme involved in medicarpin biosynthesis.  \n2. Medicarpin accumulation is explicitly linked to IOMT induction:  \n   > *\"IOMT transcripts are rapidly induced following elicitation, prior to the increase in IOMT activity and **medicarpin accumulation**.\"*  \n3. The enzyme methylates precursors (e.g., daidzein) in the pathway leading to medicarpin.  \n4. Medicarpin is a well-characterized phytoalexin in alfalfa, and its biosynthesis is the central theme of the study.  \n\n**Answer: Medicarpin**"}
{"idx": 829, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene most commonly mutated in Tay-Sachs disease?", "gold_answer": "HEXA", "predicted_answer": "The gene most commonly mutated in Tay-Sachs disease is **HEXA**.  \n\n**Answer: HEXA**  \n\n**Explanation:**  \n- Tay-Sachs disease results from mutations in the **HEXA gene**, which encodes the α-subunit of β-hexosaminidase A (Hex A).  \n- The context describes mutations in exons 5 and 8 of the α-chain (HEXA), leading to Hex A deficiency and a late-infantile disease phenotype, consistent with Tay-Sachs.  \n- HEXA mutations are the primary genetic cause of Tay-Sachs disease"}
{"idx": 830, "label_json": "{ \"label\": \"True\" }", "question": "DX-88 is investigational name of which drug?", "gold_answer": "Ecallantide", "predicted_answer": "Answer: Ecallantide"}
{"idx": 831, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 832, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "The disease associated with ectopic expression of the protein encoded by the DUX4 gene is **Facioscapulohumeral Muscular Dystrophy (FSHD)**.  \n\nAnswer: Facioscapulohumeral Muscular Dystrophy"}
{"idx": 833, "label_json": "{ \"label\": \"False\" }", "question": "Which is the process that Conserved noncoding elements mostly regulate?", "gold_answer": "development", "predicted_answer": "Conserved noncoding elements mostly regulate **gene expression**, particularly in developmental processes.  \n\nAnswer: gene expression"}
{"idx": 834, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZEB2", "predicted_answer": "Answer: ZEB2"}
{"idx": 835, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits clotting factor **Xa**.\n\n(Note: While the provided context does not explicitly mention betrixaban, it is a well-established direct oral factor Xa inhibitor. The context discusses novel oral anticoagulants targeting specific coagulation factors, aligning with betrixaban's mechanism of action as a factor Xa inhibitor.)"}
{"idx": 836, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.  \n\nKey evidence:  \n1. **Bach1 deficiency/reduction** leads to **higher HO-1 expression** in response to H₂O₂.  \n2. **Bach1 overexpression** **abolishes HO-1 induction** by H₂O₂, causing increased ROS accumulation.  \n3. The text explicitly states Bach1 regulates oxidation through the **\"negative control\"** of HO-1 expression.  \n\nConclusion: BACH1 represses HO-1 transcription under oxidative stress.  \n\n**Answer: Repressor**"}
{"idx": 837, "label_json": "{ \"label\": \"True\" }", "question": "What is the enzymatic activity of the breast cancer associated gene BRCA1?", "gold_answer": "E3 ubiquitin ligase activity", "predicted_answer": "Answer: E3 ligase activity"}
{"idx": 838, "label_json": "{ \"label\": \"True\" }", "question": "Which type of lung cancer is the most strongly associated with Lambert-Eaton syndrome?", "gold_answer": "small-cell lung cancer", "predicted_answer": "Based on the context and medical knowledge:\n\n**Small-cell lung cancer (SCLC)** is the type most strongly associated with Lambert-Eaton myasthenic syndrome (LEMS).\n\nWhile the reported case describes LEMS occurring with non-small-cell lung cancer (NSCLC), the context explicitly states this is an \"unusual association.\" The well-established medical fact is that LEMS is most commonly a paraneoplastic syndrome associated with SCLC, occurring in approximately 50-60% of LEMS cases"}
{"idx": 839, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the hormone abnormalities commonly associated with Williams syndrome (Williams-Beuren syndrome, WBS) are **thyroid hormone abnormalities**, specifically:\n\n1.  **Elevated TSH (Thyroid Stimulating Hormone)**\n2.  **Low Free Thyroxine (FT4)**\n\nThese abnormalities indicate **hypothyroidism**, which in this syndrome is often linked to **thyroid hypoplasia** (underdevelopment of the thyroid gland). The context emphasizes that thyroid function and morphology disorders are reported in WBS, necessitating regular screening and surveillance"}
{"idx": 840, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene mutation associated with McLeod syndrome is **XK**.  \n\n**Answer:** XK"}
{"idx": 841, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?", "gold_answer": "DNMT1", "predicted_answer": "Based on established biological knowledge (as the provided context focuses on *de novo* methylation and a novel dehydroxymethylase activity, not maintenance):\n\n**Answer: DNMT1**\n\n**Explanation:**\n1.  The context discusses **DNMT3A and DNMT3B**, which are **de novo methyltransferases** responsible for establishing *new* methylation patterns.\n2.  The enzyme responsible for **maintaining** existing cytosine-5-methylation patterns after DNA replication is **DNMT1**. It recognizes hemi-methylated sites (where the parent strand is methylated and the daughter strand is not) and methylates the cytosine on the daughter strand.\n3.  While the context reveals a novel bidirectional function (methylation *and* dehydroxymethylation) for DNMT3A/B, it does not alter the established role of DNMT1 in maintenance methylation. The question specifically asks about the enzyme involved in *maintenance*"}
{"idx": 842, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 843, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the specific number of TAp73 isoforms identified in humans is **not stated**.\n\nThe context mentions:\n1.  p73 exists in \"a wide range of isoforms\".\n2.  The study specifically investigated \"two N-terminal isoforms, TAp73 and ΔNp73\".\n3.  It does not provide a total count of identified TAp73 isoforms in humans.\n\nAnswer: The context does not specify the number of TAp73 isoforms identified in humans"}
{"idx": 844, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits clotting factor Xa. \n\nThis is directly indicated in the context by:  \n- Reference to betrixaban as a novel anticoagulant with \"anti-Xa activity.\"  \n- Its grouping with other novel oral anticoagulants targeting factor Xa (e.g., via the universal reversal agent PRT4445 for anti-Xa anticoagulants).  \n\n**Answer: Factor Xa**"}
{"idx": 845, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Based on the context provided:\n\n**Betrixaban inhibits clotting factor Xa.**\n\nThis is explicitly stated in the first sentence of the context: \"A randomized evaluation of betrixaban, an oral **factor Xa inhibitor**, for prevention of thromboembolic events after total knee replacement\".\n\nAnswer: Factor Xa"}
{"idx": 846, "label_json": "{ \"label\": \"False\" }", "question": "Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms. What is the name of the analogous process in prokaryotic organisms?", "gold_answer": "CRISPR-Cas", "predicted_answer": "Answer: prokaryotic silencing"}
{"idx": 847, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: stroke"}
{"idx": 848, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on standard biomedical knowledge (as the specific drug betrixaban is not mentioned in the provided context), betrixaban is a direct inhibitor of **factor Xa**.\n\n**Answer: factor Xa**"}
{"idx": 849, "label_json": "{ \"label\": \"True\" }", "question": "How many tissue kallikrein genes are present in the human genome?", "gold_answer": "15", "predicted_answer": "Based on the context, the human genome contains **15 tissue kallikrein genes** (KLK1 through KLK15).  \n\nThis is evidenced by:  \n- Explicit mention of KLK1 to KLK15 in the study.  \n- Specific examples: KLK1, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14 (expressed in brain regions), and KLK2, 3, 12, 15 (not expressed).  \n\nAnswer: **15**"}
{"idx": 850, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "dermatitis herpetiformis", "predicted_answer": "Answer: dermatitis herpetiformis  \n\n**Explanation:**  \nThe context explicitly states that children with \"dermatitis herpetiformis\" (DH) have a rash controlled by dapsone, which responds to a gluten-free diet. This rash—characterized by IgA deposits and affecting sites like elbows, knees, and buttocks—is the hallmark cutaneous manifestation of gluten sensitivity"}
{"idx": 851, "label_json": "{ \"label\": \"False\" }", "question": "Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?", "gold_answer": "phosphatase 2B", "predicted_answer": "Answer: calcineurin (CaN)"}
{"idx": 852, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies is **alpha-synuclein**.  \n\nKey evidence from the context:  \n1. Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.  \n2. Inclusion bodies formed by synphilin-1A \"recruit alpha-synuclein\" and resemble Lewy bodies.  \n3. Alpha-synuclein is explicitly recruited to synphilin-1A inclusion bodies in neurons.  \n\nAnswer: **alpha-synuclein**"}
{"idx": 853, "label_json": "{ \"label\": \"True\" }", "question": "Which protein is affected by dusp8 activation?", "gold_answer": "JNK", "predicted_answer": "Based on the context, DUSP8 (also referred to as M3/6 or hVH-5) is a **JNK phosphatase**. Therefore, activation of DUSP8 directly affects:  \n**JNK**  \n\n**Explanation:**  \n- The context identifies M3/6/hVH-5 as a JNK-specific phosphatase that dephosphorylates (inactivates) JNK.  \n- DUSP8 is the gene symbol for the protein M3/6/hVH-5.  \n- Thus, DUSP8 activation dephosphorylates JNK, reducing its activity"}
{"idx": 854, "label_json": "{ \"label\": \"True\" }", "question": "Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?", "gold_answer": "Calcineurin", "predicted_answer": "Answer: calcineurin"}
{"idx": 855, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Answer: XK"}
{"idx": 856, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: alpha-synuclein"}
{"idx": 857, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the text does not specify the number of TAp73 isoforms identified in humans. It mentions \"all TAp73 and DeltaNp73 isoforms\" but does not provide a numerical count for TAp73 isoforms specifically.\n\n**Answer:** The context does not specify the number of TAp73 isoforms"}
{"idx": 858, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)"}
{"idx": 859, "label_json": "{ \"label\": \"True\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "fungi", "predicted_answer": "Based on current classification, microsporidia belong to the **Fungi** kingdom. This is supported by:\n- Close evolutionary relationship with zygomycetes (a fungal group)\n- Shared syntenic gene pairs (RPS9-RPL21) with fungi\n- Unfused gene structures matching fungal patterns\n- Sex-locus architecture similarities to zygomycetes\n\nAnswer: Fungi"}
{"idx": 860, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "The ROSIER scale is used for **acute stroke**.\n\nAnswer: acute stroke"}
{"idx": 861, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?", "gold_answer": "autosomal dominant", "predicted_answer": "Based on the genetic mechanism described (deletion of D4Z4 repeats on chromosome 4q35), Facioscapulohumeral muscular dystrophy (FSHD) follows an **autosomal dominant** mode of inheritance. This is consistent with established biomedical knowledge, where a single mutated copy of the affected chromosome 4 region is sufficient to cause the disease. The context's emphasis on genetic testing and genetic counseling further supports this inheritance pattern"}
{"idx": 862, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "The ROSIER scale is used for **stroke**"}
{"idx": 863, "label_json": "{ \"label\": \"True\" }", "question": "Which kinase is inhibited by the small molecule KN-93?", "gold_answer": "CaM kinase II", "predicted_answer": "Answer: CaM kinase II (Ca²⁺/calmodulin-dependent protein kinase II)"}
{"idx": 864, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: alpha-synuclein  \n\n**Key evidence from context:**  \n- Alpha-synucleinopathies are defined by abnormal deposition of alpha-synuclein in neurons/glial cells.  \n- Lewy bodies (a hallmark of Parkinson's and dementia with Lewy bodies) are explicitly categorized under alpha-synucleinopathies.  \n- The text states: \"Accumulations of alpha-synuclein in all these disorders have in common a fibrilar configuration,\" confirming alpha-synuclein as the core component.  \n\n\\boxed{\\text{alpha-synuclein}}"}
{"idx": 865, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 866, "label_json": "{ \"label\": \"False\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "Dermatitis herpetiformis", "predicted_answer": "The typical rash associated with gluten is a **papulovesicular rash**, as described in the context of dermatitis herpetiformis (DH). This rash is characterized by blisters and resolves with a gluten-free diet or dapsone treatment.  \n\n**Answer: Papulovesicular rash**"}
{"idx": 867, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits Factor Xa.  \n\nAnswer: Factor Xa"}
{"idx": 868, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Answer: Xist\n\n**Explanation:**  \nThe context explicitly states: \"We used mutations and chemical inhibition affecting different epigenetic marks as well as **inducible Xist expression**...\"  \nXist is the long non-coding RNA responsible for initiating and maintaining X-chromosome inactivation (Xi) by coating the inactive X chromosome and recruiting silencing complexes"}
{"idx": 869, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Based on the context, betrixaban inhibits **factor Xa (FXa)**. This is directly stated in the excerpt: \"New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.\" Betrixaban is a direct FXa inhibitor, aligning with this description.\n\n**Answer: Factor Xa**"}
{"idx": 870, "label_json": "{ \"label\": \"True\" }", "question": "Are most driver gene mutations synonymous or non-synonymous?", "gold_answer": "non-synonymous", "predicted_answer": "Based on the context, most driver gene mutations are **non-synonymous**. The study specifically verified somatic mutations including:\n- 51 missense (non-synonymous)\n- 10 nonsense (non-synonymous)\n- 1 splicing-site mutation (non-synonymous)\n- 10 INDELs (non-synonymous)\n\nNo synonymous mutations (which do not alter amino acid sequences) were identified as driver mutations. The key driver genes implicated (TP53, EP300, LPHN2, etc.) all harbored these non-synonymous mutations. \n\n**Answer: non-synonymous**"}
{"idx": 871, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Based on the context, Imatinib (Gleevec) targets the **Bcr-Abl** tyrosine kinase.\n\nThis kinase results from the Philadelphia chromosome translocation and is the driver of chronic myeloid leukemia (CML). Imatinib inhibits its dysregulated activity"}
{"idx": 872, "label_json": "{ \"label\": \"False\" }", "question": "Which protein is causing Netherton syndrome?", "gold_answer": "LEKTI", "predicted_answer": "Answer: human kallikrein 5 (hK5)"}
{"idx": 873, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: stroke"}
{"idx": 874, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Mepolizumab?", "gold_answer": "interleukin-5", "predicted_answer": "Answer: Interleukin-5 (IL-5)\n\nExplanation:  \nMepolizumab is a monoclonal antibody that specifically targets interleukin-5 (IL-5), a cytokine critical for eosinophil maturation, activation, and survival. This mechanism is confirmed by the context:  \n- Mepolizumab significantly reduced eosinophil counts in blood and sputum.  \n- Reduced eosinophilic inflammation directly correlated with fewer asthma exacerbations.  \n- The study concludes eosinophils are key effector cells in asthma exacerbations, aligning with IL-5's role in eosinophil regulation.  \n\n(Source: Context explicitly links reduced eosinophils to clinical efficacy, and pharmacological knowledge confirms IL-5 as the target.)"}
{"idx": 875, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium pump of the sarcoplasmic reticulum?", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "predicted_answer": "Answer: SERCA (Sarco/Endoplasmic Reticulum Ca²⁺-ATPase)"}
{"idx": 876, "label_json": "{ \"label\": \"True\" }", "question": "To the ligand of which receptors does Denosumab (Prolia) bind?", "gold_answer": "RANKL", "predicted_answer": "Answer: RANKL (Receptor Activator of Nuclear Factor-kappaB Ligand)"}
{"idx": 877, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: stroke"}
{"idx": 878, "label_json": "{ \"label\": \"False\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: ABL tyrosine kinase"}
{"idx": 879, "label_json": "{ \"label\": \"True\" }", "question": "What histone trimethylation has been associated to RNA splicing?", "gold_answer": "H3K36Me3", "predicted_answer": "Answer: H3K36me3  \n\n**Explanation from context:**  \nThe context states: *\"Surprisingly, the H3K36Me3 levels are comparable among the alternative polyadenylation sites themselves.\"* While the study focuses on **alternative polyadenylation**, **H3K36me3** (histone H3 lysine 36 trimethylation) is a well-established epigenetic mark associated with **RNA splicing**, particularly in recruiting splicing factors and marking actively transcribed exons. The context confirms its presence near polyadenylation sites, aligning with its broader role in RNA processing"}
{"idx": 880, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine  \n\n**Explanation:**  \nThe context explicitly states that JTV519 (K201) is a \"1,4-benzothiazepine derivative\" (first paragraph). This classification is consistent across both provided contexts, confirming its chemical group origin"}
{"idx": 881, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the characteristic hormone abnormality in Pendred syndrome is **impaired thyroid hormone synthesis**, specifically demonstrated by a **positive perchlorate discharge test**. This indicates a defect in iodine organification, where the thyroid fails to properly incorporate iodine into thyroglobulin for hormone production.\n\nKey evidence from the context:  \n- Patients with SLC26A4 mutations showed significantly greater radioiodine discharge after perchlorate administration (\\(p=0.09\\)) compared to mutation-negative patients.  \n- The perchlorate test directly assesses organification defects, a hallmark of Pendred syndrome.  \n- While hypothyroidism and goiter may occur, the core biochemical abnormality is the organification failure.  \n\nAnswer: **Impaired thyroid hormone synthesis (iodine organification defect)**"}
{"idx": 882, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context:\n**BACH1 is a repressor.**\n\nKey evidence from the context:\n1.  **Constitutive HO-1 expression in Bach1 absence:** \"in the absence of Bach1, ho-1 became expressed constitutively at high levels\" - This means Bach1 normally *prevents* high HO-1 expression.\n2.  **Antagonism with activator Nrf2:** \"we documented antagonistic activities of Bach1 and Nrf2\" - Nrf2 is the known activator; Bach1 opposes its action.\n3.  **Direct comparison to a repressor:** \"generating a simple feedback loop whereby the substrate effects repressor-activator antagonism\" - Explicitly labels Bach1 as the repressor and Nrf2 as the activator in the feedback loop.\n4.  **Role in repression:** \"Chromatin immunoprecipitation revealed that small Maf proteins participate in both repression and activation of ho-1\" - Implicates Bach1 (which complexes with small Mafs) in the repression mechanism"}
{"idx": 883, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Based on the context, the **ROSIER scale** is used for **acute stroke**.\n\n**Key evidence from the context:**\n1.  The study developed a \"stroke recognition instrument\" (later named the ROSIER scale) specifically for patients with **suspected acute stroke** admitted from the emergency room (ER).\n2.  Its purpose is the \"initial differentiation of **acute stroke** from stroke mimics in the ER.\"\n3.  Validation was performed on cohorts of patients referred with **suspected acute stroke**.\n4.  Performance metrics (sensitivity, specificity, PPV, NPV) are reported for diagnosing **stroke** versus non-stroke conditions (mimics).\n\n**Answer: Acute stroke**"}
{"idx": 884, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Answer: transcribed strands"}
{"idx": 885, "label_json": "{ \"label\": \"True\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "fungi", "predicted_answer": "Answer: Fungi"}
{"idx": 886, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 887, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits clotting Factor Xa.\n\nAnswer: Factor Xa"}
{"idx": 888, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Answer: alpha-synuclein\n\nBased on the context:\n- Lewy bodies are the pathological hallmark of dementia with Lewy bodies (DLB)\n- The text explicitly states: \"its aggregation constitutes one of the first steps preceding Lewy body formation\" (where \"its\" refers to alpha-synuclein)\n- The entire therapeutic focus is on preventing alpha-synuclein aggregation\n- All four anti-aggregation strategies target alpha-synuclein specifically\n\nThis confirms alpha-synuclein as the primary protein component of Lewy bodies"}
{"idx": 889, "label_json": "{ \"label\": \"False\" }", "question": "Which is the main calcium pump of the sarcoplasmic reticulum?", "gold_answer": "SERCA2", "predicted_answer": "Answer: SERCA2a"}
{"idx": 890, "label_json": "{ \"label\": \"True\" }", "question": "Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?", "gold_answer": "beta-Trcp", "predicted_answer": "Based on the context, the E3 ubiquitin ligase mediating IFNAR1 ubiquitination and degradation is **beta-Trcp**. This is indicated by the statement that Tyk2 stabilization of IFNAR1 was \"dependent neither on its binding to **beta-Trcp** nor IFNAR1 ubiquitination,\" implying beta-Trcp is the relevant E3 ligase for this degradation pathway. \n\nAnswer: beta-Trcp"}
{"idx": 891, "label_json": "{ \"label\": \"True\" }", "question": "In which kingdom do microsporidia belong, according to their current classification scheme?", "gold_answer": "fungi", "predicted_answer": "Answer: Fungi"}
{"idx": 892, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 893, "label_json": "{ \"label\": \"True\" }", "question": "Is APOBEC3B protein predominantly cytoplasmic or nuclear?", "gold_answer": "nuclear", "predicted_answer": "Based on the context, APOBEC3B is **nuclear** during interphase. The text explicitly states: \"During interphase the APOBEC3 proteins have different subcellular localizations: cell-wide, cytoplasmic or nuclear.\" While it does not list each protein's specific interphase localization, it later confirms that APOBEC3B (along with AID and APOBEC3A) alters the cell cycle and causes genomic DNA damage, which requires nuclear access. This is further supported by its established role in carcinogenesis (e.g., breast cancer) via DNA deamination in the nucleus"}
{"idx": 894, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Answer: antiparallel\n\nExplanation: The context describes \"side-to-side\" assembly where complementary nucleation sites near the actin-binding end of each subunit initiate heterodimer formation. The subsequent association involves supercoiling to form a rope-like rod, consistent with an antiparallel orientation where the N- and C-termini of each subunit are at opposite ends. The zipper analogy and lock-and-key structure further support antiparallel alignment for correct pairing of homologous segments"}
{"idx": 895, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, patients with Allan-Herndon-Dudley syndrome (caused by MCT8 mutations) exhibit altered concentrations of **thyroid hormones**, specifically:\n\n1.  **Elevated serum T3 (triiodothyronine)**\n2.  **Decreased serum T4 (thyroxine)**\n3.  **Elevated serum reverse T3 (rT3)**\n\n**Reasoning from the context:**\n*   MCT8 is identified as a transporter for both T4 and T3.\n*   Mutations in MCT8 cause the syndrome.\n*   The context describes the critical role of thyroid hormone transport (specifically T4 and T3) into the brain for development.\n*   The observed hormone alterations (high T3, low T4, high rT3) are the classic biochemical hallmark of MCT8 deficiency, resulting from impaired cellular uptake of T3 and compensatory mechanisms.\n\nAnswer: **Elevated serum T3, decreased serum T4, and elevated serum reverse T3.**"}
{"idx": 896, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Answer: CYP17A1"}
{"idx": 897, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 acts as a **repressor**.  \nKey evidence:  \n- The context explicitly states \"the repression of HO-1 reporter activity by Bach1\".  \n- Repression is attenuated when IHABP is co-transfected, leading to increased HO-1 expression.  \n- The mechanism involves IHABP sequestering BACH1 in the cytoplasm to relieve its repressive effect on target genes like HO-1.  \n\nAnswer: **Repressor**"}
{"idx": 898, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main calcium pump of the sarcoplasmic reticulum?", "gold_answer": "SERCA", "predicted_answer": "Answer: SERCA (Sarco/Endoplasmic Reticulum Calcium ATPase)  \n\n**Key points from the context:**  \n1. Explicitly states: *\"SERCA is a membrane protein... pumps free cytosolic calcium into intracellular stores\"*.  \n2. Specifies *\"SERCA is mainly represented by the SERCA2a isoform in the heart\"*.  \n3. Describes its role in cardiac muscle contraction via sarcoplasmic reticulum (SR) calcium handling.  \n\nNo other calcium pump is mentioned, confirming SERCA as the primary SR calcium pump"}
{"idx": 899, "label_json": "{ \"label\": \"False\" }", "question": "What does mTOR stands for?", "gold_answer": "mammalian target of rapamycin", "predicted_answer": "Answer: mechanistic target of rapamycin"}
{"idx": 900, "label_json": "{ \"label\": \"True\" }", "question": "Which bone protein is used in archaelogy for dating and species identification?", "gold_answer": "collagen", "predicted_answer": "Answer: collagen (specifically alpha1(I) collagen)  \n\n**Key points from context:**  \n- The study analyzes fossil protein sequences, explicitly mentioning **\"alpha1(I) collagen sequences\"** in the T. rex analysis.  \n- Collagen is the most common bone protein preserved in fossils and is routinely used for:  \n  - **Radiocarbon dating** (via carbon in collagen)  \n  - **Species identification** (via peptide mass fingerprinting or sequencing)  \n  - **Stable isotope analysis** (diet/climate reconstruction)  \n\nThe context's criticism of the T. rex data hinges on mismatched collagen sequences, confirming its role in species identification. No other bone proteins are referenced"}
{"idx": 901, "label_json": "{ \"label\": \"True\" }", "question": "What is the mode of inheritance of Romano Ward long QT syndrome?", "gold_answer": "autosomal dominant", "predicted_answer": "Answer: Autosomal dominant\n\nExplanation: Romano-Ward syndrome is the autosomal dominant form of long QT syndrome, characterized by prolonged QT intervals on ECG and risk of ventricular arrhythmias, without associated congenital deafness. This contrasts with Jervell and Lange-Nielsen syndrome, which is autosomal recessive and includes deafness"}
{"idx": 902, "label_json": "{ \"label\": \"True\" }", "question": "Which amino acid residue appears mutated in most of the cases reported with  cadasil syndrome?", "gold_answer": "cysteine", "predicted_answer": "Answer: cysteine"}
{"idx": 903, "label_json": "{ \"label\": \"True\" }", "question": "What is generic name of drug Adempas?", "gold_answer": "Riociguat", "predicted_answer": "Answer: Riociguat"}
{"idx": 904, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Answer: Xist RNA"}
{"idx": 905, "label_json": "{ \"label\": \"True\" }", "question": "Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?", "gold_answer": "Calcineurin", "predicted_answer": "Calcineurin"}
{"idx": 906, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are common in Williams syndrome ?", "gold_answer": "thyroid", "predicted_answer": "Answer: hypercalcemia\n\nCommon hormone abnormalities in Williams syndrome include elevated calcium levels (hypercalcemia), particularly during infancy. While the presented case focuses on hypothyroidism (elevated TSH with normal thyroid hormones), this is not a core feature of Williams syndrome. Hypercalcemia is the most consistently reported endocrine abnormality in this condition"}
{"idx": 907, "label_json": "{ \"label\": \"True\" }", "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?", "gold_answer": "LepChorionDB", "predicted_answer": "Answer: LepChorionDB"}
{"idx": 908, "label_json": "{ \"label\": \"True\" }", "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?", "gold_answer": "FSHD", "predicted_answer": "The disease associated with ectopic expression of the protein encoded by the gene DUX4 is **Facioscapulohumeral Muscular Dystrophy (FSHD)**, specifically the FSHD1 subtype.  \n\n**Key evidence from the context:**  \n- FSHD1 is caused by a contracted D4Z4 repeat array (<10 repeats), leading to decreased epigenetic repression.  \n- This contraction results in \"FSHD-specific variegated DUX4 expression in sporadic muscle nuclei.\"  \n- Ectopic DUX4 expression drives the disease pathology in skeletal muscle"}
{"idx": 909, "label_json": "{ \"label\": \"True\" }", "question": "Which thyroid hormone transporter is implicated in thyroid hormone resistance syndrome?", "gold_answer": "MCT8", "predicted_answer": "Answer: MCT8\n\nBased on the context:\n- The patient has a **missense mutation of the MCT8 gene**.\n- MCT8 is explicitly identified as the transporter responsible for T<sub>3</sub> uptake in neurons, and its dysfunction explains the neurological phenotype and abnormal thyroid hormone levels (high free T<sub>3</sub> with normal TSH).\n- This mutation causes a form of thyroid hormone resistance (Allan-Herndon-Dudley syndrome), where impaired MCT8 function leads to peripheral tissue resistance and characteristic biochemical abnormalities"}
{"idx": 910, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: Bcr-Abl tyrosine kinase"}
{"idx": 911, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "medicarpin", "predicted_answer": "Based on the context, the major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.\n\n**Key evidence from the context:**  \n1. IFR is explicitly described as \"the penultimate enzyme in **medicarpin** biosynthesis\".  \n2. The accumulation of **medicarpin** is directly linked to IFR induction in elicited alfalfa cell cultures.  \n3. Medicarpin glucoside accumulates in healthy plant parts, further confirming its role as the key phytoalexin.  \n\nAnswer: **medicarpin**"}
{"idx": 912, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 913, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 914, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 915, "label_json": "{ \"label\": \"True\" }", "question": "Which is the gene mutated in type 1 neurofibromatosis?", "gold_answer": "NF1", "predicted_answer": "The gene mutated in type 1 neurofibromatosis is **NF1**.  \n\n**Key evidence from the context:**  \n- The protein studied is **neurofibromin** (the product of the NF1 gene).  \n- Mutations at lysine 1423 were detected in **neurofibromatosis patients**.  \n- Functional assays (e.g., yeast ira complementation) directly assess **NF1 function**.  \n\nAnswer: **NF1**"}
{"idx": 916, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nHere's the supporting evidence from the context:\n1.  The study focuses on how phenylpropanoid glycosides (PPGs) induce the protective gene *HMOX1* by \"affecting the balance of NRF2 and BACH1 transcription factors.\"\n2.  It states that hydroxytyrosol (HYD), a potential bioactive metabolite of PPGs, modifies \"Nrf2/Bach1 nuclear protein levels\" and activates *HO-1* transcription.\n3.  The context implies that reducing BACH1's influence (or increasing NRF2's) leads to the activation of *HMOX1* expression. Specifically, the active PPGs (FB, EC) and HYD work by counteracting BACH1's repressive effect on the *HMOX1* gene.\n\nTherefore, BACH1 acts as a repressor of *HMOX1* gene expression"}
{"idx": 917, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "Based on the context provided:  \n**Answer: X-linked dystonia-parkinsonism**  \n\nExplanation:  \nThe context explicitly states: \"*X-linked dystonia-parkinsonism/Lubag disease*\", indicating that \"Lubag disease\" is synonymous with \"X-linked dystonia-parkinsonism\""}
{"idx": 918, "label_json": "{ \"label\": \"True\" }", "question": "What is the Drosophila melanogaster Groucho protein?", "gold_answer": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor", "predicted_answer": "The Drosophila melanogaster Groucho protein is a **transcriptional corepressor**.  \n\nBased on the context:  \n- It mediates repression through histone deacetylase (Rpd3)-dependent mechanisms.  \n- It recruits Rpd3 to chromatin, deacetylating histones H3/H4.  \n- This increases nucleosome density, leading to transcriptional repression of target genes (e.g., the *vestigial* quadrant enhancer).  \n\nAnswer: **Transcriptional corepressor**"}
{"idx": 919, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by the drug Gevokizumab?", "gold_answer": "IL-1β", "predicted_answer": "Based on the context, the molecule targeted by Gevokizumab is **interleukin-1β (IL-1β)**.  \n\nKey evidence from the context:  \n- The study analyzes crystal structures of Gevokizumab's Fab in complex with IL-1β.  \n- Gevokizumab occupies an allosteric site on IL-1β, directly binding to it and attenuating IL-1β signaling.  \n- Both Gevokizumab and Canakinumab (another antibody drug) target IL-1β, albeit via distinct binding modes.  \n\nAnswer: **interleukin-1β (IL-1β)**"}
{"idx": 920, "label_json": "{ \"label\": \"True\" }", "question": "Which type of lung cancer is the most strongly associated with Lambert-Eaton syndrome?", "gold_answer": "small-cell lung cancer", "predicted_answer": "Answer: Small cell lung cancer (SCLC)\n\n**Explanation:**  \nThe context explicitly states that cytologic examination confirmed SCLC (small cell lung cancer) in the patient with Lambert-Eaton syndrome. SCLC is the most strongly associated lung cancer with LEMS, as it frequently presents as a paraneoplastic syndrome due to autoantibodies targeting voltage-gated calcium channels"}
{"idx": 921, "label_json": "{ \"label\": \"True\" }", "question": "Is Rheumatoid Arthritis more common in men or women?", "gold_answer": "women", "predicted_answer": "Based on the context, Rheumatoid Arthritis is more common in women. The study explicitly states:\n*   \"Colombian women with RA are more at risk...\"\n*   It identifies several adverse factors and outcomes specifically for women (early age at onset, polyautoimmunity, abdominal obesity, higher disability, worse prognosis).\n*   The conclusion highlights \"the high rates of disability and worse prognosis observed in women with RA in LAC.\"\n\nWhile the context does not provide a direct male-to-female prevalence ratio, the consistent focus on the increased burden, risk factors, and worse outcomes for women clearly indicates that RA is more common and severe in women within this Latin American population.\n\n**Answer: Women**"}
{"idx": 922, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Secukinumab?", "gold_answer": "interleukin-17A", "predicted_answer": "Answer: Interleukin 17 (IL-17)  \n\nThe context explicitly states: \"Interleukin 17 (IL-17) is thought to be a key inflammatory cytokine in the development of ankylosing spondylitis\" and identifies secukinumab as a \"targeted therapy\" that successfully reduced clinical signs of the disease. Secukinumab is a monoclonal antibody specifically designed to inhibit IL-17"}
{"idx": 923, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)"}
{"idx": 924, "label_json": "{ \"label\": \"True\" }", "question": "Which MAP kinase phosphorylates the transcription factor c-jun?", "gold_answer": "Jnk", "predicted_answer": "Answer: Jnk"}
{"idx": 925, "label_json": "{ \"label\": \"True\" }", "question": "Which is the E3 ubiquitin ligase which ubiquitinates IkB leading to its proteasomal degradation?", "gold_answer": "SCF(β-TrCP)", "predicted_answer": "Based on the context, the E3 ubiquitin ligase that ubiquitinates IκB leading to its proteasomal degradation is **β-TrCP**.\n\n**Key evidence from the context:**\n1.  \"In vivo ablation of β-TrCP results in accumulation of all the IκBs and complete NF-κB inhibition.\"\n2.  \"As many details of IκB-β-TrCP interaction have been worked out...\"\n3.  The context explicitly states β-TrCP is the target for inhibitor development to block IκB degradation.\n\nβ-TrCP is the substrate recognition component (F-box protein) of an SCF-type E3 ubiquitin ligase complex (SCF^β-TrCP)"}
{"idx": 926, "label_json": "{ \"label\": \"True\" }", "question": "Which deficiency is the cause of restless leg syndrome?", "gold_answer": "iron", "predicted_answer": "Answer: Iron deficiency\n\nNote: While the provided context discusses Periodic Limb Movement Disorder (PLMD), which is often associated with Restless Legs Syndrome (RLS), it does not explicitly state the cause of RLS. However, based on established biomedical knowledge, **iron deficiency** is a well-documented primary cause of RLS, as it disrupts dopamine synthesis and iron-dependent neurological pathways. Other deficiencies (e.g., magnesium, folate) may contribute, but iron deficiency is the most clinically recognized driver"}
{"idx": 927, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Based on the context provided:\n\n**Answer: CYP17A1**\n\n**Explanation:**\n1.  The context explicitly states that orteronel is an \"investigational CYP17A1 inhibitor\".\n2.  The results described (suppression of estradiol, testosterone, androstenedione, and 17-hydroxyprogesterone; lack of effect on corticoid pathway) are consistent with selective inhibition of CYP17A1 (17α-hydroxylase/17,20-lyase), a key enzyme in androgen biosynthesis.\n3.  The conclusion directly states that orteronel suppresses estradiol \"through selective inhibition of CYP17A1 activity\""}
{"idx": 928, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)\n\nThe context explicitly discusses inhibitors of the reverse mode of the Na⁺/Ca²⁺ exchanger (NCX(REV)), including PPADS, KB-R7943, and SN-6. While SEA0400 is not directly mentioned in the text, it is a well-established specific inhibitor of NCX, aligning with the subject of the study. The question refers to the same ion exchanger (NCX) as the primary focus of the context"}
{"idx": 929, "label_json": "{ \"label\": \"False\" }", "question": "Which hormone abnormalities are characteristic to Pendred syndrome?", "gold_answer": "thyroid", "predicted_answer": "Based on the context, the characteristic hormone abnormality in Pendred syndrome is **hypothyroidism** due to impaired thyroid hormone synthesis. This results from defective iodide transport (caused by pendrin deficiency), leading to:\n- Reduced iodine-rich thyroglobulin in follicular colloid\n- Aberrant intracellular thyroid hormone synthesis\n- Oxidative stress and follicular destruction  \nThese disruptions culminate in insufficient production of thyroid hormones (T3/T4).\n\n**Answer: Hypothyroidism**"}
{"idx": 930, "label_json": "{ \"label\": \"True\" }", "question": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?", "gold_answer": "Chaperone-mediated autophagy (CMA)", "predicted_answer": "Chaperone-mediated autophagy (CMA)\n\nAnswer: Chaperone-mediated autophagy"}
{"idx": 931, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nKey evidence from the text:\n1.  **Inverse regulation with HO-1**: Expression of HO-1 and Bach1 is inversely regulated. When Bach1 expression increases (e.g., by interferon-gamma or desferrioxamine), HO-1 expression decreases.\n2.  **Targets Maf recognition element for repression**: Bach1 targets a Maf recognition element (MARE) in the human HO-1 gene that is required for repression of a reporter gene by hypoxia.\n3.  **Mechanism**: Bach1 forms a heterodimer with a small Maf protein and binds to the MARE to repress transcription of the HO-1 gene.\n\nAnswer: **Repressor**"}
{"idx": 932, "label_json": "{ \"label\": \"False\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets the **template strand** of actively transcribed genes.  \n\n**Reason:** TCR is triggered when RNA polymerase stalls at DNA lesions *during transcription*. This process specifically repairs the strand being transcribed (the template strand), as it is directly scanned by the RNA polymerase complex. The non-transcribed (coding) strand is repaired by global NER pathways, not TCR.\n\nAnswer: Template strand"}
{"idx": 933, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: stroke"}
{"idx": 934, "label_json": "{ \"label\": \"True\" }", "question": "Treatment of which disease was investigated in the MR CLEAN study?", "gold_answer": "Acute ischemic stroke", "predicted_answer": "Based on the context, the disease investigated in the MR CLEAN study was **acute ischemic stroke (AIS)**.  \n\n**Key evidence from the context:**  \n1. The meta-analysis explicitly evaluates \"endovascular therapies for **acute ischemic stroke**\".  \n2. MR CLEAN is one of the prospective randomized controlled trials (RCTs) included in this meta-analysis.  \n3. The trials specifically focus on patients with **large vessel occlusion (LVO)**, a subtype of acute ischemic stroke.  \n\nAnswer: Acute ischemic stroke"}
{"idx": 935, "label_json": "{ \"label\": \"True\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "dermatitis herpetiformis", "predicted_answer": "The typical rash associated with gluten is **dermatitis herpetiformis**.  \n\n**Key evidence from the context**:  \n- The study explicitly focuses on patients with \"dermatitis herpetiformis,\" a condition linked to gluten sensitivity.  \n- The rash is described as a primary symptom (e.g., \"transient rash\" or \"persistent mild rash\" triggered by dietary gluten).  \n- The investigation confirms oats do not activate this rash, reinforcing dermatitis herpetiformis as the gluten-associated rash.  \n\n**Answer**: dermatitis herpetiformis"}
{"idx": 936, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 937, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: acute stroke"}
{"idx": 938, "label_json": "{ \"label\": \"True\" }", "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?", "gold_answer": "medicarpin", "predicted_answer": "Based on the context, the major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.  \n\nKey evidence from the context:  \n- During elicitor treatment (simulating stress), radiolabeled phenylalanine was incorporated \"predominantly into medicarpin.\"  \n- Medicarpin is identified as a phytoalexin in this system, with its accumulation induced by stress.  \n- The data also suggest medicarpin may be released from its conjugate (MGM) under stress conditions.  \n\nAnswer: **medicarpin**"}
{"idx": 939, "label_json": "{ \"label\": \"True\" }", "question": "Which enzyme is inhibited by Orteronel?", "gold_answer": "CYP17A1", "predicted_answer": "Answer: CYP17A1"}
{"idx": 940, "label_json": "{ \"label\": \"False\" }", "question": "What is the typical rash associated with gluten ?", "gold_answer": "Dermatitis herpetiformis", "predicted_answer": "Based on the context, the typical rash associated with gluten is:\n\n**Papulovesicular rash**\n\nThis is explicitly stated in the context: \"It presents as a **papulovesicular rash**...\" referring to dermatitis herpetiformis (DH), the gluten-sensitive skin condition. The context further confirms this rash is associated with gluten ingestion and resolves with a gluten-free diet"}
{"idx": 941, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nThe evidence from the context:\n1.  It is explicitly called a \"transcription repressor Bach1\" in the first sentence.\n2.  It states that heme \"inactivate[s] the repressor Bach1\".\n3.  Its DNA-binding activity (as part of a MafK hetero-oligomer) represses genes, and heme binding inhibits this DNA-binding activity, leading to derepression (induction) of the target genes"}
{"idx": 942, "label_json": "{ \"label\": \"False\" }", "question": "Which residue of alpha-synuclein was found to be phosphorylated in Lewy bodies?", "gold_answer": "Parkinson", "predicted_answer": "Based on the context, the residue of alpha-synuclein phosphorylated in Lewy bodies is **Ser129**.  \n\nThe context explicitly states:  \n- Lewy bodies contain fibrillar aggregates of α-synuclein.  \n- Only 4% or less of total α-synuclein is phosphorylated at **Ser129** in the normal brain, but this phosphorylation accumulates in Parkinson's disease.  \n- Accumulation of **Ser129-phosphorylated α-synuclein** leads to Lewy body formation and neurodegeneration.  \n\nAnswer: Ser129"}
{"idx": 943, "label_json": "{ \"label\": \"True\" }", "question": "What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?", "gold_answer": "SECIS", "predicted_answer": "Answer: SECIS (SelenoCysteine Insertion Sequence)"}
{"idx": 944, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "benzothiazepine", "predicted_answer": "Based on the context provided:\n\n**Answer: 1,4-benzothiazepine**\n\n**Explanation:**\n1.  The context explicitly states that diltiazem is a \"1,5-benzothiazepine derivative\".\n2.  It contrasts JTV519 with diltiazem (\"The effect of JTV519 was also compared with that of diltiazem\"), implying they are different derivatives within the benzothiazepine group.\n3.  As established in the previous example context (and confirmed by biomedical literature), JTV519 (K201) is specifically known as a **1,4-benzothiazepine derivative**. The current context does not contradict this classification"}
{"idx": 945, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "Based on the context, McLeod syndrome is associated with mutations in the **XK** gene. \n\nKey evidence from the context:\n1. All three McLeod patients (Be, Bi, Lh) had deletions involving the **XK locus**.\n2. Patient Bi had a deletion specifically \"from the XK to RPGR loci\".\n3. Patient Lh had a deletion \"from the XK to CYBB loci\".\n4. McLeod syndrome is established as an X-linked disorder caused by mutations in *XK*, which encodes the Kx blood group antigen. The context confirms this by identifying *XK* as the common deleted locus in patients"}
{"idx": 946, "label_json": "{ \"label\": \"True\" }", "question": "Which is the histone residue methylated by MLL1?", "gold_answer": "H3K4", "predicted_answer": "Answer: Histone H3 lysine 4 (H3K4)  \n\n*Note: While the context mentions the \"MLL histone methylase complex,\" it does not explicitly state the methylated residue. Based on established molecular biology knowledge, MLL1 (a component of the complex) methylates H3K4.*"}
{"idx": 947, "label_json": "{ \"label\": \"True\" }", "question": "What is the definitive treatment for low pressure headache?", "gold_answer": "epidural blood patch", "predicted_answer": "Based on the context, the definitive treatment for low-pressure headache (specifically Postdural Puncture Headache/PDPH) is:\n\n**Answer: Autologous Epidural Blood Patch (AEBP)**  \n\nKey evidence from the context:  \n1. PDPH is defined as a low-pressure headache caused by CSF leakage.  \n2. The text explicitly states: \"The optimum volume of blood has been shown to be 12-20 mL for adult patients\" and \"Complications of AEBP are rare,\" confirming AEBP as the standard intervention.  \n3. AEBP involves injecting the patient’s own blood into the epidural space to seal the dural puncture, stopping CSF leakage and resolving symptoms.  \n\nThis aligns with clinical guidelines where AEBP is the gold standard for refractory PDPH"}
{"idx": 948, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Based on the context, the ROSIER scale is used for **stroke** (including transient ischemic attack/TIA).\n\n**Key evidence from the context:**\n1.  It is directly compared to the Cincinnati Prehospital Stroke Scale (CPSS).\n2.  It is used as a \"stroke recognition tool on suspected [stroke] patients in the prehospital setting.\"\n3.  The reference standard is the \"final discharge diagnosis of stroke or transient ischemic attack.\"\n4.  The study evaluates its ability to diagnose stroke/TIA using metrics like sensitivity and specificity.\n5.  The conclusion states it cannot be used to \"confidently rule out or identify **stroke** as a diagnosis.\"\n\nAnswer: stroke"}
{"idx": 949, "label_json": "{ \"label\": \"False\" }", "question": "Which receptor is targeted by telcagepant?", "gold_answer": "calcitonin gene-related peptide", "predicted_answer": "Answer: calcitonin gene-related peptide receptor"}
{"idx": 950, "label_json": "{ \"label\": \"True\" }", "question": "Which drug should be used as an antidote in benzodiazepine overdose?", "gold_answer": "flumazenil", "predicted_answer": "Answer: flumazenil  \n\n**Explanation from context:**  \n- The study evaluates the use of **flumazenil** in comatose patients with suspected benzodiazepine overdose.  \n- Flumazenil is administered as an antidote to reverse benzodiazepine-induced coma, with outcomes categorized by awakening responses (complete, partial, or no change).  \n- Safety concerns (e.g., seizures) are discussed specifically in relation to flumazenil administration"}
{"idx": 951, "label_json": "{ \"label\": \"True\" }", "question": "What is the synonym of the lubag disease?", "gold_answer": "X-linked dystonia-parkinsonism", "predicted_answer": "The synonym for lubag disease is **Filipino X-linked dystonia-parkinsonism**.  \n\nAnswer: Filipino X-linked dystonia-parkinsonism"}
{"idx": 952, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na+/Ca2+ exchanger (NCX)"}
{"idx": 953, "label_json": "{ \"label\": \"True\" }", "question": "What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?", "gold_answer": "RET", "predicted_answer": "Answer: RET proto-oncogene"}
{"idx": 954, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "Stroke", "predicted_answer": "The ROSIER scale is used for **acute stroke**. \n\nAnswer: acute stroke"}
{"idx": 955, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 956, "label_json": "{ \"label\": \"True\" }", "question": "PBT2 has been tested for which disorder?", "gold_answer": "Alzheimer's disease", "predicted_answer": "Answer: Alzheimer's disease  \n\n**Explanation:**  \nWhile the specific drug PBT2 is not mentioned in the provided context, the entire review focuses on experimental treatments for cognitive decline and dementia, explicitly naming **Alzheimer's disease** and mild cognitive impairment as key disorders under investigation. PBT2 is a well-known experimental drug tested in clinical trials for Alzheimer's disease, targeting amyloid-beta aggregation. Given the context's scope, this is the disorder relevant to the query"}
{"idx": 957, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Answer: The transcribed strand (template strand)"}
{"idx": 958, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa\n\nThe context classifies betrixaban as a \"Factor X inhibitor\" (specifically an inhibitor of activated Factor X, Factor Xa), placing it within the category of novel anticoagulants that directly target specific steps in the coagulation cascade"}
{"idx": 959, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the exact number of TAp73 isoforms identified in humans **is not specified**.\n\nThe context states:\n1.  \"the role of various p73 isoforms\"\n2.  \"TAp73 isoforms exert tumor-suppressive functions\"\n\nThis confirms that **multiple** TAp73 isoforms exist, but it does not provide a specific count for humans. The text focuses on the functional consequences of TAp73 deficiency rather than enumerating the isoforms"}
{"idx": 960, "label_json": "{ \"label\": \"False\" }", "question": "To the ligand of which receptors does Denosumab (Prolia) bind?", "gold_answer": "RANKL", "predicted_answer": "Answer: RANK (Receptor Activator of Nuclear Factor-κΒ)\n\n**Direct Explanation:**  \nDenosumab (Prolia) is a monoclonal antibody that binds to **RANKL** (Receptor Activator of Nuclear Factor-κΒ Ligand). RANKL is the ligand for the **RANK receptor** on osteoclast precursors. By neutralizing RANKL, Denosumab inhibits osteoclast formation and activity, thereby reducing bone resorption. This mechanism is explicitly referenced in the context via the \"RANKL-RANK-OPG pathway.\""}
{"idx": 961, "label_json": "{ \"label\": \"False\" }", "question": "What is the gold standard treatment for Iatrogenic male incontinence?", "gold_answer": "AUS", "predicted_answer": "Based solely on the provided context, the gold standard treatment for iatrogenic male incontinence **is not explicitly stated**. The context focuses exclusively on evaluating the **Bone-Anchored Sub-urethral Sling (BAUS)** as a treatment option for this condition, demonstrating its safety and efficacy. It does not compare BAUS to other treatments or identify any alternative as the \"gold standard.\"\n\n**Answer:** The context does not specify the gold standard treatment. It only evaluates the Bone-Anchored Sub-urethral Sling (BAUS) as an effective option"}
{"idx": 962, "label_json": "{ \"label\": \"True\" }", "question": "Mutation of which gene is associated with McLeod syndrome?", "gold_answer": "XK", "predicted_answer": "The gene mutation associated with McLeod syndrome is **XK**, as explicitly stated in the context:  \n*\"McLeod phenotype associated with a XK missense mutation\"* and *\"the E327K missense mutation\"* in the XK gene.  \n\n**Answer: XK**"}
{"idx": 963, "label_json": "{ \"label\": \"False\" }", "question": "How is bladder wall thickness measured?", "gold_answer": "ultrasound", "predicted_answer": "Based on the context, bladder wall thickness (BWT) is measured using **two methods**:  \n1. **Conventional ultrasound** (manual measurement)  \n2. **The BVM 6500 device** (automatic measurement)  \n\nBoth techniques were compared in the study, with measurements taken at different bladder fillings (including 250 ml). The BVM 6500 device was limited to measurements ≤4 mm.  \n\n**Answer:** Conventional ultrasound (manual) and the BVM 6500 device (automatic)"}
{"idx": 964, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 965, "label_json": "{ \"label\": \"True\" }", "question": "Which molecule is targeted by a monoclonal antibody Secukinumab?", "gold_answer": "interleukin-17A", "predicted_answer": "Secukinumab targets interleukin-17A (IL-17A).  \n\nAnswer: IL-17A"}
{"idx": 966, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Based on the context, the transcript responsible for X-chromosome inactivation is **Xist**, as it is the key non-coding RNA transcript produced from the **X-inactivation center (XIC)** locus. This transcript initiates and propagates the silencing of one X chromosome.\n\n**Answer: Xist**"}
{"idx": 967, "label_json": "{ \"label\": \"True\" }", "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?", "gold_answer": "p53", "predicted_answer": "Answer: p53"}
{"idx": 968, "label_json": "{ \"label\": \"True\" }", "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the antibody used for immunostaining of Lewy bodies is raised against **alpha-synuclein**. This is explicitly stated in the description of dystrophic axonal terminals in the central amygdaloid nucleus:  \n*\"anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals\"*.  \n\nAdditionally, the study links Lewy body formation to alpha-synuclein accumulation in both the substantia nigra and axonal terminals.  \n\n**Answer: alpha-synuclein**"}
{"idx": 969, "label_json": "{ \"label\": \"True\" }", "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?", "gold_answer": "ZFHX1B", "predicted_answer": "Answer: ZFHX1B"}
{"idx": 970, "label_json": "{ \"label\": \"True\" }", "question": "What is the characteristic domain of histone methyltransferases?", "gold_answer": "SET domain", "predicted_answer": "The characteristic domain of histone methyltransferases is the **SET domain**.  \n\n**Answer:** SET domain"}
{"idx": 971, "label_json": "{ \"label\": \"True\" }", "question": "Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?", "gold_answer": "BRG1", "predicted_answer": "Based on the provided context, the SWI/SNF protein complex subunit demonstrated to interact with the FANCA gene product is **BRG1**.\n\nKey evidence from the context:\n1.  \"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"\n2.  \"We also found a significant increase in the molecular chaperone... among **BRG1-associated factors** isolated from a FANCA-mutant cell line...\"\n3.  \"Finally, we demonstrated **co-localization in the nucleus between transfected FANCA and BRG1**.\"\n\nAnswer: **BRG1**"}
{"idx": 972, "label_json": "{ \"label\": \"False\" }", "question": "How many TAp73 isoforms have been identified in humans?", "gold_answer": "7", "predicted_answer": "Based solely on the provided context, the exact number of TAp73 isoforms identified in humans is **not specified**.\n\nThe context states:\n1.  \"The p73 protein shares strong structural and functional similarities with p53...\"\n2.  \"**In addition to alternative splicing at the carboxyl terminus which yields several p73 isoforms**, a p73 variant lacking the N-terminal transactivation domain (Delta Np73) was described...\"\n\nWhile this confirms that alternative splicing produces **multiple p73 isoforms**, including the transactivation-competent TAp73 forms, the text does not provide a specific count for the number of TAp73 isoforms.\n\n**Answer:** The context does not specify the number of TAp73 isoforms identified in humans, only that alternative splicing yields \"several\" p73 isoforms"}
{"idx": 973, "label_json": "{ \"label\": \"True\" }", "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?", "gold_answer": "PLN", "predicted_answer": "Answer: phospholamban (PLN)  \n\nThe context explicitly identifies phospholamban (PLN) as the core regulatory molecule of SERCA2a function:  \n- It references the \"PLN/SERCA interactome\" as the key regulator of SR Ca²⁺-cycling.  \n- PLN directly inhibits SERCA2a activity, and its phosphorylation status controls Ca²⁺ uptake into the SR.  \n- Other mentioned proteins (I-1, Hsp20, HAX1, HRC) are secondary modulators within this interactome, but PLN is the primary regulator of SERCA2a.  \n\nSource: \"regulation of SR Ca-cycling by the **PLN/SERCA interactome**\" and \"depressed contractility\" linked to variants in \"Ca-cycling genes\" (including PLN)"}
{"idx": 974, "label_json": "{ \"label\": \"True\" }", "question": "ROSIER scale is used for which disorder?", "gold_answer": "stroke", "predicted_answer": "Answer: stroke (including transient ischemic attack)  \n\nThe context explicitly states that the ROSIER scale is used for the initial assessment of patients with **suspected acute stroke** in the emergency department, alongside transient ischemic attack (TIA) as part of the diagnostic target"}
{"idx": 975, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Based on the context of chronic myeloid leukemia (CML) treatment and Imatinib's role:\n\n**Answer: BCR-ABL tyrosine kinase**\n\n**Explanation:**  \nImatinib (Gleevec) is a tyrosine kinase inhibitor specifically designed to target the BCR-ABL fusion protein, which results from the Philadelphia chromosome translocation (t(9;22)). This abnormal kinase drives uncontrolled cell proliferation in CML. The context confirms Imatinib's use as first-line therapy for Philadelphia chromosome-positive CML, directly implicating BCR-ABL as its target"}
{"idx": 976, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "Alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies in Parkinson's disease is **alpha-synuclein**. \n\nThis is directly indicated by the statement: *\"autophagy is involved in alpha-synuclein degradation\"*, and the established pathological role of alpha-synuclein aggregates in Lewy bodies is a hallmark of Parkinson's disease"}
{"idx": 977, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Based on the context, the transcript responsible for X-chromosome inactivation is **Xist**.\n\n**Key evidence from the context:**\n1. Explicitly identifies \"Xist\" as the \"X-chromosome inactivation factor.\"\n2. States that \"Xist\" expression is upregulated by diesel exhaust exposure.\n3. Notes that changes in \"Xist\" expression may serve as a biomarker for diesel exhaust effects on X-chromosome inactivation mechanisms"}
{"idx": 978, "label_json": "{ \"label\": \"True\" }", "question": "Which drug is benserazide usually co-administered with?", "gold_answer": "L-dopa", "predicted_answer": "Benserazide is usually co-administered with **L-dopa (levodopa)**.\n\nAnswer: L-dopa"}
{"idx": 979, "label_json": "{ \"label\": \"True\" }", "question": "Which is the histone residue methylated by MLL1?", "gold_answer": "H3K4", "predicted_answer": "The histone residue methylated by MLL1 is **H3 lysine 4 (H3K4)**.  \n\n**Key points from context and background knowledge:**  \n- MLL1 is a histone methyltransferase that specifically targets lysine 4 on histone H3.  \n- This methylation (H3K4me) is associated with active gene transcription, consistent with the context's emphasis on MLL1's role in enabling downstream transcription.  \n- The conservation of this mechanism from yeast to humans further supports H3K4 as the canonical target site.  \n\nAnswer: **H3K4**"}
{"idx": 980, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL tyrosine kinase"}
{"idx": 981, "label_json": "{ \"label\": \"True\" }", "question": "What is the main component of the Lewy bodies?", "gold_answer": "alpha-synuclein", "predicted_answer": "Based on the context, the main component of Lewy bodies is **α-synuclein (AS)**. \n\nKey evidence from the context:  \n- Lewy bodies are a hallmark of Lewy body diseases (e.g., Parkinson disease, dementia with Lewy bodies).  \n- AS oligomerization and aggregation are directly linked to Lewy body formation.  \n- Lewy bodies contain abundant posttranslationally modified forms of AS (phosphorylated, nitrated, monoubiquitinated).  \n- The text emphasizes AS as the aggregation-prone protein central to the pathogenesis of these diseases.  \n\nAnswer: **α-synuclein**"}
{"idx": 982, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL tyrosine kinase"}
{"idx": 983, "label_json": "{ \"label\": \"False\" }", "question": "What is the characteristic domain of histone methyltransferases?", "gold_answer": "SET domain", "predicted_answer": "Based on the context, the characteristic domain of histone methyltransferases is the **C-terminus**, which contains the catalytic region responsible for methyltransferase activity. \n\nKey evidence from the context:  \n- Mutations in conserved amino acids (R1097A, W1103A, Y1120A, Y1138A, R1162A) and the metal-binding site (C1168A) in the **C-terminal catalytic region** impaired enzyme function.  \n- Deletion of the N-terminus did not abolish catalysis, confirming the C-terminus is essential for enzymatic activity.  \n- The C-terminus harbors the structural elements required for substrate binding and methylation (e.g., AdoMet binding, histone interaction).  \n\nAnswer: **C-terminus**"}
{"idx": 984, "label_json": "{ \"label\": \"True\" }", "question": "Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?", "gold_answer": "BRG1", "predicted_answer": "Answer: BRG1"}
{"idx": 985, "label_json": "{ \"label\": \"True\" }", "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?", "gold_answer": "the transcribed strand", "predicted_answer": "Based on the context, transcription-coupled repair (TCR) targets the **transcribed strand** of active genes.  \n\n**Key evidence from the context:**  \n1. TCR addresses obstacles in repairing \"the transcribed strand of active genes\" due to stalled RNA polymerase.  \n2. The stalled RNA polymerase recruits repair proteins specifically to \"damage in the transcribed strand.\"  \n3. Rad26 (yeast homolog of human CSB) enables TCR, and its overexpression increases repair of \"both the transcribed and non-transcribed strands,\" confirming TCR's primary focus on the transcribed strand.  \n\nAnswer: transcribed strand"}
{"idx": 986, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Answer: Factor Xa\n\nBased on the context:\n1. The context explicitly states that rivaroxaban, apixaban, edoxaban, and betrixaban are \"direct inhibitors of factor Xa\".\n2. It further describes them collectively as \"these four oral direct factor Xa inhibitors\".\n3. Betrixaban is included in this group of drugs that directly target and inhibit clotting factor Xa"}
{"idx": 987, "label_json": "{ \"label\": \"False\" }", "question": "Which heat shock protein is found to be upregulated during Hsp90 inhibition?", "gold_answer": "HSP70", "predicted_answer": "Based solely on the provided context, the specific heat shock protein upregulated during HSP90 inhibition is **not mentioned or identified**.\n\nThe context focuses on the *effects* of HSP90 inhibition (e.g., diminished phosphorylation of Akt, Erk, STAT3; lack of impairment on liver regeneration/repair) but does not report any measurements or observations regarding the upregulation of other specific heat shock proteins like HSP70 or HSP27 in response to this inhibition. The study specifically investigates the impact on regeneration and signaling pathways, not compensatory heat shock protein expression.\n\n**Answer:** The context does not specify which heat shock protein is upregulated during HSP90 inhibition"}
{"idx": 988, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits Factor Xa.  \n\n**Answer: Factor Xa**"}
{"idx": 989, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "Xa", "predicted_answer": "Betrixaban inhibits clotting factor **Xa**.  \n\nAnswer: Factor Xa"}
{"idx": 990, "label_json": "{ \"label\": \"True\" }", "question": "The drug JTV519 is derivative of which group of chemical compounds?", "gold_answer": "1,4-benzothiazepine", "predicted_answer": "Answer: 1,4-benzothiazepine"}
{"idx": 991, "label_json": "{ \"label\": \"True\" }", "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?", "gold_answer": "NCX", "predicted_answer": "Answer: Na+/Ca2+ exchanger (NCX)"}
{"idx": 992, "label_json": "{ \"label\": \"True\" }", "question": "Which clotting factor is inhibited by betrixaban?", "gold_answer": "xa", "predicted_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: factor Xa"}
{"idx": 993, "label_json": "{ \"label\": \"True\" }", "question": "Which is the transcript responsible for X-chromosome inactivation?", "gold_answer": "Xist", "predicted_answer": "Based on the context, the transcript responsible for X-chromosome inactivation is:\n\n**Xist RNA**\n\nThe context explicitly states: \"The mechanisms by which **Xist RNA** binds and spreads along the chromosome, and initiates **Xist-mediated chromosome silencing** remain poorly understood.\" It further discusses \"Xist RNA-binding\" and \"Xist-mediated silencing.\""}
{"idx": 994, "label_json": "{ \"label\": \"True\" }", "question": "Which hormone receptor function is altered in patients with Donohue syndrome?", "gold_answer": "insulin", "predicted_answer": "The hormone receptor function altered in patients with Donohue syndrome is the **insulin receptor**.  \n\nThis is evidenced by:  \n1. The context identifies a mutation in the *INSR* gene (p.Leu795Pro), which encodes the insulin receptor.  \n2. The mutation causes severely decreased insulin receptor autophosphorylation, impairing its signaling function.  \n3. Donohue syndrome (leprechaunism) is directly linked to insulin receptor dysfunction due to *INSR* mutations.  \n\n**Answer: Insulin receptor**"}
{"idx": 995, "label_json": "{ \"label\": \"True\" }", "question": "Is the transcriptional regulator BACH1 an activator or a repressor?", "gold_answer": "repressor", "predicted_answer": "Based on the context, BACH1 is a **repressor**.\n\nKey evidence from the context:\n1.  In the absence of Bach1, ho-1 is **constitutively expressed at high levels** under normal conditions.\n2.  Bach1 and Nrf2 (an activator) have **antagonistic activities**.\n3.  The regulation involves **repressor-activator antagonism**, with Bach1 acting as the repressor.\n4.  Bach1's activity is directly regulated by heme (the substrate), analogous to the lac repressor, which is a classic repressor protein.\n\nAnswer: **repressor**"}
{"idx": 996, "label_json": "{ \"label\": \"True\" }", "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?", "gold_answer": "antiparallel", "predicted_answer": "Answer: antiparallel heterodimers"}
{"idx": 997, "label_json": "{ \"label\": \"True\" }", "question": "Which deficiency is the cause of restless leg syndrome?", "gold_answer": "iron", "predicted_answer": "Based on the provided context:\n\n**Answer: Iron deficiency**"}
{"idx": 998, "label_json": "{ \"label\": \"True\" }", "question": "What is the generic name of Gliolan?", "gold_answer": "5-aminolevulinic acid", "predicted_answer": "Based on the context, the generic name of Gliolan is **5-aminolevulinic acid** (abbreviated as **5-ALA**).  \n\n**Key evidence from the context:**  \n1. The study focuses on \"5-aminolevulinic acid\" for malignant glioma surgery.  \n2. Gliolan is a proprietary brand name for 5-aminolevulinic acid in clinical use.  \n3. The context explicitly states: \"using or not using 5-ALA\" and \"5-ALA during habitual surgical procedures.\"  \n\n**Answer: 5-aminolevulinic acid**"}
{"idx": 999, "label_json": "{ \"label\": \"True\" }", "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?", "gold_answer": "BCR-ABL", "predicted_answer": "Answer: BCR-ABL tyrosine kinase\n\n**Explanation:**  \nImatinib (Gleevec) specifically targets the **BCR-ABL tyrosine kinase**, which is the oncogenic driver of Philadelphia chromosome-positive chronic myeloid leukemia (CML). The Philadelphia chromosome results from a translocation between chromosomes 9 and 22 (t(9;22)), creating the *BCR-ABL* fusion gene that encodes this constitutively active kinase. Imatinib inhibits BCR-ABL's activity, blocking abnormal signaling and proliferation in CML cells. The context discusses dasatinib (another BCR-ABL inhibitor) for imatinib-resistant cases, reinforcing this target"}
